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Abstract 
 
 
 
The MD will primarily examine the role of surgery in the management of the wet form 
of age related macular degeneration  (AMD) and secondarily for specific inherited 
macular dystrophies. It is postulated that in the early stages of wet AMD and other 
sub-foveal disorders involving choroidal neovascular membranes (CNV), 
photoreceptor loss is relatively limited with the disease confined to the sub-foveal 
layers, namely the choriocapilliaris-Bruch membrane-retinal pigment epithelium 
(RPE) interface. 
 
 
At this stage the retina is affected functionally and reversibly but with time the 
damage becomes permanent and irreversible. As such a critical window of 
opportunity exists to: 1. Salvage function from the existing photoreceptor pool before 
fibrovascular proliferation causes marked ‘irreversible’ photoreceptor loss 2. Treat 
any visual loss that may be due to secondary and potentially ‘reversible’ factors such 
as sub-foveal fluid and haemorrhage and 3. Mechanically restore normal anatomy. 
 
 
Previous attempts at sub-macular surgery have been associated with the loss of RPE 
in the area of the CNV during removal that secondarily causes degeneration of 
photoreceptors. Consequently, different innovative surgical approaches, including 
360-degree macular translocation and full thickness autologous RPE transplantation, 
are under investigation for the management of sub-foveal CNV. The rationale of 
surgery in both techniques is to effectively restore the choriocapilliaris-Bruch’s-RPE 
interface beneath the foveal photoreceptors and rescue function before fibrovascular 
proliferation causes marked ‘irreversible’ photoreceptor loss. 
 
 
Pilot studies have been established to: 1. Examine the surgical feasibility and the 
anatomical and functional outcomes for each procedure 2. Investigate the 
pathophysiology of the underlying disease processes.  In addition, a number of 
parameters will be investigated to evaluate the quality of recovery of vision. This will 
include assessing fixation stability, reading ability, histopathological studies and 
electrophysiological correlates. 
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I Management of Age Related Macular Degeneration and 
other Macular Disease 
 
 
 
Irreversible central visual loss is the profoundly debilitating end stage of a number of 
macular diseases. The best documented, age related macular degeneration (AMD), 
is characterised by degeneration of the retinal pigment epithelium (RPE) and 
associated secondary loss of the overlying neuroretina (Bressler et al., 1994). The 
most severe form of the disease, exudative AMD, is further recognised by the 
development of the sub-foveal choroidal neovascular membrane (CNV) that 
invariably results in a rapid and marked visual loss (Green, 1999, Bressler et al., 
1992). In addition to AMD, CNV also comprises the intrinsic element when 
considering severe visual loss in pathological myopia, presumed ocular 
histoplasmosis syndrome (POHS), angiod streaks and a variety of other disorders 
(Adelberg et al., 1995, Avila et al., 1984, Lim et al., 1993, Thomas et al., 1994, 
Berger and Kaplan, 1992). 
 
 
AMD is the leading cause of severe visual impairment and legal blindness in the 
developing world among those aged over 65 (Vingerling et al., 1995, van Leeuwen et 
al., 2003a, van Leeuwen et al., 2003b, Mitchell et al., 1995, Attebo et al., 1996, Klein 
et al., 1992, Cruickshanks et al., 1997, Augood et al., 2006). The disorder is 
categorised into the non-exudative (dry) form and the exudative (wet) form. The dry 
form accounts for the majority of cases and 10% of the severe visual loss associated 
with AMD. This is attributable to geographic atrophy, a confluent loss of 
choriocapilliaris and RPE with associated loss of overlying photoreceptors. In 
contrast, 10-20% have the wet form, 90 % of which develop severe visual loss 
(Snellen visual acuity 20/200 after two years) secondary to CNV. CNV is an in growth 
of friable fenestrated new vessels from the choriocapilliaris, through Bruch’s 
membrane, and into the RPE and neurosensory retina. This results in the mechanical 
disruption of local anatomy, fluid and lipid leakage, and haemorrhage. The net effect 
is the loss of RPE, photoreceptors and eventual fibrous scarring. Over the next 20 
years as worldwide demographics shift to the right, the prevalence of AMD is 
estimated to grow by 50% with major socio-economic implications (Wang et al., 
1999b, Wang et al., 1999a, Bressler et al., 2003, Friedman et al., 2004). 
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 In addition to disorders involving CNV, there are a number of inherited macular 
dystrophies, which result in progressive bilateral macular degeneration, and 
permanent loss of central vision (Michaelides et al., 2003, Michaelides et al., 2005, 
Francis et al., 2005). Despite a wide phenotypical variation in these disorders, a 
common observation, as with AMD, is RPE degeneration accompanying the 
neuroretinal changes. However unlike AMD, it is uncertain whether the RPE changes 
are a secondary response to primary neuroretinal dysfunction, or whether RPE 
driven dysfunction results in neuroretinal degeneration. 
 
 
The purpose of interventions for wet AMD and other macular diseases is to 
significantly alter the natural history of visual loss, particularly that associated with 
sub-foveal CNV. The last few decades have been dominated initially by vaso-
destructive, and more recently by pharmacological therapies, directed against the 
final stages of the disease pathway – the CNV. A greater understanding of the role of 
the bio-molecular processes involved in normal retinal physiology and in the 
pathogenesis of retinal disease, together with the central role of the RPE in these 
pathways, has seen the emergence of cell based therapies and the concept of cell 
replacement with ‘healthy’ RPE.   
 
 
While significant advances have been made with pharmacological agents such as 
vascular endothelial growth factor (VEGF) inhibitors, there remains no treatment for 
advanced wet AMD where there is anatomical disruption of the retina, and there are 
presently no treatments available for the macular dystrophies. The challenge 
therefore is to offer cell based therapeutic interventions that not only restore structure 
and recover lost function but also offer a potential cure with improved vision that is 
both stable and longstanding. As such the development of advanced surgical 
techniques has resulted in a number of procedures, namely macular translocation 
and RPE transplantation that provide the real prospect of meeting these challenges. 
14
 
 
Therapeutic Approaches 
 
Strategies to treat AMD are primarily directed at the advanced stages of the disease 
only. Other than the small beneficial effects of vitamin and mineral supplementation 
(2001b), there is no proven therapy that prevents the development of AMD, and in 
particular CNV. As such numerous interventions have been suggested for CNV 
including pharmacological, radiation, photocoagulation, photodynamic and surgical 
therapies. To date the only proven treatments (level four evidence) to have a 
beneficial effect on the natural history of AMD are photocoagulation, photodynamic 
therapy with verteporfin dye injection (PDT) and more recently the anti-VEGF agents 
(Pegaptanib (Macugen™), Ranibizumab (Lucentis™), Avastin™ (bevacizumab)). 
 
 
Laser photocoagulation stabilises vision in sub-foveal lesions, however the treatment 
is associated with an immediate and often unacceptable loss of central vision due to 
irreversible direct damage to the retina (Group, 1991a, Group, 1991b, Group, 1994). 
PDT typically leads to CNV closure after treatment, but reperfusion commonly occurs 
after 3 months and re-treatments are often necessary. PDT is characterised by a loss 
of 15 letters of vision from baseline over the course of treatment, requiring an 
average of 5.5 treatments over two years (Group, 1999, Group, 2001a, Group, 
2001b). Both photocoagulation and PDT are beneficial in only a limited number of 
patients with CNV, and their main benefit is to lessen the risk of severe and moderate 
vision loss respectively in patients with sub-foveal CNV rather than reverse it. The 
current generation of anti-VEGF agents have shown more far more promise in 
regressing CNV and improving vision. Macugen™ was the first anti-VEGF treatment 
introduced and although superior to PDT in that it is effective in all types of 
neovascular AMD, it too was associated with a loss of vision over the course of 
treatment (broadly similar to PDT results) (Gragoudas et al., 2004). In contrast 
several recent studies support the use of both Lucentis™ and Avastin™ both of 
which are associated with an average improvement in vision ranging from 4.6 to 11 
letters (Rosenfeld et al., 2006, Brown et al., 2006, Heier et al., 2006, Regillo DC, 
2008, Avery et al., 2006, Spaide et al., 2006). The reported outcomes require regular 
re-treatments and the long-term efficacy of these agents is yet to be determined. 
Additionally, as the pathogenic theory of AMD is unraveled (see below), it is clear 
that the disease is a complex interplay of genetic susceptibility and environmental 
factors leading to the development of pathological oxidative and inflammatory 
processes occurring in the face of constant physiological cellular stress at the level of 
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the RPE. As such it is questionable if a single treatment targeted at one component 
of a vaso-inflammatory pathway can be considered to be curative. Furthermore, the 
anti-VEGF agents are unsuitable in the presence of significant sub-macular 
haemorrhage and or the gross loss of normal retinal architecture secondary to the 
disease (pigment epithelial detachments; RPE rips). Other non-surgical treatments 
such as indocyanine green (ICG) guided treatment of feeder vessels, interferon, 
radiation, and the anti-angiogenic role of steroids have proved to be ineffective or 
unproven in the treatment of sub-foveal CNV (Poliner LS, 1993, Desatnik et al., 2000, 
Marcus et al., 2004, Hart et al., 2002, Geltzer et al., 2007). 
 
 
The increasing prevalence of AMD, combined with the absence of a treatment 
modality resulting in an improvement in visual function and suitable for all lesion 
types prompted a search for alternative surgical therapies. A variety of surgical 
approaches have been developed for advanced AMD lesions including the 
pneumatic displacement of sub-macular blood and surgical removal of CNV. The 
former removes the cause of the immediate scotoma impairing vision however this 
treatment does not address the underlying pathology. In contrast, surgical removal of 
the CNV, alone, has not resulted in improved function (Bressler et al., 2000, Hawkins 
et al., 2004b, Bressler et al., 2004) and has only been shown to be of small benefit in 
patients with POHS with acuities of 20/100 or worse (Hawkins et al., 2004a). The 
poor results with this form of sub-macular surgery are attributed to the obligatory loss 
of RPE and underlying choriocapilliaris in the area of the CNV during removal of the 
membrane complex. It is the loss of the choriocapilliaris-Bruch’s-RPE axis that 
results in secondary degeneration of the overlying photoreceptors, consequently, 
different innovative surgical approaches, including macular translocation and RPE 
transplantation, have developed for the management of sub-foveal CNV. In the early 
stages of wet AMD, and other sub-foveal disorders, photoreceptor loss is relatively 
limited and visual loss may be secondary to the loss of retinal architecture from 
potentially ‘reversible’ factors such as sub-foveal fluid and haemorrhage. The 
rationale for surgical intervention with macular translocation and RPE transplantation 
is, following removal of the CNV, to effectively restore the choriocapilliaris-Bruch’s-
RPE interface beneath the foveal photoreceptors before CNV associated 
fibrovascular proliferation causes marked and ‘irreversible’ photoreceptor loss. 
 
In order to place foveal photoreceptors on an area of healthy choriocapilliaris-
Bruch’s-RPE two methods are presented. Firstly, moving the foveal photoreceptors 
16
 
 
to an area of healthy underlying RPE (macular translocation) and secondly moving 
healthy choriocapilliaris-Bruch’s-RPE and placing it under the foveal photoreceptors 
(RPE transplantation). Macular translocation can be achieved by inducing a retinal 
detachment followed by techniques involving incisions of the retina and direct retinal 
manipulation (‘full macular translocation’) or a chorioretinal shortening procedure 
(‘limited macular translocation’) in order to reposition the neurosensory retina over 
healthy tissue. RPE transplantation, by contrast, aims to remove and replace the 
diseased sub-foveal layers. This involves the removal of the CNV through a small 
retinotomy followed by replacement of the RPE (‘partial thickness transplantation’) or 
the choriocapilliaris-Bruch’s-RPE complex (‘full thickness’ transplantation) with 
autologous tissue. Both approaches re-align viable photoreceptors with healthy 
supporting tissue and provide the opportunity to treat the CNV either directly through 
removal or indirectly by the creation of an extra-foveal CNV location accessible to 
established non-surgical treatments. 
 
 
This thesis will examine these two surgical approaches used to treat sub-foveal 
macular disease, primarily in wet AMD, but also for an inherited macular dystrophy. 
Macular surgery aims to directly treat the pathology, restore normal retinal anatomy 
and function, as well as treating the secondary sight threatening complications (sub-
foveal fluid and haemorrhage). The aims are to examine the feasibility of the 
techniques, the anatomical restoration of foveal anatomy, and the functional success 
in terms of quantitative and qualitative recovery of vision. The thesis will also 
consider prospective applications of these techniques that may extend beyond the 
treatment of sub-foveal CNV with recent visual loss, to patients with early or dry 
macular degeneration, patients with macular dystrophies with associated sub-foveal 
dysfunction, the use of artificial RPE membranes, and the combined use of cell and 
gene replacement.
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II Background 
 
 
 
A Sub-Retinal Anatomy 
 
The retina is the image plane of the eye’s optical system and is the innermost of the 
three coats of the eye. It consists of two primary layers that are derived from the 
embryological inner and outer layers of the invaginated optic cup. These are, an 
inner neurosensory retina and an outer simple epithelium, the retinal pigment 
epithelium. The layers anatomically extend from their anterior termination at the ora 
serrata to the optic nerve head. Each layer is bound by its respective basal lamina, 
also derived from the embryonic optic cup. Thus, the RPE is bound on its external 
aspect by Bruch’s membrane and the neurosensory retina is bound at its internal 
aspect by the internal limiting membrane. The two layers adhere across a potential 
space that exists between them, known as the sub-retinal space. 
 
 
The neurosensory retina is the thin transparent layer of highly organised and 
metabolically active neural tissue where light stimuli are converted by photoreceptors 
(rods and cones) to neural impulses. The neural impulses are partially locally 
integrated before transmission to the occipital cortex via the ganglion cells in the 
optic nerve. The photoreceptors are located on the outer aspect of the neurosensory 
retina where their outer segments interdigitate with RPE cells. Photoreceptor density 
varies with location with the peripheral retina being rod dominated whilst the density 
of cones increases near the macula with the fovea consisting exclusively of cones.  
The neurosensory retina receives a dual blood supply, the inner two thirds is supplied 
via the retinal circulation and the outer third is supplied from the choroidal circulation 
via the choriocapilliaris and RPE. At the fovea, the inner layers of the neurosensory 
retina are laterally displaced to provide direct access to light to the outer layers 
consisting purely of cones. The foveal neurosensory retina is avascular and relies 
solely upon the choriocapilliaris for support. 
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The RPE is a continuous monolayer of hexagonally arranged epithelial cells that vary 
in size and shape depending on age and location. The basal aspect of the cells rest 
on Bruch’s membrane and their apical surfaces are characterised by apical microvilli 
that are intimately associated with photoreceptor outer segments. RPE cells have a 
low regenerative capacity and cell loss is accommodated by hyperplasia of adjacent 
cells resulting in loss of the regular hexagonal array, a typical finding in older eyes. 
The RPE performs a number of physical and biochemical functions that sub-serve 
local cellular and extracellular homeostasis and are pivotal to optimising 
photoreceptor function. Through the expression and activity of specific proteins the 
RPE maintains adhesion between the RPE layer and the neurosensory retina, 
synthesizes inter-photoreceptor matrix, forms a selectively permeable barrier 
between the choroid and neurosensory retina (part of the blood-retinal barrier), 
contributes to photoreceptor renewal by phagocytosing and degrading the spent tips 
of outer segments, absorbs excessive high-energy light and reduces light scatter 
within the eye, protects against light-generated reactive oxygen species, and aids the 
transport and storage of metabolites and vitamins. The RPE has also been shown to 
exert considerable trophic functions on the surrounding cellular matrix, 
choriocapilliaris, and neurosensory retina through the secretion of vasoactive factors 
such as pigment epithelial derived factor (PEDF) and VEGF. These factors are 
known to be critical to the pathways of inflammation and neovascularisation, both of 
which are implicated in the pathogenesis of AMD. Thus, the RPE layer occupies a 
central position, together with photoreceptors, effectively working together to facilitate 
transduction of the light stimulus and provide vision. 
 
 
The RPE rests on Bruch’s membrane, a modified connective tissue layer. Bruch’s 
membrane comprises five layers from the innermost RPE basal lamina, an inner 
collagenous zone, a middle elastic layer, an outer collagenous zone and the 
outermost basement membrane of the endothelial cells of the choriocapilliaris. 
Bruch’s membrane is located such that it behaves as a two-way conduit for nutrients 
and cellular breakdown products between the metabolically active RPE and the 
choriocapilliaris. The outermost component of what is considered sub-retinal 
anatomy, before the middle coat of the eye is encountered, is the choriocapilliaris. 
This is a rich network of capillaries that are fenestrated on their inner or retinal aspect 
and are also arranged in a hexagonal manner. As mentioned the choriocapilliaris 
provides a blood supply to the outer third of the neurosensory retina and an exclusive 
supply to the foveal photoreceptors. The choroidal circulation that forms the middle 
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vascular coat of the eye feeds the choriocapilliaris.
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B Clinico-Pathological Forms of Age Related Macular Degeneration 
 
Age related maculopathy  (ARM) is the precursor to AMD and is characterised by 
degenerative changes occurring in the central macular area. The earliest pathological 
changes involve the focal and diffuse accumulation of periodic acid-Schiff positive 
mebrano-granular and vesicular material in the inner layers of Bruch’s membrane 
(basal linear deposits – BlinD) and between the plasma membrane and basal lamina 
of the RPE (basal laminar deposit – BlamD) (Green, 1999). These early basal 
deposits are not routinely visualised on clinical examination and may only be seen in 
the late phases of angiography. With further accumulation of this material, the clinical 
hallmark of early AMD is seen in the form of the appearance of drusen. Drusen 
represent an accumulation of BlinD or a localised detachment of BlamD. They are 
histologically classified as hard (pinpoint discrete yellow-white lesions; <63µm) or soft 
(indistinct lesions, tendency to become confluent, calcified or filled with cholesterol, 
>63µm). In ARM, these accumulations do not account for significant visual loss but 
are known to affect macular function such as contrast sensitivity and spatiotemporal 
sensitivity (Sunness JS, 1988, Frennesson C, 1995, Midena E, 1997, Midena E, 
1994). 
 
 
In the presence of pathological deposits lying between the RPE and Bruch’s 
membrane, the progression to AMD is recognised by atrophy of the underlying 
choriocapilliaris (narrowing of vessel lumens and a reduction in the density of the 
vascular net) and of the overlying RPE (Bressler et al., 1994). Photoreceptors are 
metabolically dependent on RPE cells and marked apoptosis of the outer and inner 
nuclear layers of the neurosensory retina are observed with RPE atrophy (Dunaief et 
al., 2002). It is these secondary changes that occur with the disruption of the 
choriocapilliaris-Bruch’s-RPE-photoreceptor axis, which account for the visual loss in 
AMD. At this stage four main morphological forms of AMD can be identified – drusen 
and focal RPE pigmentary changes, geographic atrophy, RPE detachments, CNV 
and retinal angiomatous proliferation (RAP). Based on these clinical and 
morphological patterns, AMD is classified into a non-exudative or dry form (drusen 
and RPE pigment changes; geographic atrophy) and an exudative or wet form (RPE 
detachments; CNV and RAP lesions). 
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In the dry form of the disease, the histological changes outlined above result in the 
formation of drusen as well as focal detachments, hypo-pigmentation, and atrophy of 
the RPE. Within areas of RPE loss focal hyper-pigmentation may also occur and this 
corresponds to hypertrophy of RPE cells with clusters of pigmented cells present in 
the sub-retinal space and outer neurosensory retina. The visual loss in dry AMD is 
thought to occur due to impedance to the passage of nutrients and metabolic 
products between the choroid and the RPE, resulting in RPE atrophy and eventual 
photoreceptor loss. Geographic atrophy represents a form of dry disease 
characterised by confluent areas (>175µm) of RPE cell death with accompanying 
loss of overlying photoreceptors. It commonly occurs following the fading of drusen, 
in areas of RPE pigmentary disturbance, or after the resolution of an area of RPE 
detachment or CNV involution. Clinically, well-demarcated irregular patches of RPE 
and choriocapilliaris loss revealing the underlying choroidal blood vessels are 
observed. These changes are preceded by diffuse areas of increased auto-
fluorescence suggesting that excessive accumulation of RPE lipofuscin is associated 
with the pathogenesis of geographic atrophy (Holz et al., 2001, Einbock et al., 2005, 
Holz et al., 2007). 
 
 
In the wet form of the disease, choroidal vessels proliferate and pass through the 
thickened Bruch’s membrane towards the neurosensory retina. The new vessel 
complex or CNV may remain in a sub-RPE position, enter the RPE layer, or 
penetrate the RPE to enter the sub-retinal space. In this way CNV may cause 
detachments of the RPE, pigment modeling and RPE tears, and detachments of the 
neurosensory retina. The mechanical and metabolic disruption caused by the CNV to 
the choriocapilliaris-Bruch’s-RPE-photoreceptor axis is further exacerbated by the 
accumulation of extra-cellular fluid, lipid exudates and haemorrhage from the 
proliferating vessels. This all occurs on a background of dry pathological changes, 
resulting in an acute loss of vision as compared to the more chronic loss in the dry 
form of AMD. The end stage of this process of vascularisation is cell death and 
reactive gliosis precipitating the formation of an organised disciform scar and 
permanent visual loss (Bressler et al., 1992). Clinically, CNV appear as green-grey 
sub-retinal lesions and may be associated with sub-retinal and retinal haemorrhage, 
fluid or lipid. On angiography CNV lesions leak fluorescein and have been classified 
as either classic (discrete lesions that hyper-fluoresce early and uniformly with 
increasing intensity and extent) or occult (diffuse irregular fibrovascular RPE 
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detachments that hyper-fluoresce late and in a stippled manner or areas of late 
leakage of undetermined origin). 
 
 
RPE detachments are associated with soft drusen coalescing to form overlying 
serous detachments of the RPE and with exudation from sub-RPE CNV (Lafaut et 
al., 2001). Clinically RPE detachments are observed as uniform elevated lesions that 
on angiography have well demarcated borders and fill uniformly with increasing 
intensity. Large and elevated RPE detachments can induce significant tangential 
stress on the RPE leading to rupture. RPE rupture can be clearly observed as linear 
breaks with the RPE recoiling under the neurosensory retina, due to its elastic 
properties, to leave large areas of photoreceptors devoid of RPE support. Vision loss 
in RPE detachment and rupture occurs due to the mechanical disruption of the 
choriocapilliaris-Bruch’s-RPE-photoreceptor axis resulting in metabolic failure of the 
RPE or a complete absence of RPE photoreceptor support. 
 
 
RAP lesions are identified as a unique variant of wet AMD that represent new vessel 
formation extending from the neurosensory retina to the choroid. In contrast to CNV, 
RAP lesions are thought to originate as capillary proliferation in the neurosensory 
retina, extending into the sub-retinal space to either terminate as CNV lesions or to 
form retinal-choroidal anastomosis (Yannuzzi et al., 2001, Lafaut et al., 2000). There 
is however a lack of sequential histological evidence to confirm the intra-retinal 
versus choroidal origin of these lesions and recent studies suggest a choroidal origin 
for the neovascular complex with the early formation of a retinal choroidal 
anastomosis without evidence of underlying occult neovascularisation (Freund et al., 
2008, Yannuzzi et al., 2008). Clinically these vessels are associated with 
telangectasia, micro-aneurysms and intra-retinal haemorrhages in the early and 
intermediate stages, and vascularised RPE detachments in the late stages. 
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C Pathogenic Theory of Age Related Macular Degeneration 
 
AMD is a degenerative disorder of the choriocapilliaris-Bruch’s-RPE-photoreceptor 
axis at the central macular area. The hallmark of the disease is the focal and diffuse 
thickening of Bruch’s membrane. In the dry disease this is associated with 
dysfunction, atrophy and loss of the choriocapilliaris and RPE, and in the wet disease 
the development of CNV. While the clinical features of the disease are well 
documented, the exact aetiology, the primary locus of the insult, and the 
pathogenesis remain in dispute.  While certain macular diseases have been 
attributed to specific gene defects, e.g. Leber’s congenital amarousis and the gene 
RPE65 (Acland et al., 2001, Narfstrom et al., 2003), the majority, including AMD, are 
a complex interplay of several genes and an accumulation of environmental insults. 
 
 
 
The Bruch’s-RPE-Photoreceptor Axis 
 
Visual function is dependent upon an intact and healthy Bruch’s-RPE-photoreceptor 
axis and the progressive disruption of this arrangement is observed from the very 
early to the late stages of AMD. In ARM, thickening of Bruch’s membrane is clearly 
observed and it has been postulated that this impedes the flow of nutrients to and 
metabolites away from the RPE and photoreceptors. Under these circumstances 
RPE and photoreceptors have to function under sub-optimal conditions and are 
placed under ever increasing stress. It is possible to envisage how such a scenario 
could result in subsequent disease progression. The stimulus to these early changes 
remains unknown. Foveal photoreceptors are implicated, as the disease is 
predominately localised to the central macular region of the retina. Much attention 
has also been centred on the RPE, as it is considered pivotal for maintaining optimal 
photoreceptor structure and function (Marshall, 1987, Boulton and Dayhaw-Barker, 
2001). 
 
 
RPE is a highly metabolically active tissue that is subject to an array of direct 
environmental insults (light exposure, smoking, oxidative stress). RPE is placed 
under significant metabolic stress from the repeated removal and turnover of 
photoreceptor outer segments. This function results in the progressive cellular 
accumulation of a number of oxidised and phototoxic products, such as the lipid-
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protein aggregate lipofuscin, throughout life. The combination of genetic susceptibility 
and cumulative environmental damage to the RPE is thought to lead to the 
abnormalities observed in the choriocapilliaris-Bruch’s-RPE-photoreceptor interface 
in AMD. 
 
 
The RPE is a post-mitotic structure that varies in morphology, density and function 
across the retina (Panda-Jonas et al., 1996). With increasing age the RPE 
undergoes a number of irreversible structural and functional changes, particularly at 
the posterior pole. These include changes in RPE morphology (loss of cell shape, 
RPE multi-layering, atrophy, reduction in cell density and secondary increase in cell 
diameter), RPE pigmentation (increase in lipofuscin, hyper-pigmentation, decrease in 
melanosomes), accumulation of advanced glycation end products, reduction in RPE 
antioxidant systems, and molecular damage to RPE cells (mitochondrial/DNA 
damage, protein cross-linking). These changes are known to compromise RPE 
function and lead to pathological damage requiring intervention. 
 
 
 
Role of Oxidative Stress 
 
Repeated and prolonged exposure to oxidants is a feature of a number of chronic 
age-related diseases including atherosclerosis, neoplasia, and AMD (Winkler et al., 
1999, Beatty et al., 2000). The retina is particularly susceptible due to the elevated 
levels of polyunsaturated fats, high oxygen demand, and chronic light exposure of 
the photoreceptors and RPE. Oxidative stress occurs when the normal physiological 
production of reactive oxygen species (superoxide anion, hydroxyl radical, hydrogen 
peroxide) shifts towards the oxidative components. In this situation, the excess 
oxygen species impair cellular function by disrupting lipid membranes, surface 
proteins and DNA. This is particularly apparent in the RPE, which plays a pivotal role 
in photoreceptor homeostasis by the repeated removal and turnover of photoreceptor 
outer segments. The outer segments are endocytosed on the apical side of the RPE, 
processed via phagolysosomes, and the degraded material exocytosed on the basal 
side. Thus RPE cells are placed under constant and significant metabolic stress. The 
accumulation of oxidised outer segments inhibits the function of the phagolysosomes 
(Kaemmerer et al., 2007) and results in the progressive cellular accumulation of a 
number of oxidised and phototoxic products, such as the lipid-protein aggregate 
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lipofuscin, throughout life. These changes have demonstrated in the macular region 
of ageing eyes and those with AMD (Suzuki et al., 2007). 
 
 
Recently, the candidate gene approach has also yielded the identification of a locus 
on chromosome 10 containing three tightly linked genes associated with AMD. Of 
these genes, the age-related maculopathy2 (ARMS2) gene mutation results in 
reduced levels of ARMS2 mRNA, which codes for a protein that appears to have a 
functional role in mitochondrial homeostasis (Fritsche et al., 2008). Mitochondrial 
dysfunction is known to be associated with abnormalities in cellular energy supply, 
generation of reactive oxygen species, and in the initiation of the apoptotic process. 
These are all concepts that have been associated with the pathogenesis of AMD. 
Given the extremely high-energy demands of retinal tissue, the ARMS2 mutation 
serves to provide a link between a primary genetic mutation and degeneration of the 
retina. 
 
 
A number of factors affect the oxidative state of the macular region including 
protective antioxidant mechanisms such as the presence of the macular pigments: 
leutin (fovea) and zeaxanthine (para-fovea). These pigments absorb light at 460nm 
and so reduce the exposure of the photoreceptors to blue light phototoxicity. Thus 
reduced levels of macular pigment may contribute to the pathogenesis of AMD. 
 
 
Other antioxidant mechanisms include the presence of the cellular enzymes 
superoxide dismutase, mitochondrial manganese superoxide dismutase, and copper-
zinc superoxide dismutase. These enzyme systems function to compartmentalise 
and convert oxygen species into less harmful entities. A number of other molecules 
(ß-carotene, vitamins C and E) have a similar role and operate by scavenging 
oxygen species. These mechanisms have formed the basis of the AREDS 
formulation of dietary antioxidant supplementation that have demonstrated marked 
reductions in the progression of certain subtypes of AMD with modest reductions in 
the overall progression of AMD (2001b). 
 
 
Several studies have also clearly established smoking as a risk factor for AMD 
(Smith et al., 1996, Christen et al., 1996, Vingerling et al., 1996, van Leeuwen et al., 
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2003a, Khan et al., 2006b, Chakravarthy et al., 2007). Smoking is a pro-inflammatory 
activity and so in relation to retinal oxidative stress, promotes the formation of 
reactive oxygen species. Nicotine has been shown to activate retinal phopholipase 
A2, an enzyme that triggers the arachadonic acid inflammatory cascade (Sastry and 
Hemontolor, 1998) and tar contains the pro-oxidant hydroquinone. Hydroquinone has 
also been shown to reduce extracellular matrix turnover and result in sub-RPE 
deposits in a murine model (Marin-Castano et al., 2006). Smoking is also associated 
with lower levels of macular pigments (Nolan et al., 2007). 
 
 
 
Role of Inflammation 
 
The role of inflammation and the immune system has been closely implicated in the 
pathogenesis of AMD from the thickening of Bruch’s membrane, to the formation of 
drusen, and the development of CNV (Johnson et al., 2001, Hageman et al., 2001, 
Sivaprasad and Chong, 2006). Recent studies have confirmed a strong genetic 
component to AMD, with a genetic defect identified in up to three quarters of cases 
with several genes identified as having a large effect (Lotery and Trump, 2007). 
Using a ‘candidate gene’ approach, a number of studies have confirmed an 
association between inflammatory pathways, the immune system, and the risk of 
AMD. The best-documented example is the complement factor H (CFH) gene 
mutation on chromosome 1, identifying a Tyrosine – Histidine substitution at amino 
acid 402 (Y402H Polymorphism) (Edwards et al., 2005, Hageman et al., 2005, Klein 
et al., 2005). 
The complement system constitutes part of the innate immune defence and consists 
of up to thirty serum proteins that are activated by a classic (antibody binding 
stimulus) or alternate (pathogenic stimulus/cellular debris) pathway. Each pathway 
converges to produce activated C3 products that result in anaphylaxis (C3a), cell 
opsonisation that further enhances antibody binding and phagocytosis (C3b), and 
eventual target cell lysis through formation of porous membrane channels 
(membrane attack complex). 
 
 
CFH is a protein that regulates the activation of the complement cascade. Within the 
retina, CFH is produced by RPE cells and has also been localised to the choroid, 
Bruch’s membrane and the inter-photoreceptor matrix (Chen et al., 2007). CFH 
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functions to inhibit the activation of C3 and protects membranes against damage by 
activated complement. Using a CFH deficient homozygote murine model, the 
complete absence of CFH has been shown to result in the thinning of Bruch’s 
membrane, accumulation of complement C3 in the retina, altered RPE organelle 
physiology, and disorganization of photoreceptor end segments (Coffey et al., 2007). 
In population studies of AMD, the presence of the Y402H polymorphism allele in the 
gene encoding CFH is associated with a 2.7 fold increase in the risk of AMD (also 
accounting for up to 50% of the attributable risk of AMD), and this increases to a 7.4 
in homozygotes (Edwards et al., 2005, Hageman et al., 2005, Klein et al., 2005). 
When considering the effect of smoking, the Y402H polymorphism confers a relative 
risk for late AMD of 34.0 as compared to non-smokers without this polymorphism 
(Despriet et al., 2006). Furthermore, chronic exposure of RPE cells to oxidised 
photoreceptor segments down regulates the production of CFH, as do the pro-
inflammatory cytokines tumour necrosis factor-alpha and interleukin-6 (Chen et al., 
2007). 
 
 
Other complement factors implicated in AMD include complement component 2 (C2) 
and factor B (BF). As with CFH, these factors have been associated with conferring a 
degree of protection, with their absence predisposing individuals to AMD (Gold et al., 
2006). 
 
 
The exact role of complement and the Y402H polymorphism in the development of 
AMD remains undetermined. Clearly there are both genetic and environmental 
stimulators of the complement cascade which operate both at a local and systemic. 
Systemic activation of complement may combine with an altered response of the 
RPE to cellular injury, suggesting that AMD may be considered a systemic disease 
with the retina behaving as a vulnerable end organ. In this respect a number of 
studies have demonstrated elevated levels of systemic inflammatory biomarkers, 
such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) in AMD 
(Seddon et al., 2005). In addition, AMD has been shown to share common risk 
factors with atherosclerosis and Bruch’s membrane has been compared to a 
specialised vessel wall, with the macular region being a particularly vulnerable site 
(Sivaprasad et al., 2005). Conversely, local dysregulation of the complement 
cascade within Bruch’s membrane and the RPE may establish a situation where, in 
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the face of prolonged physiological stress, modified by pathological oxidative 
processes, chronic local inflammation contributes to disease progression. 
 
 
 
Role of Hypoxia and Angiogenesis 
 
Exudative AMD is characterised by CNV formation, to which angiogenesis is integral. 
Chronic hypoxia and inflammation have both been postulated as mechanisms for 
initiating the choroidal neovascular response, although a close interplay of both 
processes is the most probable scenario. Under conditions where there is thickening 
of Bruch’s membrane, together with the associated dysfunction and loss of the 
choriocapilliaris and RPE, localized hypoxia can be easily envisaged. It is well 
established that the final common pathway in angiogenesis is driven by VEGF and 
this molecule is produced in response to hypoxia associated with the RPE, the 
neurosensory retina and CNV (Gottsch et al., 1990, Shima et al., 1995). Inhibition of 
this molecule has been used to considerable therapeutic effect in exudative AMD 
(Gragoudas et al., 2004, Rosenfeld et al., 2006, Brown et al., 2006, Heier et al., 
2006, Regillo DC, 2008). While currents medical agents are antibodies or aptamers 
directed against VEGF to prevent interaction with the VEGF receptor, alternate 
therapies under investigation include interfering with the expression of VEGF mRNA, 
VEGF traps (synthetic molecules with a high binding affinity for VEGF), and agents 
directed against signal transduction post-VEGF receptor activation.  
 
 
 
Environmental Factors 
 
Environmental factors are also important in the development of AMD, with smoking 
(Christen et al., 1996, Smith et al., 1996, Vingerling et al., 1996, Khan et al., 2006b, 
Chakravarthy et al., 2007), obesity (Cho et al., 2001) and a poor diet (2001a) 
identified as significant risk factors for the disease. As mentioned atherosclerosis and 
AMD share common risk factors, and the roles of smoking and diet have been 
discussed above with respect to oxidative stress and inflammation. The exact role of 
dietary fats is still unclear and is the subject of current investigations including the 
AREDS II study. Chronic light exposure has also been suggested as a risk factor for 
AMD (Mitchell et al., 1998, Khan et al., 2006a) and is known to increase the risk of 
cataract formation. Cataracts may confer natural protection to AMD, however with 
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progress in cataract surgery, it remains to be seen whether this intervention will add 
to the threat of AMD, especially in at risk groups (Margrain et al., 2004). 
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D Natural History of Neovascular Age Related Macular Degeneration 
 
A number of studies have investigated the natural history of neovascular AMD in 
order to establish the relationship between disease presentation and progression and 
visual loss. An examination of natural history also provides valuable information on 
the influence of disease subtype, the optimal timing for intervention, a risk-benefit 
analysis for different treatment modalities, and the efficacy of new treatments. 
 
 
The macular photocoagulation study (MPS) represented the first randomised clinical 
trial for the evaluation of treatments for AMD. MPS data revealed that over 5 years 
the majority of eyes lost vision if untreated. Severe visual loss (loss of 6 lines or more 
of acuity) occurred in 65% of eyes with an initial acuity of 20/100 and a sub-foveal 
CNV. In terms of treatment, MPS demonstrated favourable outcomes with thermal 
laser photocoagulation only in a small proportion of eyes with small well de-lineated 
(classic) extra-foveal and juxta-foveal lesions. Eyes with sub-foveal CNV suffered 
severe and immediate vision loss secondary to the direct effect of the treatment 
modality (Group, 1991a, Group, 1991b, Group, 1994).  
 
 
The next advance in treatment for neovascular AMD was PDT and the subsequent 
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) 
study examined both the efficacy of the treatment as well as the natural history of 
AMD. The introduction of PDT for the treatment of neovascular AMD resulted in the 
classification of CNV based on angiographic appearances as either 
classic/predominantly classic (40%) or minimally classic/occult (60%). The TAP study 
found the benefits of PDT (a loss of 15 letters or less from baseline) were limited to 
classic CNV subtypes. The control arm of the TAP study further eluded to the natural 
history of neovascular AMD and demonstrated that after 2 years severe visual loss 
occurred in 36% of eyes and 67.5% of eyes had a vision of 20/200 or worse (Group, 
1999, Group, 2001a, Group, 2001b). 
 
 
The present generation of anti-VEGF agents appear to be effective across the 
various angiographic subtypes of CNV. The first such agent, Macugen™, was found 
in the VEGF Inhibition in Ocular Neovascularisation (VISION) trials to be broadly 
similar in outcome to PDT. The control arm of the VISION study further corroborated 
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the findings of previous studies and reported a rapid 3.5 line loss of vision at 12 
months of follow up with 55% of eyes having a vision of 20/200 or worse 
(Chakravarthy et al., 2006, Gragoudas et al., 2004). The anti VEGF Lucentis™ 
superseded treatment with Macugen™ as it represented the first intervention to offer 
improved vision as an endpoint rather than stabilisation or limitation of the degree of 
visual loss. The natural history arm of the first trial to report outcomes with 
Lucentis™, the Minimally classic/occult trial of the Anti-VEGF antibody Ranibizumab 
In the treatment of Neovascular AMD (MARINA) study reported a 2.5 line loss of 
vision at 12 months with severe visual loss occurring in 14.3% of eyes and 42.9% of 
eyes having a vision of 20/200 or worse. Similarly at 2 years the MARINA study 
reported severe visual loss in 22.7% of eyes in the control group with 47.9% of eyes 
having a vision of 20/200 or worse (Rosenfeld et al., 2006). 
 
 
The studies of the untreated natural history of vision in neovascular AMD (Table 1) 
strongly suggest that following the onset of disease there is a rapid progression to 
severe loss of central vision. Most recently a meta analysis of studies of the natural 
history and prognosis of neovascular AMD reported an average loss of between 1 
and 3 lines of acuity at 3 months, 3 and 4 lines at 12 months and an increasing 
proportion losing more than 6 lines over time (Wong et al., 2008). Although the 
analysis found few studies to extend beyond 2 years, it further confirmed that if 
untreated the prognosis in neovascular AMD is very poor. 
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Table 1 Natural History for Neovascular AMD 
 
 
Treatment Modality 
Anti-VEGF 
 
Thermal 
Laser PDT 
Macugen™ Lucentis™ 
 
Study 
 
MPS * TAP ** VISION ** MARINA ** 
 
Year 
 
1994 2001 2004 2006 
 
Severe 
Loss of 
Vision † 
 
65 % 36.0 % NR 22.7 % 
 
Visual 
Acuity 
20/200 
or Worse 
 
NR 67.5 % 55.0 % 47.9 % 
 
PDT  Photodynamic Therapy 
VEGF  Vascular Endothelial Growth Factor 
MPS  The Macular Photocoagulation Study (Group, 1994, Group, 1991b, Group, 
1991a) 
TAP  Treatment of AMD with Photodynamic Therapy (Group, 2001a, Group, 1999) 
VISION  VEGF Inhibition in Ocular Neovascularisation (Chakravarthy et al., 2006) 
MARINA Minimally classic/occult trial of the Anti-VEGF antibody Ranibizumab In the 
treatment of Neovascular AMD (Rosenfeld et al., 2006) 
NR    Data Not Reported  
*    5-Year Follow Up 
**   2-Year Follow Up 
†   Greater Than 6 Lines Lost on Visual Acuity Chart 
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III Surgical Approaches 
 
 
 
A Surgical Principles 
 
The rationale for macular surgery is to treat sub-foveal pathology and restore the 
retinal anatomy to a physiological state. Ideally any intervention must occur prior to 
the onset of significant irreversible photoreceptor loss and with minimal collateral 
surgical trauma. As previously described, the pathogenesis of CNV and the 
associated changes (fluid, exudates, haemorrhage, fibrosis) are intimately associated 
with the sub-retinal structures. Therefore the physical removal of a sub-retinal lesion 
invariably results in the creation of a defect in the choriocapilliaris-Bruch’s-RPE axis 
(Thomas et al., 1992, Grossniklaus and Gass, 1998, Grossniklaus and Green, 1998). 
Intuitively then to recover function will necessitate a return to a more normal retinal 
structure. Several approaches have been undertaken and these can broadly be 
classified into sub-macular surgery for the removal of haemorrhage and CNV, 
macular translocation, and RPE transplantation. 
 
 
Sub-macular surgery primarily treats only the sub-foveal lesion and no attempt is 
made to reinstate the retinal architecture. This approach requires limited access to 
the sub-retinal space to directly remove CNV or haemorrhage. In contrast, the 
primary aim of macular translocation and RPE transplantation is to not only directly 
treat CNV but also to re-establish the choriocapilliaris-Bruch’s-RPE-photoreceptor 
complex. Each of these approaches requires the physical separation of functional 
neurosensory retina away from the underlying pathology, removal of CNV and 
haemorrhage, and restoration of the sub-retinal layers. Thus both techniques require 
a planned retinal detachment and reattachment. 
 
 
In macular translocation, restoration of the sub-retinal anatomy is achieved by 
displacing the neurosensory retina relative to the underlying sclera, choroid, RPE and 
sub-foveal lesion. In comparison, a number of approaches to RPE transplantation 
have been attempted to re-establish the sub-retinal layers. These include sub-retinal 
injections of cell suspensions derived from autologous RPE, iris pigment epithelium 
and experimental modified RPE, and autologous small macular RPE rotational 
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patches. More recently, RPE transplantation has involved replacement of the sub-
retinal defect, with a partial or full thickness choroidal-RPE graft. In the following sub-
sections, each of these approaches will be reviewed further. 
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B Sub-Macular Surgery 
 
With advances in vitreo-retinal surgical techniques a number of strategies developed 
to treat advanced neovascular AMD not amenable to medical treatment. Early 
treatments ranged from intra-operative lysis of CNV feeder vessels, to the pneumatic 
displacement or surgical removal of sub-retinal haemorrhage, and sub-macular 
membranectomy to remove CNV. These initial investigations developed into the sub-
macular surgical trials (SST), a series of prospective randomised controlled trials 
designed to establish whether membranectomy or removal of haemorrhage would 
either stabilise or provide some improvement over the natural history of neovascular 
AMD. The SST Group N and Group B trials evaluated the role of surgical removal of 
CNV and haemorrhage in neovascular AMD (Hawkins et al., 2004b, Bressler et al., 
2004). 
 
 
 
Sub-Macular Haemorrhage 
 
Sub-macular haemorrhage is known to have a very poor prognosis in neovascular 
AMD (Berrocal et al., 1996, Bennett et al., 1990). Sub-retinal haemorrhage results in 
an immediate central scotoma related to the size of the bleed, however the blood has 
a number of additional deleterious effects. These include a direct toxic effect of iron 
liberated from the blood on the choriocapilliaris, mechanical damage to photoreceptor 
outer segments from traction due to fibrin contraction, and reduced photoreceptor 
metabolism secondary to the blood uncoupling the photoreceptors from the RPE and 
acting as a diffusion barrier (Glatt and Machemer, 1982, Toth et al., 1991). 
 
 
A number of techniques for the management of sub-macular haemorrhage have 
been evaluated without removal of concomitant CNV. Reports have described 
pneumatic displacement of sub-retinal blood away from the fovea using intra-vitreal 
gas or air and prone posturing with or without intra-vitreal recombinant tissue 
plasminogen activator (r-TPA) to lyse the sub-retinal clot (Hesse et al., 1999, Hassan 
et al., 1999, Hattenbach et al., 2001, Handwerger et al., 2001).  Alternate techniques 
describe a pars plana vitrectomy (PPV) followed by either sub-retinal injection of r-
TPA (Haupert et al., 2001, Olivier et al., 2004) or the creation of a posterior 
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retinotomy with direct mechanical clot extraction (with or without r-TPA) prior to gas 
exchange and posturing (Ibanez et al., 1995). 
 
 
Most of these reports have been small case series with short follow up and poor 
visual outcomes despite reasonable success in anatomical clearance of 
haemorrhage (Table 2). While the displacement of the clot away from the fovea has 
obvious advantages, crucially the underlying pathology remains untreated. 
Furthermore the procedure requires swift intervention from onset of haemorrhage 
and subsequent medical intervention to prevent further disease progression – the 
most commonly cited cause for a failure to significantly improve vision. Additionally 
the use of intra-vitreal r-TPA was also questioned due to low penetrance into the sub-
retinal layer and reports of retinal toxicity above 25µg/0.1ml (Johnson et al., 1990). 
 
 
 
Sub-Macular CNV 
 
de Juan and Machemer were the first to report sub-macular surgery for CNV 
and sub-retinal haemorrhage (de Juan and Machemer, 1988). They described 
a technique involving a PPV, creation of a posterior retinotomy, infusion of 
balanced salt solution and removal of the CNV. Intraocular bleeding was 
controlled with raised irrigation pressures or heavy perfluorocarbon liquid. A 
complete gas exchange with prone posturing completed the procedure. Their 
pilot study of 4 patients confirmed the surgical technique and resulted in 
improvement in vision in 3 of the patients. The technique was adopted for the 
SST for the treatment of CNV.
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SST Group N Trial 
 
The Group N trial treated patients with large sub-foveal CNV lesions, secondary to 
neovascular AMD, ineligible for treatment under MPS guidelines on the basis that 
surgical removal of the CNV would halt or delay foveal photoreceptor loss and hence 
result in improved vision. 454 patients were randomised to the surgical (226) or 
control (228) arm of the trial and followed up for at least 2 years. No statistical 
difference in measured visual parameters was observed between the groups at any 
time after 3 months of follow up (Hawkins et al., 2004b).  
 
 
 
SST Group B Trial 
 
The Group B trial examined CNV removal and evacuation of sub-retinal 
haemorrhage in patients with predominately haemorrhagic AMD lesions. The 
premise of the trial was that removal of blood and CNV would halt or delay macular 
damage from such lesions leaving a smaller affected area and hence better vision. 
Use of r-TPA to assist clot removal was left to the discretion of the surgeon. 336 
patients were randomised to the surgical (168) or control (168) arm of the trial and 
followed up for 2 years. The trial found no benefit to surgery except for a small 
reduction in severe visual loss in patients with an initial acuity of 20/100-10/160. 
Surgery was not recommended as the probability of stable or improved vision was no 
different to that for the entire surgical group and the complication rate for surgery was 
considerable (Bressler et al., 2004). 
 
 
The attempts in the aforementioned studies to remove CNV and haemorrhage 
revealed that membranectomy and removal of blood resulted in associated loss of 
the sub-retinal structures and without these structures visual recovery would 
ultimately be limited. Histopathological specimens of extracted CNV secondary to 
AMD frequently have a sub-RPE and RPE component (Thomas et al., 1992, Thomas 
et al., 1994, Grossniklaus and Gass, 1998, Grossniklaus and Green, 1998). In the 
SST, 84% of excised CNV demonstrated RPE involvement. Clearly without RPE the 
choriocapilliaris as well as the photoreceptors are lost and visual recovery is severely 
compromised. Thus anatomical restoration is a pre-requisite of functional recovery, 
given that under disease conditions a critical pool of viable photoreceptors still exists. 
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To recover lost function and address this problem novel surgical techniques such as 
macular translocation and RPE transplantation were proposed and developed. 
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C Macular Translocation 
 
 
 
1 Strategies 
 
Macular translocation has been defined as any surgery that has the primary goal of 
relocating the central neurosensory retina or fovea intra- or post-operatively 
specifically for the management of macular disease (Au Eong, 2001). Several 
treatment strategies have been developed to reposition the foveal photoreceptors to 
an area of intact choriocapilliaris-Bruch membrane-RPE. In so doing macular 
translocation effectively converts a sub-foveal lesion to a juxta- (1-199µm from foveal 
centre) or an extra- (>200µm from the foveal centre) foveal lesion that can be treated 
with more conventional treatments. Alternatively, macular translocation may be 
combined with sub-macular surgery, in which case the fovea is located to an area 
outside the RPE defect that commonly results from the removal of CNV. 
 
 
The techniques of macular translocation were originally classified according to the 
size of the surgical retinotomy / retinotomies required (Au Eong, 2001). The two main 
approaches are: 
 
I Macular Translocation with Large Curvilinear Retinal Incision 
 
 
This technique was further sub-classified into: 
 
 Macular Translocation with 360-degree Circumferential Retinotomy 
(MT360) 
or Full Macular Translocation 
 
 Macular Translocation with Large but Less Than 360-degree 
Retinotomy 
 
The mechanism of translocation involved the freeing of the retina from its 
anterior attachment via a large or 360-degree retinotomy after the creation of 
a segmental or complete retinal detachment. This technique allowed the 
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macula or entire retina respectively to pivot around the optic disc and so 
reposition the fovea.    
 
 
II Macular Translocation with Punctate or No Retinotomy 
 or Limited Macular Translocation (LMT) 
 
 This technique was further sub-classified into: 
 
 LMT with Chorioscleral Shortening 
 
 LMT without Chorioscleral Shortening 
 
The mechanism of translocation involved the creation of redundancy of the 
retina through chorioscleral shortening following a localised retinal 
detachment. Chorioscleral shortening may be achieved through either 
chorioscleral infolding/imbrication or outfolding/outpouching. The redundant 
retina is subsequently displaced relative to the sclera, choroid and RPE. With 
infolding the retina drapes over the infolded eye wall, whereas in outfolding 
the internal surface of the eye wall is reduced. 
 
 
An alternate method of creating retinal redundancy without chorioscleral 
shortening is achieved through stretching of the retina during the formation of 
a localised retinal detachment. Subsequent post-operative upright head 
posturing allows the buoyancy of an intra-vitreal gas bubble to support the 
superior retina while the sub-retinal fluid used to create the detachment 
stretches the redundant retina downwards (de Juan and Vander, 1999). 
 
Translocation may result in foveal displacement inferiorly, superiorly, or nasally 
depending on the lesion characteristics (see below) and the technique employed. 
Temporal displacement is effectively not possible due to the attachment of the 
papillomacular bundle at the optic disc. The terms retinal or macular rotation applies 
only to procedures in which anterior retinal attachments are freed and the entire 
retina or macula is rotated around the optic disc i.e. translocation with large 
curvilinear incisions of the retina. In all other forms of macular translocation the retina 
remains intact and is effectively displaced rather than rotated. 
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Any procedure, which successfully relocates the fovea to an area outside the 
margins of a sub-foveal lesion, is termed ‘effective macular translocation’. The lesion 
size, shape and eccentricity are of less importance as the crucial determinant in 
achieving effective translocation is the distance between the foveal centre and the 
inferior or superior border of the lesion (with all points being equidistant from the 
temporal margin of the disc – the point of pivot) (Kubota et al., 2001). This is referred 
to as the ‘minimum desired translocation’.  While this is conceptually the smallest 
foveal displacement to achieve effective translocation, in practice a larger 
translocation is preferred. The advantages of the fovea being sited well away from 
the original lesion include ensuring the underlying choriocapilliaris-Bruch membrane-
RPE are healthy/disease free, lessening the chances foveal involvement in cases of 
recurrence, and reducing the risk of collateral damage during further treatments to 
the original lesion. However, large post-operative displacements are also associated 
with complications such as intractable diplopia/cyclotropia. In addition, there is very 
little evidence base for the effectiveness of extra-macular choroid and RPE in 
suitably maintaining long-term foveal function. 
 
 
2 Techniques of Retinal Displacement 
 
The two most common techniques of macular translocation employed are full macular 
translocation with 360-degree retinotomy (MT360), as based on the model first described by 
Machemer and Steinhorst (Machemer R, 1993a, Machemer R, 1993b) and to lesser extent, 
limited macular translocation (LMT), as described by De Juan and associates (de Juan et al., 
1998, Imai et al., 1998). The concept of retinal relocation was first proposed by Lindsey et al 
(1983) (Lindsey et al., 1983) with successful shifting of the retina in rabbits and primates. 
Tideman et al (1985) (Tiedeman et al., 1985) later reported successful 45º rotation of the 
retina employing a technique involving segmental retinal detachment, a relaxing retinotomy, 
gas-fluid exchanges, retinal tacking, and silicone oil tamponade. This procedure was however 
complicated by proliferative vitreoretinopathy (PVR) and subsequent retinal detachment.  
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Macular Translocation with Full 360-degree Retinotomy  
 
Almost a decade later Machemer and Steinhorst (Machemer R, 1993a) developed an 
animal model for translocation which was then modified for a pilot human study of 
three patients (Machemer R, 1993b) (Table 3). The original procedure involved the 
following steps: 1 vitrectomy with lensectomy, 2 creation of a complete retinal 
detachment, 3 360-degree retinotomy, 4 retinal rotation and reattachment.  Retinal 
separation from the RPE was achieved by means of an infusion of lactated Ringer’s 
solution into the sub-retinal space, accessed via a transscleral approach. A 360-
degree peripheral retinotomy was then performed and the retina stabilised with a 
fluid-air exchange prior to retinal rotation. Rotation was achieved through repeated 
gentle stroking movements of the retina and the application of suction to the 
periphery in a tangential direction. Finally the retina was reattached with gas 
tamponade. The study not only demonstrated the feasibility of the technique but also 
confirmed through microscopic findings the restoration of the RPE-photoreceptor 
complex. 
 
For the subsequent human study the technique was modified with the additional 
steps of removal of sub-retinal blood and membranes after retinotomy, stabilisation of 
the retina with perfluorocarbon prior to retinal rotation, retinal reattachment by 
photocoagulation of the retinotomy edge and tamponade with silicone oil. In this 
preliminary study PVR with retinal detachment developed in two of the three patients 
resulting in poor visual outcomes. A third patient improved vision from 1/200 to 20/80, 
however at the cost of image tilt, diplopia and cyclotropia (Machemer R, 1993b). 
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Macular Translocation with Partial Retinotomy 
 
To reduce the problem of poor visual outcomes associated with PVR and retinal 
detachment Ninomiya et al (1996) (Ninomiya Y, 1996) performed macular 
translocation with a smaller 180º flap retinotomy (Table 3). In this technique following 
vitrectomy ± lensectomy, a segmental retinal detachment was created with a sodium 
hyaluronate infusion. The retina was pre-treated with endodiathermy along the 
planned incision line that extended circumferentially from the superotemporal to the 
inferotemporal arcade, half way between the optic disc and equator. The pre-treated 
retina was cut and an 180º retinal flap elevated and reflected back to allow removal 
of CNV. The flap was unfolded with a fluid-air exchange and rotated with suction to 
the inferior edge in an inferonasal direction. This created an inferotemporal radial fold 
of redundant retina and a superotemporal strip of bare RPE. Following drainage of 
sub-retinal fluid by repeated aspiration, photocoagulation was placed along the 
retinotomy edge and silicone oil tamponade applied. In this pilot study of three 
patients, two patients achieved vision of 20/20 and 20/70 respectively, however the 
technique was also complicated by PVR and detachment. In addition the temporal 
retinotomy and area of bare RPE remaining after rotation resulted in nasal field loss 
in all patients and neovascular glaucoma in one case. To date three further studies 
performed translocation with a smaller flap retinotomy, and Table 4 summarises the 
visual outcomes and complications of this modification to MT360.    
 
 
Limited Macular Translocation with Chorioscleral Shortening 
 
To address the complications of macular translocation as described above (PVR, 
detachment, image tilt, diplopia, cyclotropia) a technique of retinal displacement 
avoiding large retinotomies was developed using an animal model by Imai et al 
(1998) employing chorioscleral shortening with infolding (Imai et al., 1998). The 
procedure involved the following steps: 1 partial scleral resection, 2 vitrectomy, 3 
sub-total retinal detachment, 4 chorioscleral shortening, and 5 retinal reattachment. 
The scleral resection was crescenteric in shape, parallel to the limbus, located 
circumferentially in the superotemporal quadrant, and of partial (75%) thickness. A 
sub-total/temporal retinal detachment was created via transscleral retinal 
hydrodissection with an infusion of lactated Ringer’s solution and chorioscleral 
shortening was achieved by suturing together the edges of the dissected scleral bed 
to create infolding. A partial fluid-air exchange was subsequently performed, and the 
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fovea displaced inferiorly. Ringer solution with heparin was then used to flatten the 
detached retina, resulting in further migration of the redundant retina away from the 
scleral indentation. 
 
In the subsequent pilot human study of three patients (Table 3), de Juan et al (1998) 
(de Juan et al., 1998) modified the technique and the sub-total retinal detachment 
was created by retinal hydrodissection through small posterior retinotomies rather 
than a transscleral route. Furthermore, following chorioretinal shortening, a partial 
fluid-air exchange was performed without draining sub-retinal fluid and intraocular 
manipulation used to facilitate movement of the redundant retina. Finally, gas 
tamponade and upright post-operative posturing were used to displace the retina 
inferiorly and achieve retinal flattening. Following retinal reattachment the CNV was 
treated conventionally. In the animal study the scleral resection was placed 
superotemporally to produce inferior foveal displacement, however in two of the three 
patients, the scleral resection was placed in the inferotemporal quadrant to achieve 
superior foveal displacement. In this study a vision of 20/100 was achieved in all 
cases and there was no incidence of PVR. This method of translocation however still 
resulted in one patient developing a post-operative retinal detachment and distortion 
and cyclotropia remained problematic (Table 3). 
 
These pilot studies confirmed the conceptual basis for foveal relocation and the 
feasibility of the surgical techniques. Subsequent surgery broadly proceeded along 
the paths of full and to a lesser extent limited macular translocation with further 
refinements to reduce the complication rates that limit the effectiveness of each 
approach. Full macular translocation offered the advantages of direct access to sub-
retinal pathology and the potential for large and more controlled foveal displacements 
allowing foveal relocation well away from any residual disease. In contrast, limited 
translocation aimed to restore the same RPE-photoreceptor complex by avoiding 
large retinotomies and with less ocular misalignment. 
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3 Evolution of Surgical Techniques 
 
Macular Translocation with Full 360-degree Retinotomy  
 
Several modifications of translocation surgery have taken place since the techniques 
of MT360 and LMT were first described. These have been driven primarily by the 
need to improve visual outcomes and reduce complication rates.  The first major 
modification, as described above, was the use of a partial (180 degree / 150 degree) 
rather than a full (360-degree) retinotomy by Ninomyia et al (1996) (Ninomiya Y, 
1996). This was intended to reduce the rate of PVR and detachment, however the 
four studies to date to use this modification have met with limited successes (Table 
4).  
 
 
Ohji et al (1998) (Ohji M, 1998) modified the technique by performing retinal 
detachment through an internal approach via a small retinotomy in the first case in 
their series. This technique was further successfully employed by Wolf et al (1999) 
(Wolf et al., 1999) in five of their series of seven eyes. Retinal detachment performed 
via an internal approach allowed a more controlled detachment and reduced the risk 
of retinal puncture (and the consequent risk of PVR) and failure of formation of 
detachment inherent in introducing the infusion cannula into the sub-retinal space 
from a scleral approach. This group also made more extensive use of 
perfluorocarbon to control the retina prior to retinal rotation and reattachment.  
 
 
Eckardt et al (1999) (Eckardt C, 1999) reported the next modification to MT360 by 
employing advances in vitreo-retinal and performing torsional muscle surgery as 
either a primary or secondary procedure. Primary globe counter-rotation was 
performed at the beginning of translocation surgery and secondary counter-rotation 
at a later date depending on the strabismus findings. This was introduced to address 
post-operative diplopia and cyclotropia deemed to be an unavoidable side effect of 
translocation surgery. This study also made full use of improvements in vitreoretinal 
instrumentation since the first reports of MT360. This included the use of wide-angle 
viewing systems (BIOM, Moeller-Wedel) and scleral fixated wide-angle illumination 
fibre optics (TotalView Chandelier, DORC) to perform the most extensive vitrectomy 
possible and to minimise the trauma of surgery. Perfluorocarbons were also used as 
previously described but additionally to control the detached retina prior to 360º 
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retinotomy. Finally, the use of customised instruments, such as special atraumatic 
retinal forceps, further minimised surgical trauma. This technique allowed for much 
greater foveal shifts (Ohji et al., 2001) with vision less affected by recurrences in 
CNV. These modifications were reflected in the results where 18/30 (60%) patients 
were able to read newsprint and 22/30 (73%) patients had stable or improved vision. 
Furthermore all of the patients undergoing torsional muscle surgery were free of 
complaints of diplopia and cyclotropia.  
 
 
Toth et al (2001) (Toth and Freedman, 2001) made further refinements to the 
technique by initially creating a single infusion micro-retinotomy and subsequently 
completing retinal detachment by a slow sub-retinal injection via a silicone round ball 
cannula held over the micro-retinotomy. In addition, this group used a two-function 
tissue manipulator for illumination during lesion removal and translocation, thus 
eliminating the need for any additional scleorstomies. Furthermore, retinal rotation 
was performed with a modified diamond dusted silicone tip that allowed retinal 
manipulation and perfluorocarbon injection for better control of the retina once placed 
in its new location. In this study, the fovea was always translocated superiorly unless 
contraindicated by the size and position of the CNV. Superior translocation was 
justified because: 1 PVR and detachment frequently affect the inferior retina and 
macula, 2 haemorrhage from larger CNV extends inferiorly to affect the RPE at an 
inferior site, and 3 advancement of the inferior oblique is more effective for correcting 
torsion following superior translocations than advancement of the superior oblique 
tendon for inferior translocations. 
 
 
Further modifications to MT360 have included the use of calcium and magnesium 
free fluid instead of balanced salt solution to facilitate retinal detachment by Faude et 
al (1999) (Faude et al., 1999, Faude et al., 2001). This was successfully used by 
Aisenbrey at el 2002 (Aisenbrey et al., 2002a, Aisenbrey et al., 2002b), however 
reports have questioned the use of low calcium and magnesium levels on retinal 
(Szurman P, 2000) and RPE (Roider J, 2000) ultrastructure (Szurman P, 2000) and 
ERG amplitudes (Luke et al., 2001, Luke et al., 2007). Fujikado et al (2001) (Fujikado 
et al., 2001) also successfully used a calcium- and magnesium-free solution infused 
into the vitreous cavity to facilitate the creation of an intentional retinal detachment, 
followed by infusion of balanced salt solution into the sub-retinal space. 
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Pertile et al (2002) (Pertile and Claes, 2002) used specifically designed curved 
scissors (DORC International) to perform the 360º retinotomy. These allowed the 
retinotomy to be performed as peripherally as possible and avoid the variable amount 
of unwanted retinectomy that accompanies the use of a vitreous cutter. 
 
 
Kubota et al (2003) (Kubota et al., 2003) reported a modified technique for creating 
total retinal detachment. After creating a small retinal detachment with a 39-gauage 
needle, a 20-guage silicone-tipped needle was then placed in the hole created by the 
needle, and balanced saline solution injected sub-retinally at a high flow rate, 
reducing the surgical time. 
 
 
Cekic et al (2003) (Cekic et al., 2003) developed two continuous outflow devices to 
aid in the separation of retina from RPE and retinal manipulation. The first, a rigid 
needle, was developed to create a safe retinal detachment by keeping intraocular 
pressure low. The second, an injection needle with a soft tip facilitated injection of 
perfluorocarbon while manipulating the retina. Both instruments were successfully 
used in 54 cases. 
 
 
Limited Macular Translocation 
 
Lewis et al (1999) (Lewis et al., 1999) reported the first modification to the technique 
of LMT as described by de Juan et al (1998) (de Juan et al., 1998). Instead of scleral 
resection, imbrication was achieved by the use of mattress sutures placed in partial 
thickness through the sclera. The sutures were placed circumferentially between the 
rectus muscles close to the equator and tied after completion of the vitreous surgery. 
In their pilot study of 10 patients, the authors felt the technique was unpredictable in 
the degree of displacement achieved (114-1919µm) and compromised by 
complications of retinal fold formation (30%) and retinal detachment (10%). However 
vision improved in 40% patients and 20% achieved vision of ≥ 20/100 with post-
operative image tilt and distortion persisting in only one patient. 
 
 
Theoretically scleral shortening with imbrication does not create the required retinal 
redundancy, as the internal surface area of the globe at the level of the 
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RPE/choroid/sclera remains unchanged. Some of the redundant retina is draped over 
the ridge of infolded sclera and choroid, limiting the degree of translocation. To 
address this problem as well as the surgical limitations of unpredictable, minimal or 
no foveal displacement and the formation of retinal folds across the fovea Kamei et al 
(2000) (Kamei, 2000) reported the use of scleral clips to create radial outpouching to 
achieve chorioscleral shortening. Kamei and associates compared three different 
methods of scleral shortening in porcine eyes: 1 circumferential imbrication with 
sutures, 2 circumferential imbrication with scleral clips, and 3 radial outpouching with 
scleral clips. The foveal displacement achieved was 2377µm, 2582µm and 3386µm 
respectively with radial outpouching showing significantly more displacement. Kamei 
and associates also demonstrated that circumferential imbrication displayed the 
greatest deformation of the globe and formation of undesirable retinal folds. Similarly 
in a cadaveric study, Lin et al (2000) (Lin et al., 2000) used radial mattress sutures to 
produce significantly greater displacement with outpouching as compared with 
imbrication. These initial studies suggested scleral outpouching to be a more predictable 
and effective method of limited translocation with formation of a single retinal fold in a desired 
location. 
 
 
Meyer et al (2000) (Meyer CH, 2000) reported the first human study that compared 
the degree of displacement with the differing techniques of translocation. The study 
reported mean distances of displacement of 1100µm for outpouching, 1710µm for 
imbrication, and 3718µm for MT360. Subsequently, Benner et al (2001) (Benner et 
al., 2001), Lewis et al (2001) (Lewis, 2001), and Kamei et al (2004) (Kamei et al., 
2004) utilised the technique of outpouching for macular translocation (Table 5). Table 
6 provides data for the largest consecutive series of LMT with circumferential 
imbrication for comparison and the results demonstrate that chorioscleral 
outpouching to be an effective and equivalent technique for scleral shortening. 
 
 
Sullivan et al (2002) (Sullivan et al., 2002) performed scleral imbrication with a 
modified scleral retraction technique. In their cadaveric study they reported that use 
of a scleral retraction suture, which produces a double infolding of the sclera, 
resulted in a flatter fold compared to the standard suture technique and produced 
890µm of shortening. In the three patients who subsequently underwent LMT with 
the modified suture, two achieved visions of 20/100 or better with three lines of 
improvement. The mean displacement achieved was 2003 (1400 – 2400) µm and the 
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technique was suggested as an adjunct to the standard suture technique, especially 
in patients where clips may pose a threat of perforation. 
 
 
Kamei et al (2004) (Kamei et al., 2004) modified the technique of chorioscleral 
shortening from radial to diagonal outpouching in order to make the surgery easier 
and obviate the risk of a choroidal fold involving the fovea. The anatomic and visual 
results were again comparable to those achieved with the circumferential imbrication 
(Table 6) and radial/circumferential outpouching techniques (Table 5). 
 
 
Counter – Rotation Surgery 
 
An immediate complication of shifting the fovea to a new ectopic position is the 
creation of horizontal, vertical, and cylcotorsional strabismus. The cyclovergence 
amplitudes of a normal person are less than 6 degrees and it is known that 
individuals are unable to fuse or tolerate large degrees of cyclotorsion. Studies of 
patients with ocular motility disorders have shown that, in individuals with up to 15 – 
20 degrees of torsion, subjective torsion disappears with monocular fixation despite 
persistent mechanical torsion of the eye. This is thought to be due to perceptual and 
proprioceptive adaptations associated with long-standing changes in the environment 
or by suppression if the fellow eye has good vision (Fujikado et al., 1998). The 
cyclotropia induced by LMT and MT180 is of the order of approximately 20 degrees, 
however with MT360 the degree of rotation achieved results in cyclotorsion that 
greatly exceeds 20 degrees (Table 3). Thus, in early studies post-operative diplopia 
and cyclotropia were considered to be unavoidable but tolerable side effects of the 
surgery. 
 
 
Seaber and Machemer 1997 (Seaber JH, 1997) demonstrated the aforementioned 
adaptation in two patients with post-operative torsion of up to 55 degrees with use of 
the operated eye alone following MT360. Under binocular conditions however 
patients reported considerable cylcotorsional disorientation. They found the 
peripheral retina of the fellow eye had perceptual precedence despite poor central 
visual acuity, in contrast to the reduced peripheral retina of the operated eye. Hence 
they suggested translocation more suitable for situations in which the vision in the 
non-operated eye was expected to be lower than the predicted vision in the operated 
53
 
 
eye. Furthermore patching of the fellow eye was the suggested management for 
cylcotorsional disorientation. This complication was subsequently addressed by 
simultaneous or secondary extraocular muscle surgery to counter-rotate the globe. 
 
 
Counter-rotation surgery commonly involves the oblique muscles with additional 
rectus surgery to augment the degree of rotation. The exact nature of the muscle 
surgery depends upon the direction of rotation of the retina and the timing of the 
surgery. The fovea may be translocated superiorly or inferiorly depending on the 
precise location and degree of extension of the CNV. Superior translocation is the 
preferred method because: 1 PVR more frequently affects the inferior retina thus a 
superior rotation is less likely to result in retinal detachment, 2 Haemorrhage from 
CNV extends inferiorly potentially affecting the quality of the inferior RPE, 3 
Haemorrhage from any recurrence is more likely to track across an inferiorly rather 
than a superiorly translocated macula, 4 A greater degree of excyclotorsion, via 
tucking/advancement of the inferior oblique, is possible than incyclotorsion, from 
advancement of the superior oblique tendon, for the correction of cyclotorsion - 
favouring a superior translocation. 
 
 
Counter rotation surgery may be performed as a primary or a secondary procedure. 
The advantage of a primary procedure is that is allows for the fovea to be placed 
exactly such that it corresponds to the prior muscle surgery and thus avoid/minimise 
any post-operative cyclotropia. The disadvantages are that muscle surgery further 
extends the duration of surgery and does not necessarily eliminate the need for a 
secondary procedure due to phenomena such as unwinding of the globe. The 
advantage of a secondary procedure is that subsequent muscle surgery can be 
specifically tailored to post-operative strabismological results; the disadvantage is 
that patients potentially experience the disabling side effects of post-operative 
cyclotropia. 
 
 
Eckardt et al (1999) (Eckardt C, 1999) were the first to report macular rotation with 
successful prevention of the disorientating cyclotropia by performing globe counter 
rotation both as a combined primary or a secondary procedure. As a primary 
procedure, the extraocular muscle surgery was carried out at the start of the 
procedure and involved the eye to be translocated as well as the fellow eye if 
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necessary. Surgery was performed on the oblique muscles to achieve a maximum of 
15 degrees of cyclotorsion, with additional surgery on two or four recti to augment the 
degree of rotation up to 50 degrees. Depending on strabismological findings, further 
surgery could be performed on the operated eye or the fellow eye, including 
recession of the superior and lateral muscles of the fellow eye.  
 
 
Eckardt and associates developed a method of torsional rectus surgery that allowed 
a greater degree of counter rotation than previously reported in the literature (Table 
7).  For superior rotation, surgery on the oblique muscles comprised a 12-mm tuck of 
the inferior oblique and a 12mm recession of the superior oblique. Oblique muscle 
surgery was augmented by surgery on the recti, which rather than conventional 
transposition, involved splitting the recti into 15 – 17 mm strips approximately one 
quarter of the muscle width. For an excyclotorsion the strips were crossed under the 
original muscle and moved clockwise (right eye) and counter clockwise (left eye) and 
repositioning them at the insertion of the adjoining rectus muscle. In their study, five 
patient did not undergo any extraocular muscle surgery, of which 60% reported 
considerable disorientation from post-operative diplopia and cyclotropia. For the 
twenty-five patients who underwent primary/secondary counter rotation, 96% were 
free of symptoms of diplopia and image tilt. 
 
 
Freedman et al (2000) (Freedman et al., 2000) and Fujikado et al (2001) (Fujikado et 
al., 2001) later performed muscle surgery using a modification of the oblique surgery 
described above, where to correct for an incyclotorsion the superior oblique  was 
recessed and the inferior oblique tucked and transposed to the upper border of the 
lateral rectus.  Other variations to counter-rotation surgery include Freedman et al 
(2002, 2003) (Freedman et al., 2002, Freedman et al., 2003) who combined surgery 
on the oblique muscles with  transposition of the lateral recti. Table 8 summarises the 
studies that have utilised these techniques or modifications thereof with the majority 
of the surgery performed as a primary combined procedure. Rates of cyclotropia 
greater than 15 degrees range from 0 to 23 %, with symptomatic diplopia being 
reported with a frequency of 0 – 33 %.  These studies suggest that counter-rotation 
surgery is effective at reducing large degrees of cyclotorsion produced by MT360 
when graded to match pre-operative torsion, however residual torsion precludes the 
reestablishment of binocular function and any resultant diplopia ultimately limits the 
overall visual success of the original surgery. 
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4 Complications 
 
The initial promise of macular translocation as an effective treatment for sub-foveal 
CNV has been limited by the timing and occurrence of intra- and post-operative 
complications. These range from mechanical intra-operative (iatrogenic retinal tears, 
insufficient rotation) and mechanical post-operative (retinal detachment with PVR, 
macular pucker, hypotony) to pathological post-operative (SRNVM disease 
recurrence, macular oedema) and visual post-operative (torsion, micropsia) (Table 
9). Indeed the evolutions of the treatment and the various modifications to the 
surgical techniques outlined in the previous section have been driven by the need to 
minimise complications and improve visual outcomes. 
 
 
Since the first report of macular translocation by Machemer and Steinhorst 
(Machemer R, 1993b), retinal detachment, PVR, and torsion have been identified as 
the major factors that limit the success of the procedure. The desire to minimise 
these particular complications led to the first major modifications of translocation 
surgery, directed primarily at reducing the size of the retinotomy – translocation with 
partial retinotomy (Ninomiya Y, 1996) and limited macular translocation (de Juan et 
al., 1998) (Table 3).  These pilot studies, whilst reporting a reduced rate of retinal 
detachment, were markedly limited in their size (three patients) and hence the 
significance of their outcomes. In the absence of large scale randomised control 
trials, subsequent case series of translocation with partial retinotomy (Table 4) and 
limited macular translocation (Table 11) have failed to consistently establish 
significant improvements in the overall rate of complications. Of particular note, 
translocation with partial retinotomy offered no improvement in retinal detachment or 
PVR rates (Table 4). In comparison, limited macular translocation, whilst having 
comparable detachment and PVR rates to later modifications of full macular 
translocation (Table 13), is beset with a high rate of a number of complications that 
significantly limit the visual outcome. These include a high susceptibility to disease 
recurrence from insufficient translocation, diplopia, and astigmatism (Table 11). 
 
 
The pivotal study to demonstrate reduced rates of post-operative retinal detachment, 
PVR, and torsion was conducted by Eckardt et al (1999) (Eckardt C, 1999). Eckardt 
and associates employed modern day vitreoretinal techniques (customised 
instruments, contemporary viewing and illumination systems, use of perfluorocarbons 
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to manipulate the retina) to perform the procedure with the most extensive vitrectomy 
and in a much more atraumatic manner with respect to the retina than previously 
described. These modifications dramatically improved PVR and detachment rates 
and were employed by subsequent series of full macular translocation with similar 
results (Table 10).  This group was also the first to directly address the significant 
problem of post-operative torsion by performing primary or secondary globe counter-
rotation surgery. In their study, this procedure eliminated symptoms of diplopia and 
cyclotropia and these results were replicated in subsequent studies (Table 10). 
 
 
Macular translocation is complex and involved sub-retinal surgery and as described 
above, susceptible to a number of complications, with the accompanying risk of 
visual loss. The procedure has been reported to range from 3.5-6.5 hours (2000) and 
clearly this reflects a degree of surgical experience and improvement thereof in 
technique and instrumentation with time (Toth and Freedman, 2001). Consequently, 
this will impact upon the complication rate and this is witnessed in the improvements 
in complication rates reported by individual study groups over time (Eckardt C, 1999, 
Eckardt C, 2002) (Toth and Freedman, 2001, Toth et al., 2004, Cahill et al., 2003, 
Park and Toth, 2003) (Table 10). Ultimately, the effectiveness of macular 
translocation as a procedure is closely related to the occurrence and timing of the 
aforementioned complications (Tables 12-13) and minimising and managing these is 
as critical as achieving anatomical success during surgery. 
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5 Effectiveness 
 
The effectiveness of any treatment may be judged by a wide variety of criteria 
however common central goals of any intervention are to halt and ideally reverse 
disease progression, to restore a physiological state in terms of anatomy and 
function, and to achieve a positive impact with respect to the quality of life of the 
patient. Translocation surgery aims to attain these goals by directly treating the sub-
foveal pathology (CNV, haemorrhage, fluid) and restoring retinal anatomy. The ideal 
endpoint with respect to the treatment of macular disease is therefore to provide 
stable central vision of good quality. The effectiveness of full and limited translocation 
to date is considered below along these lines, by examining the impact upon several 
aspects of retinal function as well as visual outcomes.  
 
 
Retinal Function and Surgery 
 
Macular translocation, particularly with 360-degree retinotomy and retinal rotation, 
involves extensive surgery, during which the retina is placed under a considerable 
degree of stress. Several factors have been identified which influence the anatomical 
and functional outcome of translocation surgery. These include the number of retinal 
photoreceptors cut during retinotomy, the amount of retina treated with 
photocoagulation, the speed and duration of retinal detachment, intra-operative 
mechanical, light and ischaemic stress, and the type of irrigating solution applied 
during surgery. Several studies have investigated clinicopathological correlates 
examining the effects of surgery on various aspects of retinal function; the key 
findings are detailed below.  
 
 
It has been established that the extent, duration, and height of retinal detachment 
correlates with visual outcome and electroretinogramd (ERG) responses after 
reattachment (Kim et al., 1996). Luke et al (2001) (Luke et al., 2001) examined 
electrophysiological changes before and after MT360 and noted a significant 
reduction in photopic a- and b-waves after surgery. This study also observed a 
positive correlation between the duration of surgery and the amplitude reduction in 
ERG responses. Terasaki et al (2002) (Terasaki et al., 2002) also reported similar 
functional alterations in full-field ERGs after MT360. These studies suggest 
impairment of photoreceptor outer segments following MT360 and this is supported 
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by a number of ultrastructural studies demonstrating a loss of photoreceptor outer 
segments after translocation (Machemer R, 1993a, Lafaut et al., 2000). These results 
therefore suggest that to optomize retinal function with MT360, the emphasis is on 
minimising the duration of detachment and the overall surgical time.  
 
 
Later work by Terasaki et al (2004) (Terasaki et al., 2004) examined focal macular, 
rather than full field, ERGs following MT360. This group demonstrated improvements 
in focal macular ERGs that correlated well with visual outcome indicating that 
macular function was recoverable. Thus, while MT360 may cause a significant global 
electrophysiological decrease, this study suggested that macular function was less 
affected, preserved or restored. 
 
 
Another factor that influences the functional result after translocation surgery is the 
retinal trauma incurred during the detachment process. This is partly influenced by 
the type or composition of irrigation used to create the retinal detachment. The use of 
calcium- and magnesium-free fluid instead of balanced salt solution has been shown 
to facilitate and accelerate detachment (Faude et al., 2001, Szurman P, 2000, Faude 
et al., 1999). Szurman et al (2000) (Szurman P, 2000) injected a calcium-free 
buffered solution into the sub-retinal space in rabbits and demonstrated reduced 
retinal adhesion. However, this study also found swelling and fragmentation of 
photoreceptor outer segments with partial loss of the plasma membrane. It is 
proposed that outer segments are torn away or damaged during the detachment 
process. To further reduce this trauma several modifications have been introduced to 
the detachment stage of the surgical technique including the use of silicone ball-
tipped cannula (Toth and Freedman, 2001) and continuous outflow devices (Cekic et 
al., 2003) for improved sub-retinal infusion. Thus, techniques to minimise the degree 
of neuroretinal trauma would seem appropriate, however continued research is 
required to determine their importance with respect to morphological and functional 
recovery following MT360. 
 
 
Cekic et al (2004) investigated the effects of translocation surgery on the retinal 
circulation. This study demonstrated that choroidal perfusion parameters in the new 
foveal region did not change after MT360 (Cekic et al., 2004b). Further work by this 
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group also quantified retinal circulation times before and after surgery and found that 
MT360 did not alter the retinal macrocirculation in the long term (Cekic et al., 2004a).  
 
 
The effect of surgery on the morphology of the relocated macula was examined by 
Terasaki et al, 2003 (Terasaki et al., 2003). Pre and post-operative optical coherence 
topography revealed the newly located macula after MT360 had a normal concave 
foveal configuration with normal thickness. Thus, the retinal appears to adequately 
adapt to the extensive mechanical insult of translocation surgery. 
 
 
Visual Outcomes and Surgery 
 
The distance visual outcomes for full thickness and limited macular translocation 
surgery are listed in Tables 14 and 15 respectively. As previously discussed the 
effectiveness of translocation is closely related to the timing and occurrence of 
complications and this is reflected in the visual outcomes. 
 
 
When considering only series with 10 patients or more treated for neovascular AMD, 
full macular translocation shows improved mean visual outcomes compared to 
limited translocation for percentage improvement in 3 lines of visual acuity (23.9 vs. 
18.3 %) and the percentage with a visual acuity greater than 20/100 (46.3 vs. 37.4 
%) (Table 16). When the percentage with a visual acuity greater than 20/40 is 
examined, full translocation shows a significantly improved outcome over limited 
translocation (15.4 vs. 3.6 %) (Table 16). 
 
 
Traditionally, distance acuities have dominated as an outcome measure for 
investigations of the eye, however near vision and reading ability are one of the most 
important visual tasks. Reading ability relies on a number of factors including, 
contrast sensitivity, stable fixation, size, density and position of a central scotoma, 
and position of the preferred retinal locus in relation to any scotoma (Legge et al., 
1992, Sunness et al., 1996, Crossland et al., 2004a, Crossland et al., 2005a). In 
terms of near acuity and reading speeds, very few studies have used these 
parameters to document visual outcomes for macular translocation surgery, and 
these are outlined in Table 17 (Eckardt et al, 1999; Fujikado et al, 2002; Abdel-
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Meguid et al, 2003; Mruthyunjaya et al, 2004; Toth et al, 2004). Finally, Cahil et al 
(2005) demonstrated MT360 was associated with improvements in vision-related 
quality of life measures (National Eye Institute Visual Function Questionnaire). The 
degree of improvement was greatest in patients with a post-operative improvement in 
vision and not related to a change in the general health of the subjects (Cahill et al., 
2005). 
 
 
The results outlined in Tables 14-16 strongly suggest that despite being more 
involved surgery, full translocation offers direct treatment of sub-foveal disease, 
together with physiological restoration of retinal anatomy and function. The studies 
discussed above indicate that the retina, considering the upheaval of the 
neurosensory layer in full translocation, is minimally impaired (in terms of vascular 
status, morphology, electrophysiology), and when successful results in positive 
functional recovery. In contrast, limited translocation, whilst being relatively less 
disruptive surgery does not treat sub-foveal disease, is equally vulnerable to sight 
threatening complications such PVR, retinal detachment and diplopia and is much 
more susceptible to disease recurrence. This thesis will go on to examine in detail full 
macular translocation, the feasibility of the technique, the anatomical restoration of 
foveal anatomy, and the functional success in terms of quantitative and qualitative 
recovery of vision. 
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Table 16 360-degree and Limited Macular Translocation: Comparison of 
Distance Acuity Outcomes 
 
 
 
Visual Outcomes / Mean Percentage * 
  
 
 
Method of 
Translocation 
 
 
Improving 3 
Lines VA VA ≥ 20/100 VA ≥ 20/100 
 
Full 
 
23.9 46.3 15.4 
 
Limited 
 
18.3 37.4 3.6 
 
* Mean Outcomes From Series Of 10 Patients Or More (Tables 14 and 15) 
Treated For Age Related Macular Degeneration 
VA  Visual Acuity
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D RPE Transplantation 
 
 
 
1 Strategies 
 
The RPE maintains retinal homeostasis by occupying a critical and strategic position 
as a physical, metabolic, and regulatory intermediary between the neurosensory and 
underlying vascular structures of the retina. In this capacity, healthy RPE is crucial to 
facilitating the function of photoreceptors and hence providing good vision. This 
intimate relationship has led to the concept of replacement of the RPE as a 
therapeutic option, particularly with respect to recent advances in our understanding 
of the involvement of the RPE in modulating the surrounding extracellular and 
cellular environment, and in the pathogenesis of retinal disease at a bio-molecular 
level. 
 
 
As discussed, the choriocapilliaris-Bruch’s-RPE axis is subject to cumulative damage 
in susceptible individuals, leading to the development of the dry and wet forms of 
AMD. Historically, treatments for wet AMD have moved away from vaso-destructive 
towards pharmacological interventions directed primarily at arresting a single 
component of the final pathogenic pathway of the disease process, namely CNV 
formation. In view of this, cell based therapies, designed to restore the 
choriocapilliaris-Bruch’s-RPE-photoreceptor axis, have emerged and offer the 
possibility of not only a physical restoration of structure and recovery of lost function, 
but of a potential cure in terms of improving the condition of already diseased cells 
and so offering long term stable vision. In this respect, we can begin to consider the 
concept of healthy RPE replacement as a treatment modality. 
 
 
RPE transplantation reinstates the choriocapilliaris-Bruch’s-RPE-photoreceptor axis 
that is crucial to the vision. Over the past two decades a number of strategies have 
been employed, initially with animal models and more recently with human studies. 
Effective transplantation requires, an appropriate and viable cell source, a safe and 
repeatable method of delivery, the ability to surmount issues surrounding potential 
rejection, and recovery of structure and function. To this end a number of 
approaches have been undertaken including the use of pigment epithelium from 
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sources other than the retina, homologous and autologous grafting, the use of RPE 
cell suspensions and full thickness sheets of RPE, and pedicled macular flap RPE 
grafts as well as free peripheral RPE patch grafts.  
 
 
Of the approaches mentioned above, autologous full thickness free patch grafts, 
harvested from the mid-periphery of the retina, have become the technique of choice 
to treat both primary RPE and photoreceptor driven retinal dystrophies as well as 
more complex diseases such as AMD. Briefly, the technique involves the creation of 
a localised foveal detachment through a small retinotomy, removal of any CNV, 
followed by replacement of the RPE (‘partial thickness transplantation’) or the 
choriocapilliaris-Bruch’s-RPE complex (‘full thickness’ transplantation) with 
autologous tissue. Both approaches re-align viable photoreceptors with healthy 
supporting tissue improving photoreceptor function and provide the opportunity to 
treat any CNV directly. 
 
 
The following sections, will review the progress that has been made to date in this 
field, including background animal studies and the evolution and effectiveness of the 
techniques. RPE transplantation offers a vast opportunity for a new generation of 
more directed retinal treatments, and the scope for a curative ‘halo’ effect upon the 
neurosensory retina. 
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2 Animal and Cell Based Human Studies 
 
Animal studies have served to explore a number of key areas for achieving 
successful transplantation. These include determining the ideal source of cell for 
investigation and transplantation, optimising methods for the collection and delivery 
of RPE, understanding the mechanisms involved in the assimilation transplanted 
material, establishing the degree of physiological restoration of the RPE layer in 
terms of anatomy and function, and examining the extent and stability of any 
recovery or reversal of RPE driven retinal disease. 
 
 
Sources of Cell for Transplantation 
 
A number of sources of RPE have been used for transplantation (Table 18).  Early 
studies in mammalian species, initially employed adult (Gouras et al., 1984), and 
later embryonic RPE cells (Del Priore et al., 2003b) in autologous, homologous and 
heterologous approaches. With improvements in cell culture and genetic 
engineering, modified RPE cells became available with the ability to study the effect 
of growth factors, and mark and follow the effects of RPE and retinal cellular 
metabolism (Abe et al., 2005, Abe et al., 1999). More recently, iris pigment 
epithelium, which is embryonically derived from the same neuroepithelium as the 
RPE, has been transplanted to the retina, and recent advances in stem cell 
technology have exploited progenitor retinal and neural stems to provide RPE for 
transplantation (Warfvinge et al., 2006, Haruta et al., 2004) . 
 
 
Techniques of Cell Delivery 
 
Transplantation first became possible with improvements in RPE cell culture and the 
concomitant detailed understanding of RPE ultrastructure, morphology, biochemistry 
and physiology (Flood et al., 1980, Flood et al., 1984, Boulton et al., 1982). As a 
result of this work, cultured RPE cells were transplanted into the sub-retinal space of 
simian eyes, initially using an open-sky technique (Gouras et al., 1984, Gouras et al., 
1985), Whilst allowing straightforward access to the sub-retinal space, the open-sky 
approach was limited by the inability to reattach the neurosensory retina. Thus, whilst 
RPE attachment to Bruch’s membrane could be studied, the effect of the donor RPE 
cells in a restored physiological state could not. To circumvent this difficulty, 
105
 
 
investigators adopted closed techniques of RPE cell delivery that offered a much less 
disruptive end result. Two methods of closed RPE cell delivery were described; 
predominantly in animal studies, an external approach was used to access the sub-
retinal space and inject RPE cells through a posterior trans-scleral route (Li and 
Turner, 1988b). In contrast, the internal approach delivered RPE cell suspensions to 
the sub-retinal space via a trans-retinal route. This involved a pars plana vitrectomy, 
creation of a small retinotomy, and the injection of RPE cell suspensions through a 
micropipette into the sub-retinal space (Lopez et al., 1987, Brittis et al., 1987) or the 
introduction of larger RPE patch grafts with explant injectors (Thumann et al., 2006) 
or with aspiration-reflux spatulas (Maaijwee et al., 2007). The closed internal 
approach provided a number of advantages by offering a more controlled method of 
cell delivery that did not result in any trauma or inflammation to the choroid or 
Bruch’s membrane, and mirrored techniques of vitreoretinal surgery in humans. 
 
 
Techniques of Cell Collection 
 
A number of techniques have evolved for the collection of RPE cells for either culture 
or transplantation. Initial reports gathered RPE cell suspensions by enzymatic 
degradation from enucleated eyes with the cells isolated by centrifuge (Flood et al., 
1984, Flood et al., 1980).  The first report to describe a method for the harvesting 
and storing of intact viable sheets of RPE cells was described by Tenzel (1997). 
Intact sheets of RPE were enzymatically cleaved from their basement membrane 
and embedded in 50% gelatin. The study demonstrated that sheets of RPE cells 
were suitable for retinal transplantation if harvested within 24 hours of death and 
maintained 82% viability for as long as 48 hours if stored at 4 degrees C (Tezel et al., 
1997).
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The aforementioned work referred to homologous RPE transplantation, whereas for 
autologous transplantation, the RPE cells are required to be harvested from the 
same eye. Early studies used an external trans-scleral method to gather RPE cells 
(Lane et al., 1989, Wongpichedchai et al., 1992), however more recently, trans-
retinal approaches have been adopted, for the benefits outlined above,  to collect 
either RPE cell suspensions (Phillips et al., 2003) or full and partial thickness RPE 
patch grafts (Maaijwee and van Meurs, 2006). 
 
 
Graft Integration  
 
A number of studies have identified several factors that lead to the successful 
assimilation and subsequent function of transplanted RPE into host tissue. These 
include the presence of a substrate on which to receive the cells, namely a healthy 
Bruch’s membrane or a synthetic equivalent, suitable extracellular matrix or scaffold, 
and the expression of appropriate cell adhesion molecules.  
 
 
Early studies established that epithelial cells fail to survive in suspension and that 
separating RPE from its extracellular matrix induces apoptosis. This apoptosis was 
prevented when RPE was harvested onto extracellular matrix, fibronectin or laminin 
(Tezel and Del Priore, 1997), suggesting that prior to transplantation these cells must 
rapidly reattach to a substrate. The natural substrate for RPE cells is Bruch’s 
membrane and it has been demonstrated that the ability of transplanted RPE cells to 
repopulate Bruch’s membrane depends on the age of the donor tissue and the 
ultrastructural layer available for reattachment, both reflecting the state of any pre-
existing disease. 
 
 
As previously mentioned a number of ageing changes are known to occur at the 
choriocapilliaris-Bruch’s-RPE interface related to the deposition and accumulation of 
lipid-protein aggregates. These deposits affect the ability of the choroidal blood 
supply to adequately support the photoreceptors. In fact early studies have 
demonstrated that metabolic impedance or conductance across Bruch’s membrane 
naturally declines with age (Starita et al., 1995). This is thought to be secondary to 
tissue remodeling, with the process being accelerated by lipid deposition in AMD 
(Starita et al., 1996), and localised to the inner collagenous layer (Starita et al., 
108
 
 
1997). These studies suggested that any potential substrate for RPE required 
adequate conductance, or treatment of the pre-existing substrate, the inner 
collagenous layer of Bruch’s, to improve conductance to sustain photoreceptor 
function.  
 
 
The apoptosis rate of attached cells has been shown to increase with attachment to 
deeper layers of Bruch’s membrane (Tezel et al., 1999, Tezel and Del Priore, 
1999a). Later studies with RPE cell repopulation of human Bruch’s membrane 
attributed similar results to age-related changes in the inner collagen layer. 
Subsequent treatment of Bruch’s to determine the effect of cleaning and/or an 
extracellular matrix protein coating (a mixture of laminin, fibronectin and vitronectin) 
on the reattachment, apoptosis, proliferation, and final surface coverage of the 
transplanted RPE cells revealed that the age-related changes in the inner 
collagenous layer that impair repopulation could be reversed (Tezel et al., 2004). 
Similarly treatment of the donor tissue has been shown in studies to modify RPE 
attachment. Studies with porcine RPE, where the TGF-beta family of cytokines 
mediates the density-dependent growth suppression of RPE in vitro, demonstrated 
that neutralizing these cytokines by adding anti-TGF-beta antibodies could result in 
more rapid growth of the RPE in vivo (Tezel and Del Priore, 1999b). From this work it 
is clear that such biological modifications of the graft and the recipient site offer 
future targets for successful transplantation therapies 
 
 
A body of in vitro and in vivo work has also examined various artificial substrates for 
RPE cells. These have ranged from biological membranes such as porcine lens 
capsule (Turowski et al., 2004), human amniotic membranes (Ohno-Matsui et al., 
2006), and sheets of cross-linked collagen (Bhatt et al., 1994) or fibrinogen 
(Oganesian et al., 1999), to synthetic materials such as ployetherurethanes (Williams 
et al., 2005). Although all these studies have demonstrated improved ability to 
support RPE in terms of outcome measures such as cellular morphology, phenotypic 
differentiation, restoration of a monolayer, rejection/inflammation and photoreceptor 
survival over naïve RPE cells, as yet no single substrate has demonstrated the 
flexibility, robustness, biostability and biocompatibility to allow secure delivery and 
transplantation. 
109
 
 
To circumvent difficulties with rejection and make use of Bruch’s as a natural 
substrate, autologous RPE transplantation utilizes a full thickness mid-peripheral 
RPE-choroidal graft with its own intact substrate (van Meurs and Van Den Biesen, 
2003). These grafts were originally placed on debrided sub-foveal Bruch’s in a 
porcine model and the graft successfully revascularised via bridging vessels from the 
underlying choroids to the choriocapilliaris of the graft. The grafts survived for 12 
weeks and it is postulated that the adjacent proximity to the choroidal blood supply is 
sufficient to maintain RPE survival whilst revascularisation is established between 
the donor and recipient sites (Maaijwee and van Meurs, 2006). 
 
 
In addition to an intact Bruch’s membrane, cell adhesion molecules have also been 
shown to be vital to successful RPE transplantation. In particular, the cadherins and 
integrins are essential in RPE cell adhesion to Bruch’s membrane and surrounding 
cells to form a uniform monolayer. Cadherins are adhesive molecules found at 
adherens and desmosomes and are implicated in cell-cell adhesion and cellular 
orientation. Integrins are transmembrane glycoproteins that posses subunits which 
are receptors for collagen, laminin, and fibronectin – all of which are components of 
Bruch’s membrane (Hynes, 2002). The integrins have also been implicated in 
determining cell polarity and retinal adhesion (Nandrot et al., 2008), phagocytosis of 
photoreceptor outer segments (Feng et al., 2003, Finnemann et al., 1997), and 
interacting with the complement system to aid adhesion (McLaughlin et al., 2003).  
 
 
Graft Success 
 
The aim of transplantation is to rescue failing macular function and in vivo animal 
models of transplantation have utilized the Royal College of Surgeons (RCS) rat to 
examine photoreceptor function. The RCS rat carries a RPE mutation resulting in the 
loss of photoreceptor outer segments phagocytosis. The subsequent accumulation of 
sub-retinal debris leads to a rod-cone dystrophy and RPE transplantation has been 
shown to reverse these effects (Lund et al., 2001b, Li and Turner, 1988a, Coffey et 
al., 2002, Wang et al., 2005a). Using this model early RPE transplantation studies 
demonstrated RPE cells established a normal relationship with photoreceptors and 
that there was histological rescue of the neuroretina (Li and Turner, 1988b, Li and 
Turner, 1988a). In addition to the photoreceptors, RPE transplantation was also 
shown to maintain the underlying vasculature and the choriocapilliaris in particular 
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(Majji and de Juan, 2000). Later RCS studies with RPE allo- and xeno-grafts further 
demonstrated functional recovery using physiological and behavioral testing (Lund et 
al., 2001a, Coffey et al., 2002). RPE transplantation was able to recover complex 
visual function such as centre-periphery distinction, identifying directional change, 
contrast sensitivity and pattern discrimination (Coffey et al., 2002, McGill et al., 
2004). 
 
 
From animal studies the obvious mechanism for the documented recovery is direct 
contact between RPE cells and the immediate layers above and below. Early studies 
with cell suspensions and later with sheets of autologous transplantation 
demonstrated that the formation of a monolayer is a prerequisite for successful 
transplantation.  As discussed above this relies on correct cellular orientation, 
adequate association between the RPE and its substrate, and correct binding 
between neighbouring RPE cells and the surrounding intercellular matrix. Beyond 
this a number of trophic factors have also been implicated in successful 
transplantation. These include basic fibroblast growth factor (bFGF), ciliary 
neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF), and glial cell 
line-derived neurotrophic factor (GDNF). Trophic factors explain findings where 
recovery extends beyond the immediate graft area, where recovery occurs when 
RPE cells have been introduced into the vitreous cavity, and where recovery occurs 
when transplantation involves glial tissue (Castillo et al., 1997, Sauve et al., 2002, 
Wang et al., 2005b, Abe et al., 2005) 
 
 
The degree to which RPE transplantation in animal studies has sustained the 
outcomes described above has varied depending upon a number of factors. When 
considering the tissue transplanted from an immunological viewpoint, rejection will 
clearly affect graft survival. Although the sub-retinal space is considered a privileged 
site, the anatomical disruption secondary macular disease, particularly AMD, and 
from the tissue delivery process itself, compromises this situation. In this respect, 
autologous transplants are more advantageous than allo- and xeno-grafts, however 
the latter two methods allow more scope tissues to be modified prior to 
transplantation. For example, as mentioned above, the gene encoding BDNF has 
been transduced into RPE delivered to the sub-retinal space in a rat model with 
successful neuroprotection of the retina (Abe et al., 2005). This model allows for RPE 
cells to act as a vehicle for gene replacement therapy. 
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A number of animal studies have investigated the role of the host immune system in 
allogenic and xenogenic grafts. In rats, RPE allografts have survived from 2 to 12 
months with chronic rejection occurring and an incompatibility in MHC class I and II 
antigens identified as a limiting factor (Zhang and Bok, 1998, Li and Turner, 1991). 
Similarly, in rat studies using xenografts from human and porcine RPE sources, 
grafts have survived from 2 to 10 months prior to rejection (Grisanti et al., 2002, Abe 
et al., 1999, Coffey et al., 2002, Wang et al., 2005b). In these studies the sub-retinal 
RPE xenografts are protected from a strong cellular rejection, with an absence of 
lymphocytes, but seem to undergo a slow functional deterioration, reflected by a 
decline in their capability to rescue adjacent photoreceptors. Despite the absence of 
an acute lymphocytic response, allograft and xenograft studies have identified an 
increase in the production of interleukins (IL-1 and IL-6) (Abe et al., 1999, Enzmann 
et al., 2000), as well as a glial and macrophage response (Del Priore et al., 2003a, 
Lai et al., 1999, Gabrielian et al., 1999). This inflammatory response appears be 
modifiable by systemic and local immunosuppression, (Del Priore et al., 2003a, Lai et 
al., 2000, Wang et al., 2002), as well as the use of a RPE substrates (Oganesian et 
al., 1999, Bhatt et al., 1994), although in no such study has a graft survived beyond 
12 months. Thus, in allogenic and xenogenic graft transplantation the immune 
response remains one of the most important limiting factors. 
 
 
Other factors identified as determinants of graft survival include the number of cells 
transplanted, the age of the donor cells, and time between RPE cells being 
harvested and transplanted (Castillo et al., 1997, Li and Turner, 1991). The success 
of the graft is also dependant upon the degree of residual photoreceptor function in 
the host and the secondary downstream structural losses resulting from the disease 
process. 
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Human Transplantation Studies 
 
The large body of animal studies demonstrating successful transplantation of RPE 
onto Bruch’s membrane, with associated photoreceptor survival and or functional 
recovery, together with a lack of treatment modalities for human retinal diseases, led 
a number of investigators to examine the feasibility of human RPE transplantation. A 
number of retinal abnormalities are potentially treatable by RPE transplantation, 
including neovascular AMD, geographic atrophy and some macular dystrophies. 
 
 
Historically, poor outcomes for patients with CNV led to the development of early sub-macular 
surgical techniques directed at sub-retinal membranectomy and removal of haemorrhage (de 
Juan and Machemer, 1988, Blinder et al., 1991, Thomas et al., 1992, Thomas et al., 1994). 
Histological examination of the excised CNV revealed concomitant loss of RPE and the 
dissected sub-retinal bed was incompletely repopulated with proliferating or migrating RPE 
(Grossniklaus et al., 1994, Lopez et al., 1991, Hsu et al., 1995). The loss of RPE support was 
secondarily associated with choriocapilliaris atrophy and loss of photoreceptors (Korte et al., 
1984, Pollack et al., 1996, Akduman et al., 1997). The results of these early studies were later 
confirmed by the sub-macular surgical trials (Hawkins et al., 2004a, Bressler et al., 2004, 
Hawkins et al., 2004b, Grossniklaus and Green, 1998). Together with animal studies, this 
body of work further supported the need for RPE replacement. Subsequently human 
transplantation studies have predominantly focused on treating neovascular AMD with the 
rationale that RPE repopulation of the dissected bed restores sub-retinal anatomy and 
provides the necessary metabolic and trophic support to the neuroretina. 
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Techniques of Transplantation 
 
The first report of human RPE transplantation was presented by Peyman et al 1991 
for end stage AMD (Peyman et al., 1991). In their study they described two 
techniques, one case involving homologous transplantation with adult RPE and a 
second involving an autologous macular RPE-choroid rotational flap. Using 
vitreoretinal techniques previously outlined, the study described pre-operative 360-
degree photocoagulation at the ora and surrounding the arcades, the preparation of 
a large retinal flap created within the margins of the pre-operative laser, removal of 
the sub-macular scar, and replacement of the RPE cells, using either a full thickness 
autologous pedicle graft, or a homologous adult RPE patch with Bruch's membrane 
and choriocapilliaris. Following retinal reattachment, 360-degree endolaser was 
applied with silicone oil tamponade and an encircling band. Fourteen months 
following the procedure, visual acuity in the patient with a pedicle graft had improved 
from counts fingers to 20/400 and the patient fixated over the transplanted RPE cells. 
After 10 months, the homologous graft in a second patient had become encapsulated 
with a fine sub-retinal membrane without neovascular tissue and visual acuity had 
not improved. This finding was thought to be secondary to presumed graft rejection. 
No intra-operative or post-operative complications resulting from the surgery were 
reported in either patient. 
 
From this first reported human case, methods of RPE harvesting and surgical techniques of 
cell delivery have developed along the lines of the type of transplantation undertaken, namely 
homologous or autologous. Over the last decade the later has prevailed, driven primarily by 
the practicalities of obtaining suitable tissue for transplantation, and the advantages of 
avoiding issues of tissue matching and rejection inherently present with homologous 
transplantation. 
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Homologous Foetal Transplantation 
 
The aforementioned case of homologous transplantation described by Peyman et al 
(1991) utilized a sheet of RPE from a patient who had suffered a traumatic eye injury 
requiring enucleation. Subsequent studies of transplantation for AMD have harvested 
RPE, as sheets or cell aggregates, from both adult and foetal sources. Gouras et al 
(1994) successfully demonstrated that foetal RPE cells could be cultured by 
removing small patches of this layer from the choroid of the foetal eye. These RPE 
patches were cultured to give rise to healthy, epithelioid monolayers in vitro within 1-
2 weeks, with correct polarity and the ability to phagocytose outer segments. 
Furthermore the patches were capable of being lifted off a confluent monolayer and 
transferred to another culture dish without risking the viability of either the old or the 
new culture, and so providing a means of transplanting an organized, polarized patch 
of human RPE from one place to another (Gouras et al., 1994). 
 
 
A cultured foetal RPE patch (15-17 weeks gestational age) was subsequently 
employed by Algerve et al (1994)) (Algvere et al., 1994). In their study, five patients 
with AMD (pre-operative visual acuity 0.08-0.2) underwent removal of sub-retinal 
fibrovascular membranes using pars plana vitrectomy techniques. The foetal RPE 
was cultured (2-7 days) and transplanted as a rolled monolayer patch into the sub-
retinal space via a cannula through the retinotomy employed for CNV removal. 
Following reattachment, endotamponade was achieved with either gas or silicone oil. 
Three RPE transplants were placed in the fovea and two were placed in a para-
foveal location. All transplants survived for 3 months and were found to increase in 
size to cover part of the epithelial defect caused by removal of the fibrovascular 
membrane. SLO microperimetry indicated that visual function was present in four of 
the transplants at 1 month but in only two at 3 months after surgery. Function over 
the transplants, especially those in the fovea, was compromised by cystoid-like 
macular oedema. The latter complication was thought to be the result of chronic 
rejection and a compromised blood/retinal barrier. 
 
 
A later study by the same group (Algerve et al, 1997) investigated whether human 
RPE allografts were tolerated or rejected in the sub-retinal space and also examined 
the feasibility of RPE transplantation in subjects with exudative and non-exudative 
AMD (Algvere et al., 1997). This study employed both patches (delivered as a rolled 
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sheet via a cannula), as well as cell aggregates (delivered as cell suspensions via a 
micropipette) of foetal cultured RPE (13-20 weeks of gestational age), transplanted 
via a small retinotomy into the sub-retinal space of five patients after surgical removal 
of sub-foveal fibrovascular membranes, and to four subjects with dry geographic 
atrophy. Suspensions of RPE cells were transplanted to four other patients with non-
exudative AMD. In disciform lesions, RPE transplants developed macular oedema 
concomitant with gradual reduction of visual acuity, implying host-graft rejection, over 
1-6 months. In geographic atrophy, three of four transplants showed little change in 
shape and size after 12 months with one transplant slowly rejected. In non-exudative 
AMD, RPE suspension transplants showed no evidence of rejection and were 
associated with the disappearance of drusen; visual acuity remained stable and SLO 
microperimetry confirmed retinal function over the transplanted area. They concluded 
that human RPE allografts were not invariably rejected in the sub-retinal space 
without immunosuppression, with lower rejection occurring in non-exudative than 
exudative AMD. Once again an intact blood-retinal barrier was thought to protect 
against rejection and it was felt that it was technically feasible to transplant human 
RPE into the sub-macular space without adversely affecting visual function in non-
exudative AMD over relatively long periods of time. 
 
 
Similarly Weisz et al (1999) reported a case of foetal RPE transplantation for end stage 
geographic atrophy (Weisz et al., 1999). In their report a suspension of RPE cells was infused 
via a micropipette into the sub-retinal space through a retinotomy along the superotemporal 
arcade at the edge of the area of atrophy. No endotamponade was applied. The patient's 
vision remained unchanged for 5 months after the surgery. Although the feasibility of foetal 
RPE transplantation to the sub-retinal space was again confirmed subsequent investigations 
revealed leakage and staining at the level of the outer retina, a progressive sub-retinal fibrosis 
in the area of the transplant, and a concerning lymphocyte response against phosducin and 
rhodopsin. 
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Homologous Adult Transplantation 
 
Following on from the original case report by Peyman et al (1991), and on the 
background of a number of animal studies demonstrating RPE cell viability on 
artificial substrates, Tezel et al (1997) described a method for the harvesting and 
storing of intact viable sheets of adult human RPE cells (Tezel et al., 1997). The cells 
were harvested from 21 cadavers eyes using the enzyme Dispase. The sheets were 
embedded in 50% gelatin containing 300 mM sucrose and stored at 4 degrees C. 
The viability of the cells, as well as their ability to proliferate in vitro, was studied for 
96 hours after harvesting. Subsequent microscopic examination of the RPE sheets 
confirmed the cells appeared suitable for retinal transplantation if harvested within 24 
hours of death and maintained 82% viability for as long as 48 hours if stored at 4 
degrees C. The study confirmed the feasibility of isolating and harvesting intact 
sheets of viable adult human RPE using the enzyme Dispase. 
 
 
This technique was subsequently utilized by Del Priore et al (2001) in a case report 
of adult human transplantation (Del Priore et al., 2001). An 85-year-old patient with 
bilateral choroidal neovascularisation underwent sub-foveal membranectomy 
combined with transplantation of a sheet of human adult RPE under the foveal centre 
in the right eye. The RPE sheet was delivered and unfolded via a cannula through 
the retinotomy utilized for CNV removal and following retinal reattachment an air 
tamponade was applied. The patient was immunosuppressed post-operatively with 
prednisone, cyclosporine, and azathioprine. The patient died from congestive heart 
failure 114 days after surgery with a lack of visual improvement. Subsequent 
histological examination revealed the transplant site contained clusters of round, 
pigmented cells that did not form a uniform monolayer in most areas. There was loss 
of the photoreceptor outer segments and native retinal pigment epithelium in the 
centre of the transplant bed, with disruption of the outer nuclear layer predominantly 
over regions of multilayered pigmented cells. Cystic spaces were also present in the 
inner and outer retina. The morphological findings were consistent with the clinical 
outcome. 
 
 
Progressing on from successful enzymatic harvesting of RPE cells, Valtink et al 
(1999) proposed RPE cell banking, akin to a cornea bank, as a prerequisite to have 
well-differentiated, characterized cells to hand when required for research or 
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therapeutic purposes. This group enzymatically isolated RPE cells from donor eyes 
and cultured them for subsequent HLA typing, cryopreservation in liquid nitrogen, 
and registration on a donor list (RPE cell bank) (Valtink et al., 1999b). 116 typed cell 
cultures were stored as a source for 7 subsequent cell transplantations with matching 
HLA type in patients suffering from RPE degenerative diseases (Valtink et al., 
1999a). 
 
 
The homologous transplantation studies detailed above have shown limited success in terms 
of restoration of function, with foetal RPE transplantation for non-exudative disease providing 
the most positive outcomes. Likely explanations for the poor clinical outcomes include the 
significant difficulties associated with tissue matching and rejection, but additionally, the RPE 
cell loss secondary to the need for cell harvesting and preservation prior to transplantation, 
the surgical learning curve, and the method of RPE delivery with increased overall cellular 
manipulation over autologous techniques. Considering the latter, the above studies have 
delivered homologous RPE to sub-retinal locations, through small retinotomies used initially 
to create localized detachments. The RPE is introduced either as sheets or patches via a 
cannula and unfolded, or as cell suspensions via a micropipette. The advantage of using 
sheets of RPE is that a pre-formed correctly orientated monolayer can be specifically placed 
over the diseased area. This is however offset against the technical difficulties encountered 
when delivering a relatively large sheet through a small retinotomy. The sheet will require 
additional manipulation to mount it (usually rolled) on or into the cannula or micropipette and 
then correctly unfold and position it to prevent multi-layering and folding, although foetal and 
gelatin fixed patches unfold spontaneously. This can be circumvented by creating a large flap 
retinotomy as per Peyman et al (1991) however this warrants the need to create a much more 
extensive detachment adding additional complexity and time to the procedure. An alternate 
method of RPE delivery is to inject cell suspensions into the sub-retinal space. While this is a 
far simpler method, it has the disadvantage that the formation of a monolayer cannot be 
guaranteed, with cells incorrectly orientated or not attaching to Bruch’s membrane and 
entering the vitreous cavity. As mentioned, despite the poor functional outcomes, the body of 
work on homologous transplantation provided considerable information on techniques of cell 
harvesting, culture and viability, for future studies examining artificial RPE substrates and 
stem cell derived sources of RPE. 
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Autologous Transplantation 
 
 
Autologous transplantation has a number of advantages over homologous 
transplantation. Primarily it avoids the problems of tissue compatibility and rejection 
by harvesting RPE cells from the patient and relocating to the diseased area, there is 
less overall manipulation of the graft and associated cell loss, there is no risk of 
transmitting any disease from one patient to another, and it avoids ethical and 
religious conflicts arising from using foetal or cadaveric sources of RPE.  
 
 
In the first description of autologous human transplantation Peyman et al (1991) 
fashioned a large retinotomy and rotated a full thickness pedicle graft into position. 
Stanga et al (2001) employed a similar technique, however surgery was performed 
through a small retinotomy and all but one of the study patients underwent 
transplantation with a free rather than a pedicle graft (Stanga et al., 2001). The small 
retinotomy offered the advantage of reducing nerve fibre and subsequent filed loss 
from a large retinotomy, reduced risk of PVR, no need for pre-operative laser, and 
reduced surgical time. In their study, six patients with untreated exudative AMD 
underwent surgical excision of the sub-foveal CNV with RPE translocation and were 
followed from 1 to 10.5 months. The surgery consisted of a standard vitrectomy with 
excision of the CNV through a small retinotomy and a localized detachment. Using 
vertical sub-retinal scissors introduced through the retinotomy a 500-1500µm 
pedicled full thickness RPE-choroid graft was fashioned from the edge of the RPE 
defect in the first patient and a free graft in the remaining five patients. Once 
fashioned, the grafts were immediately positioned under the fovea to maintain the 
correct RPE orientation, again using the vertical scissors, with gas tamponade 
following reattachment. The study demonstrated that RPE could be effectively 
translocated, at the time of CNV removal, from the edge of the RPE defect to a sub-
foveal location. Optical coherence tomography (OCT) showed the translocated RPE 
as an area of increased optical reflectivity with optical shadowing external to it and 
graft autofluorescence revealed viable translocated RPE. Microperimetry was 
performed with a cross fixation target and this was seen when projected on the 
translocated RPE. Photopic 10-2 perimetry, photopic fine matrix mapping, and 
confocal laser scanning ophthalmoscopy (cLSO) confirmed the presence of central 
visual function. At an average follow up of 4.5 months, the visual acuity remained 
stable in all but one patient (83.3%), with no patients improving their vision. The 
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complications reported in the study included two patients in whom it was not possible 
to place the patch under the desired retinal location, one with an inverted graft, one 
patient with a sub-retinal bleed, and one patient developing PVR with a total retinal 
detachment. The study confirmed that para-foveal transplanted RPE was capable of 
supporting limited photoreceptor function in patients with AMD and that the absence 
of a pedicle suggested revascularization of the graft was a possibility, although there 
was limited follow up on patients receiving the free graft. 
 
 
A second study by Stanga et al (2002) further investigated the feasibility of this 
technique and the visual function over the translocated RPE with longer follow up (12 
to 32 months) (Stanga et al., 2002). In addition to the six previously treated, three 
further patients with untreated exudative AMD underwent surgical RPE translocation 
as detailed above however the technique was slightly modified. In the second study, 
the sub-retinal scissors created two sides of a triangular graft and a second 
retinotomy was created to cut the third side. Once again a pedicle graft was 
fashioned for the first patient with free grafts for the remainder. Long term follow up 
of this cohort revealed surgery was successful in seven of nine patients. The 
recorded complications remained the two patients with inadequate graft placement, 
the one patient with an inverted graft, and the one patient who experienced a total 
PVR with detachment. Post-operative investigations confirmed viable transplanted 
tissue with the presence of central visual function. At an average follow up of 19.7 
months follow up, visual acuity remained stable in 6 patients (66.7%), deteriorated in 
two patients (22.2%) (one uncomplicated surgery and the PVR detachment), and 
improved in one patient (11.1%) (CF to 6/60). Significantly, the improvement 
occurred with a free graft with 12 months follow up, providing strong indirect 
evidence for graft revascularization. The results of both studies demonstrated that 
not only was autologous transplantation technically possible, but in addition to 
anatomical restoration, it also offered real functional recovery. 
 
 
A long term follow up of the cohort of patient who underwent successful 
transplantation from the above study was performed by McLaren et al (2005) 
(MacLaren et al., 2005). Four of the 9 patients who originally underwent surgery and 
whose results were reported after 2 years of follow-up were reviewed again 5 to 6 
years after surgery. Visual acuity, imaging, angiography, and the maintenance of 
overlying foveal fixation were used to assess the long-term success with 
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comparisons made to the original 2-year follow-up data. The assessment revealed 
that over the long term, vision had declined further in 3 patients and improved slightly 
in 1 patient. Significantly, all 4 patients had lost foveal fixation and autofluorescence 
of the graft, which had been present at the original 2-year follow-up assessment. The 
RPE graft, however, seemed viable when assessed by OCT and angiography, and 
no patient suffered a recurrence of the CNV. The study confirmed anatomical graft 
survival in the sub-foveal space for at least 5 to 6 years, although functional rescue 
appeared to be transient. It was postulated that the long-term loss of graft 
autofluorescence, foveal fixation, and ultimately vision might be secondary to chronic 
photoreceptor apoptosis, initiated either by the original trauma of surgery, or a 
continuation of the disease process itself. Conversely the graft or trophic factors 
released by it may have slowed the natural course of disease driven apoptosis, and 
the loss of autofluorescence simply reflect the death of overlying photoreceptors 
secondary to loss of disc shedding.  It was also suggested that as the graft was 
harvested from an extra-foveal region, it was likely to be diseased and compromised 
from the outset. Thus, the placement of diseased RPE under the densely packed 
foveal photoreceptors may have overburdened the graft leading to apoptosis.  
Finally, the use of extra-foveal RPE also created a defect in an area that would 
otherwise have been used as an alternate fixation point when foveal fixation is lost. 
In this regard visual loss was compounded after graft failure and this was in fact 
found to be the case, as the one patient who improved vision had reestablished 
fixation at the edge of the central defect. This study suggested that while macular 
RPE may survive and initially support photoreceptor function, ultimately this method 
of transplantation was unable to sustain long-term recovery of function. 
 
 
Using a similar technique to that outlined by Stanga et al (2001), Angunawela et al 
reported a 4 year follow up on a pedicled graft (Angunawela et al., 2005).  The graft 
was fashioned in the sub-retinal space with vertical scissors and repositioned 
successfully under the fovea following CNV removal. The case was complicated with 
a PVR detachment however angiography revealed the graft remained vascularised at 
4 years and the patient maintained counting fingers vision. This study also confirmed 
long-term anatomical graft survival however no detailed functional analysis of the 
graft was offered. The RPE rotation techniques described above, and early macular 
translocation studies (Machemer R, 1993b, Eckardt C, 1999) provided the strongest 
proof of principle that non-foveal, autologous RPE from eyes with AMD could to a 
limited degree support foveal function. 
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The next stage in the evolution of autologous RPE transplantation was the use of 
peripheral rather than macular RPE. This was first presented by Binder et al (2002) 
in the form of sub-macular injections of nasally harvested RPE cell suspensions 
(Binder et al., 2002). The study was based on previous observations of RPE loss 
associated with neovascular AMD, the fact that the nasal retina contains more RPE 
than the other quadrants and is much less involved in this disease process, the fact 
that Bruch’s membrane may be locally fragmented rather than absent, and on the 
requirement for RPE replacement to maintain photoreceptor viability. The early 
homologous studies showed no visual improvement and late immune reactions 
necessitating immunosuppression, and the autotransplantation studies detailed 
above showed sequestration after long periods of observation, although both 
Peyman et al (1991) and Stanga et al  (2001, 2002) demonstrated some recovery of 
function. These rotation techniques had a relatively high complication rate and this 
prompted Binder et al (2002) to look for a technical solution that could provide fresh 
autologous RPE with reduced risk. In addition to density of RPE, the nasal retina was 
chosen for ease of controlled RPE cell aspiration and mobilization to a sub-foveal 
site, and a secure area for a retinotomy with respect to subsequent tamponade. In a 
prospective study, 14 eyes (13 patients) with neovascular AMD (2 classic; 2 occult; 
10 mixed lesions; all had angiographic growth of lesion between 3 and 9 months 
previously with substantial acuity decline and baseline acuities ranged between CF 
and 20/50 {6 out 14 had VA < 20/200}) underwent sub-retinal CNV removal with 
simultaneous transplantation of RPE harvested from the nasal sub-retinal area of the 
same eye. Following standard sub-retinal techniques for CNV excision, a second 
retinotomy was created nasal to the optic disc with a sub-retinal pick and a shallow 
detachment created. With a blunt bent 20 gauge vitreoretinal cannula, RPE cells 
were gently mobilized over a 2-4 disc diameter area and the cell suspension 
aspirated with a micropipette connected to a tuberculin syringe. Two thirds were 
transplanted slowly through the first retinotomy created for CNV removal and to avoid 
reflux of cells at the time of transplantation the intraocular pressure was further 
lowered. One third of the RPE cells were sent for cell differentiation and if the amount 
of cells was low (<5000/ml), the procedure was repeated. Finally, the vitreous was 
cleared of any visible pigment cells and the surgery completed with gas tamponade 
and prone posturing for a few days. Post-operatively, at the 12 month follow up point, 
best-corrected visual acuity was improved 2 or more lines in eight eyes (57.1%), 
remained the same (+/- 1 line) in five eyes (35%), and decreased by more than 2 
lines in one eye (7.1%). Pair wise t test showed significant improvement after 1 
month (P = 0.0031, P = 0.0062) as well as 1 year (P = .0066, P = .0105). Satisfactory 
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reading vision between Jaeger 1 and 4 was achieved in three eyes (21.2%) and no 
significant intra-operative or post-operative complications were reported including 
recurrence of CNV. The study however was not able to confirm the optimal number 
of cells for transplantation, whether the functional results observed were a direct 
effect of the transplanted cells restoring the photoreceptor-RPE-choriocapilliaris axis 
or an indirect effect whereby transplanted cells were supporting existing RPE 
function as bystanders, either directly or through the secretion of trophic factors, and 
whether adequate cellular confluency was required or achieved. The study added to 
the preceding body of work suggesting that autologous RPE transplantation with sub-
macular surgery was a reasonable treatment option for neovascular AMD 
 
 
Binder et al (2004) reported a second consecutive series of 39 eyes (predominantly 
occult lesions) in which they slightly modified their surgical technique to further 
improve cell delivery and minimise any potential complications (Binder et al., 2004). 
In the later study once mobilized, the RPE cells were removed from the eye, 
centrifuged and diluted with BSS plus solution, and then injected under the retina 
with the additional use of perfluorocarbon to reduce RPE cell reflux during sub-retinal 
delivery. Cell counts were performed as per the original study to assess cell numbers 
and quality, and finally, if required, laser was applied to the retinotomy. The second 
study design compared membrane excision and transplantation (group 1 – 39 eyes) 
with membrane excision alone (group 2 – 14 eyes) and in addition to distance acuity 
outcomes, also examined functional recovery through multifocal electroretinography 
(mfERG) and reading ability. In group 1, visual acuity improved significantly, two or 
more lines in 21 (53.8%) patients; remained stable in 12 patients (30.8%); and 
decreased two or more lines in 6 patients (15.4%; P=0.0062). In group 2, the 
corresponding values were 21.1%, 57.8%, and 21.1% (P=0.5377). Overall, the net 
change was gain in 1 line in the control group compared with 2 lines in the 
transplanted group. In addition, the difference in reading acuity was also significant 
between the two groups (mean change in group 1: 1.85 +/- 0.42 vs. 0.43 +/- 0.47 in 
group 2; P=0.0001). Furthermore mfERG response density changes were 
significantly different between groups 1 and 2 (P=0.0094) although no significant 
decreases in central visual field defects were detected. The reported complications 
included 4 cases of PVR detachment (10.2%) presumed to be due to reopening of 
the retinotomy with reflux of RPE cells. The study further confirmed that CNV 
removal with autologous RPE transplantation of RPE was a beneficial supplement to 
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membrane excision alone in patients with neovascular AMD and may be regarded as 
a reasonable treatment option. 
 
 
A modification of the above technique for harvesting RPE cell suspensions was 
proposed by van Meurs et al (2004) (van Meurs et al., 2004) in a series of eight 
consecutive patients treated for neovascular AMD. In this method, three weeks pre-
operatively, laser photocoagulation was used to delineate an area of inferior 
peripheral retina for RPE cell harvesting. Three hours prior to surgery, blood was 
collected from the patient to obtain autologous serum. Subsequent surgery involved, 
lensectomy if phakic, vitrectomy, and CNV excision. An inferior retinectomy was 
performed to minimize the effects of any resulting scotoma and RPE cells were 
collected from this location using a modified bent 21 gauge aspiration cannula with 
an 8-O nylon loop to scrape RPE off Bruch’s membrane and simultaneously aspirate 
the cells. The pre-operative laser retinopexy partly overcame any disadvantage from 
a lack of subsequent inferior tamponade. The RPE cells were then removed from the 
eye, centrifuged with autologous serum to prevent cell adhesion to the tubing, and 
poly-L-lysine injected into the sub-macular space to promote adhesion of the RPE 
cells to Bruch’s membrane. The cells were counted and tested for viability and then 
injected into the sub-retinal space and perfluorocarbon used to control RPE cell 
reflux. The surgery was completed with air, gas, or silicone oil tamponade and one 
day of supine posturing followed by prone posturing. The results revealed that at a 
follow up ranging from 3 months to 16 months, the vision remained stable in five 
patients (62.5%) and deteriorated in three (37.5%). A pigmented area was observed 
in the transplantation site in only one patient and fixation was present at the edge of 
the RPE defect in three patients, but not over the pigmented area in the only patient 
with visible pigmentation. PVR detachment was the major complication occurring in 
the three patients with a reduction in vision and this was thought to be secondary to 
the creation the large retinectomy with aspiration of RPE cells leading to breakdown 
of the blood-retinal barrier, unsuccessful prevention of RPE reflux with 
perfluorocarbon, reflux of poly-L-lysine promoting RPE adhesion to the retina, and 
the inferior retinectomy coming into contact with the aqueous phase (containing 
inflammatory cells) when using lighter than water tamponades. With this technique 
autologous peripheral RPE cell transplantation after membrane extraction was 
technically possible in a sterile manner, but was associated with a high proliferative 
vitreoretinopathy rate. Furthermore, RPE cell repopulation was only observed in one 
patient and the study revealed no measurable positive effect on functional outcome. 
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This led to the author abandoning this technique and proposing transplantation using 
full thickness patches harvested from the mid periphery.  
 
 
The most current method of autologous RPE transplantation was first described by 
van Meurs and Biesen (2003) (van Meurs and Van Den Biesen, 2003).  With the 
limited results achieved using diseased macular RPE patch grafts, and the difficulties 
of using suspensions that do not adequately attach to aged or damaged Bruch’s or 
fail to form a satisfactory monolayer, it was postulated that transplantation of an 
intact peripheral monolayer would be required to achieve a functional transplant. Van 
Meurs and Biesen proposed a technique that involved harvesting a full thickness 
RPE-choroid patch from the superior mid periphery and placing it via a retinotomy 
under the fovea following CNV excision. Briefly, following vitrectomy, the CNV was 
excised through a small para-macular retinotomy and the donor site for the patch 
graft (1.5 – 2.0 mm) delineated with endodiathermy, which also avoided any potential 
choroidal haemorrhage. The retina was subsequently removed from within the donor 
site and, using vertical scissors, a patch of RPE-choroid was fashioned from within 
the diathermy marks. Prior to graft delivery the host site was prepared by injection of 
BSS plus into the sub-macular space to maintain the height of the localized 
detachment originally created to remove the CNV. Using a spatula, the free patch 
was then repositioned under the fovea through the para-macular retinotomy. This 
delivery technique was used only for the first three patients as it was found that the 
elasticity of the RPE-choroid caused the graft to roll up into a cigar shape requiring 
considerable manipulation to unfold and correctly place it. Thus, for the next two 
patients, graft capture and delivery was achieved with customised forceps, and 
thereafter with a specially designed aspiration-reflux cannula (DORC Surgical 
Instruments, The Netherlands). The latter, requiring a bimanual technique, involved 
the graft being aspirated onto the end of a modified flat spatula and introduced by the 
surgeon through the retinotomy to the desired sub-retinal position. The graft was 
then released from the spatula by gentle reflux and simultaneous injection of 
perfluorocarbon by the assistant to flatten the localized macular detachment and 
maintain the sub-retinal position of the graft. The advantages of this technique being 
that it minimized the trauma to the graft, it ensured correct orientation of the graft, 
and it allowed a more controlled release of the graft. The disadvantages being 
attempted graft repositioning is cumbersome if the graft unfolds incorrectly, requiring 
reversal of the aforementioned steps, and added graft manipulation and so graft 
positioning is essentially a one shot procedure.  Other disadvantages include graft 
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damage secondary to delivery through a small retinotomy, similarly the retinotomy 
limits the size of the graft resulting in inadequate coverage of the RPE defect and a 
loss of revascularization if this in part relies on contact with healthy RPE-choroid at 
the edge of the defect, and the graft becoming entangled around the cannula 
preventing smooth release. The surgery was completed with laser photocoagulation 
to the mid-peripheral retinotomy site and silicone oil tamponade. The oil was 
removed at three months combined with cataract extraction and lens implantation.  
 
 
In their study, van Meurs and Biesen treated six patients with neovascular AMD 
(minimally classic) with this technique. The pre-operative visual acuity ranged from 
20/400 to 20/200 with an average duration of visual loss of 38.8 days (range 2 - 70 
days). At an average follow up of 10 months (7 – 14 months) the acuity improved in 
five patients (83.3%) and remained stable in one (16.7%) and ranged from 20/64 to 
20/200. A 2-line improvement was seen in three patients (50%). Post-operatively, the 
patch graft appeared flat and had a brown furry aspect in four patients and in these 
four patients fixation was demonstrated on the patch graft. Revascularization was 
visible on fluorescein and indocyanine angiography in three patients however it was 
not possible to determine whether perfusion of the graft was secondary to contact of 
the graft to remaining recipient vessels or due to in-growth of new vessels, with a 
possible trophic effect of the graft on the recipient bed. RPE autofluorescence also 
revealed almost normal macular intensity over the patch graft after excitation with a 
confocal scanning laser with an Argon (488 nm) beam in four patients. This indicated 
the presence of lipofuscin from the normal turnover of photoreceptor outer segments 
by RPE strongly suggesting normal interaction between photoreceptors and the 
RPE. The study demonstrated that transplantation of an autologous full-thickness 
patch of mid peripheral RPE to the macula following CNV extraction was technically 
feasible. Furthermore the graft was able to revascularise, remain unfibrosed, survive 
to be functional beyond a year, and that mid peripheral was capable of supporting 
foveal function. 
 
 
A follow up study was performed by van Meurs et al (2006) to evaluate long term 
visual outcome for autologous mid peripheral full thickness RPE transplantation and 
to identify pre-operative factors that correlate with vision after one year (van Meurs et 
al., 2006). A consecutive series of 58 patients with neovascular AMD underwent 
surgery as outlined above. In terms of modifications to the surgical technique, 
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following the initial full-thickness choroidal incision to fashion the graft, a long spatula 
was used to sweep under the patch prior to cutting the rest of the graft free. This was 
performed in order to release any attachments between the choroid and the sclera, 
and so allow free release of the patch graft prior to cutting the reminder of the graft. 
The best corrected Early Treatment Diabetic Retinopathy Study (ETDRS) vision was 
measured pre-operatively and at one (n=58) and two years (n=19 of 58) post-
operatively and converted to a logarithm of minimal angle of resolution (logMAR) 
score. 52 of these patients had pre-operative imaging, including colour images and 
angiography. The correlations between pre-operative vision, lesion type 
(predominantly or minimally classic, occult or haemorrhagic), size (in disc areas) of 
the lesion, size of sub-retinal hemorrhage, duration of visual loss and ETDRS vision 
at 12 months were tested with uni– and multivariate analysis. The mean pre-
operative vision was 0,96 logMAR and post-operatively this mean showed a 
moderate improvement at 1 year to 0,90 logMAR and at 2 years to 0,77 logMAR. 
Pre-operative vision was 20/80 or better in 2 patients (3.4%) and after 1 year 20/80 
or better in 14 (24.1%). At the 2 year point, of the 19 patients still being followed up, 
4 had visions of 20/80 or better. The duration of visual loss ranged from 3 weeks to 
11 months, with a median of 5 weeks and univariate analysis showed an inverse 
relation between duration of visual loss and vision at 12 months. Furthermore, in 
patients with a visual loss of less than 5 weeks duration, the size of the lesion and the 
size of hemorrhage were inversely related to vision at 12 months. Multivariate 
analysis, however, failed to confirm these associations. Post-operative complications 
included PVR retinal detachment in 4 patients (6.9%), suprachoroidal hemorrhage in 
1 patient (1.7%) and a recurrent or persistent choroidal neovascularisation in 9 
patients (15.5%). The study further confirmed that autologous full thickness mid 
peripheral RPE patch grafting was capable of not only stabilizing visual loss but also 
recovering lost function. No pre-operative factors were identified for improved patient 
selection, possibly due to other variables, such as the per-operative limitations of the 
technique mentioned above and the post-operative complications.  
 
 
The next major study to evaluate this technique was performed by Joussen et al 
(2006) (Joussen et al., 2006). This group treated 45 eyes of 43 patients with AMD (n 
= 42 neovascular membranes {PED 16; occult 14}, n = 3 geographic atrophy). Pre-
operative distant visual acuity ranged from 20/800 to 20/40 and reading vision 
ranged from 1.4 logarithm of reading acuity determination (logRAD) to 0.5 logRAD 
(0.04 to 0.32 Snellen equivalent). Revision surgery was required in 22 eyes as a 
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result of PVR, retinal detachment, macular pucker, or vitreous hemorrhage and in 
eight patients the patch was renewed. Post-operatively, at six months, distant visual 
acuity ranged from light perception to 20/50 and reading vision ranged from 1.4 to 
0.4 logRAD. The distance vision improved in 11 patients (24.4%), remained stable in 
5 (11.1%) and declined in 29 (64.4.%), with an increase of 15 letters in 4 eyes (9%). 
The results revealed the visual outcome was unrelated to the type of AMD. The 
angiographic studies demonstrated vascularisation of the patch graft in 40 of 42 
eyes. Furthermore, in the majority of patients, autofluorescence of the pigment 
epithelium was coincident with revascularization of the graft. Finally, fixation on the 
patch graft was positively related to visual acuity and it was postulated that pre-
operative fixation stability and microperimetry would assist selecting patients who 
would benefit from this surgical treatment. The series provided further evidence that 
autologous full-thickness transplantation of the choroid and RPE resulted in a 
vascularised and functioning graft that could lead to improved vision. The study was 
also the first to treat non-exudative disease and showed that vascularisation was 
also achieved in patients with geographic atrophy. 
 
 
Thereafter a number of studies were undertaken further examining autologous full 
thickness peripheral RPE patch grafts widening the scope to treat exudative and 
non-exudative AMD with evolution to the technique. Fawzy et al (2006) reported on a 
consecutive series of 25 patients with neovascular AMD (sub-macular haemorrhage 
(5), occult only CNV (11), classic only CNV (2), mixed CNV (1) PED (4) and rupture 
of RPE (2)) treated with this method of RPE grafting (Fawzy et al., 2006). The study 
group comprised 2 eyes with classic membranes, 11 eyes with occult membranes, 1 
eye with mixed membranes, 4 eyes with PED, 2 eyes with rupture of the RPE and 5 
eyes with massive sub-retinal bleeding were included and all patients were evaluated 
prior to patch and at 6 months and 1 year follow–up. The pre-operative acuity ranged 
from 0.3 to 1.4 (logMAR) and at 1 year post–operative vision ranged from 0.10 to 
2.10, with stabilization (± 1 line) in 5 (20%) eyes and an increase of two or more lines 
in 5 eyes (20%). Decrease of visual acuity was seen in most cases within the first 3 
months after surgery and was mainly due to chorioretinal trauma or bleeding in 6 
cases (24%), decentration of the patch in 3 cases (12%), intra-vitreal haemorrhage, 
lack of vascularisation of the graft, epiretinal membrane formation and cataract each 
in 1 eye (4%).  5 cases (20%) showed recurrence of CNV at the edge of the patch at 
6 months or one year follow–up visit and were treated with laser coagulation. From 3 
months to 1 year follow–up, 19 of 25 eyes showed no change (± 1 line) or an 
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increase of visual acuity (mean change from 3 to 12 months: increase of 0.1 
logMAR). Angiography demonstrated that in patients who demonstrated 
vascularisation of the graft after 3 months, this persisted up to 12 months. Similarly, 
there was no difference in autofluorescence of the graft between 6 months and 12 
months post-operatively. Microperimetry demonstrated that in patients with stable 
fixation at 6 months, this was maintained up to 12 months. As per the study by 
Joussen et al (2006), this study showed that at 1 year the surgery resulted in a viable 
graft and that improved vision was possible, even during the 6 to 12 month follow up 
period.  In terms of graft viability, once vascularisation of the graft was established it 
persisted throughout the 12 months observation period with no evidence of graft 
failure. However, once again the post-operative complications were considerable 
including sub-retinal haemorrhage with developing fibrosis or PVR occurring within 
the first 3–6 months.  
 
 
Kirchhof et al (2006) evaluated the technique for patients with geographic atrophy. In 
this study 18 patients were treated with a follow up of at least six months in 11 
patients (Kirchhof et al., 2006). In the absence of removing CNV, during the 
technique, Bruch’s membrane was scrapped prior to graft delivery to promote a local 
inflammatory response and encourage revascularization of the graft at the host site. 
The pre–operative visual acuity ranged from 20/800 to 20/32 (logMAR) and reading 
vision ranged from no reading vision to 0.3 (logRAD). At three months, the post–
operative vision ranged from 20/800 to 20/63, and at six months the vision ranged 
from counting fingers to 20/32 with an increase of 2 lines in 2 eyes (11.1%). 
Complications included revision surgery required in 7 eyes secondary to PVR. In 16 
eyes, revascularization was visible on angiography as early as 3 weeks after surgery 
however in one of these cases vascularisation slowly appeared after 3 months. 
Autofluorescence of the pigment epithelium was seen in all eyes independent of the 
revascularization of the graft and persisted throughout the follow–up. Microperimetry 
and fixation analysis revealed that six eyes had unstable fixation and/or extra-foveal 
fixation before surgery, of which two developed predominantly stable fixation post-
operatively. All eyes with pre-operative stable or predominantly stable fixation were 
stable or predominantly stable post-operatively. In cases with pre-operative fixation 
on a central RPE peninsula, fixation remained at this position throughout the follow–
up. Microperimetry also showed that the retina overlaying atrophic areas 
demonstrated a relative scotoma that persisted after grafting with only limited 
recovery. Finally no recurrence of RPE atrophy was observed on the patch during the 
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follow–up. This study confirmed the feasibility of the technique for geographic 
atrophy although the short follow up period could not exclude disease recurrence or 
long-term graft viability. 
 
 
Treumer et al (2006) (Treumer et al., 2007) further modified the technique by 
fashioning a circular rather than a square graft to prevent curling of the patch. In their 
consecutive series of 10 patients with AMD (n=9 neovascular disease {sub-macular 
haemorrhage (5), large occult only CNV (3), PED (1)}; n=1 geographic atrophy), who 
were followed up for 1 year, the mean logMAR acuity improved from 1.37 (0.7 to 1.8) 
to 1.24 (0.4 to 1.24). The acuity improved in seven patients (70%), remained stable 
in one patient (10%), and decreased in two patients (20%). Microperimetry 
demonstrated light sensitivity and fixation on the sheet in five cases and angiography 
demonstrated perfusion through the RPE-choroid graft in nine patients. Post-
operative complications included retinal detachment (n = 1), epiretinal membrane 
formation (n = 2), and the patient with geographic atrophy developed a CNV after 
surgery. 
 
 
The studies above demonstrate how autologous full thickness peripheral RPE 
grafting has evolved from the very first report by Peyman et al in 1991 to become the 
primary method of RPE transplantation (Table 19). The very early studies of CNV 
removal and the sub-macular surgical trials established that RPE replacement was a 
requisite for photoreceptor survival. The search for an easily accessible source of 
RPE free from the constraints of immunological compatibility drove the use of 
autologous RPE. As outlined the techniques have developed away from the use of 
macular flap grafts with potentially diseased RPE to the use of free macular then 
peripheral cell suspensions. The failure of cell suspensions to form an adequate 
monolayer illustrated that the reestablishment of near physiological sub-foveal 
architecture was required and hence the use of full thickness grafts comprising 
choriocapilliaris-Bruch’s-RPE. 
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4 Complications 
 
 
A number of complications have been reported in the studies of human 
transplantation detailed above. As with macular translocation these have 
compromised the outcome of the surgery.  Unlike full macular translocation, whereby 
the core surgical technique has remained unchanged since its first description, with 
evolutions to the surgery designed to address the complication rates, transplantation 
surgery has only relatively recently settled on the method of transplantation first 
described by van Meurs and Biesen (2003). With on going investigations, this 
technique has yet to undergo further scrutiny and modification. 
 
 
Considering the human studies, no intra or post-operative complications were 
reported in the first report by Peyman et al (1991) utilizing the open sky technique of 
transplantation, however this was only a single case report of adult homologous and 
autologous transplantation. Algerve et al (1994) were the first to report the current 
method of graft delivery (rolled monolayer patch) through the small retinotomy 
created for CNV removal. In this series (homologous foetal RPE patch, n=5) again no 
intra-operative complications were reported, however cystoid macular oedema was 
reported 3 months post transplantation. Similarly a later series by this group (Algerve 
et al, 1997), transplanting both foetal RPE patches (n=5,exudative AMD), and cell 
suspensions (n=4,geographic atrophy), reported no intra-operative complications but 
again reported cystoid macular oedema in cases of exudative AMD, occurring with 1-
6 months. Likewise, Weisz et al (1999) (homologous foetal RPE cell suspension, 
geographic atrophy) and Del Piore (2001) (homologous adult RPE patch, exudative 
AMD) both reported no complications other than a progressive rejection, in their 
single case reports. These early reports established that sub-retinal delivery of RPE 
through a small para-foveal retinotomy was relatively straightforward and the late 
complications were secondary to immunological rejection, a problem inherent with 
homologous transplantation. 
 
 
In subsequent series of autologous transplantation, with development of the 
technique and increasing numbers treated, a small number of intra-operative 
complications were reported (Table 20). Stanga et al (2001, 2002) et al (autologous 
macular RPE patch, n=9) reported two cases in which the patch was not located at 
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the desired sub retinal position, and one where the patch was inverted. van Meurs et 
al. (2004) (autologous peripheral RPE suspension, n=8) reported two cases of RPE 
reflux into the vitreous cavity on cell, and one case of an intra-operative inferior RD 
requiring silicone oil secondary to failure of the pre-operative laser around the donor 
site. In all subsequent series involving autologous peripheral patch grafts (n=166), 
there have been a relatively small number of intra-operative complications. These 
include a fibrous fold across the graft (van Meurs and Biesen, 2003, n=6), two folded 
patches van Meurs et al, 2006, n=58), one inverted grafts (Joussen et al, 2006), ten 
sub-retinal haemorrhages at the donor site, peripheral retinal break, and four macular 
hole formation during CNV extraction (Joussen et al, 2006, n=45). 
 
 
In addition to the late complications associated with homologous grafting mentioned 
above, a number of post-operative complications have been reported for autologous 
graft studies (Table 21). The occurrence of haemorrhage, particularly sub-retinal, has 
a profound effect on graft success and vision secondary to the direct toxic effects of 
the blood, the graft associated fibrosis that the blood induces, and the anatomical 
disruption of the photoreceptor-graft-choroidal axis. In the immediate post-operative 
period massive sub-retinal hemorrhage was reported in 40% of patients by Joussen 
et al (2006). This study reported that the larger the haemorrhage the poorer the 
visual outcome, with clearance of the blood and re-grafting required for very large 
bleeds. Furthermore, sub-retinal haemorrhage was found to be more common in 
patients on antiplatelet therapy and with occult CNV. Late post-operative 
haemorrhage was also reported by van Meurs and Biesen (2003), however this was 
found to resolve spontaneously and was not related to CNV recurrence and Fawzy et 
al (2006) also reported sub-retinal haemorrhage in 6 of 25 cases (24%). 
Suprachoroidal haemorrhage and vitreous haemorrhage were also reported, with 
one case of the former encountered each by van Meurs et al (2003) and Joussen et 
al (2006), and 16 cases of the later by Binder et al (2004) (14), Joussen et al (2006) 
(1), and Fawzy et al (2006) (1).  
 
 
PVR detachments are a serious sight threatening complication in vitreoretinal 
surgery and much effort is undertaken to minimize this complication. The techniques 
of RPE transplantation themselves pose a potential risk by exposing RPE cells to the 
vitreous cavity, both at the time of CNV removal, as well as at the graft donor and 
host site during graft harvesting, delivery, sub-retinal manipulation, and post-
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operatively. These factors are of particular concern with the autologous peripheral 
patch graft technique, as PVR detachments were not reported with homologous 
grafting. This was likely due to a combination of graft delivery through a very small 
retinotomy via a micropipette minimizing RPE reflux and the small numbers in these 
studies. Among the studies of autologous transplantation, the rates of PVR 
detachment are summarized in Table 21. Stanga et al (2001, 2002) reported 1 case 
(11.1%) of a total PVR detachment in this series of 9 patients treated with a macular 
patch graft. Using the same technique, the single case reported by Angunawela et al 
(2005) was also complicated by a PVR detachment. With the use of RPE cell 
suspensions Binder et al (2002) reported no post-operative complications, however 
in their second study (2004) 4 of 39 patients (10.3%) developed PVR detachments 
secondary to reopening of the retinotomy. Using this technique, van Meurs et al 
(2004) reported 3 cases of PVR in 8 patients (37.5%). Autologous peripheral full 
thickness patches also showed a high rate of PVR, with this complication reported in 
4 of the 58 patients (6.9%) in the second series by van Meurs et al (2006), in 17 
(PVR) + 11(epiretinal membrane (ERM) – a form of PVR) of 45 patients (38.8% + 
24.4% respectively) by Joussen et al (2006), in 1 patient (ERM) of 25 patients (4%) 
by Fawzy et al (2006), in 7 patients of 18 patients (38.9%) by Kirchhof et al (2006), 
and in 1 (PVR) + 2 (ERM) of 10 patients (10% and 20% respectively) by Treumer et 
al (2006).  
 
 
Measures to tackle the formation of PVR include the use of prophylactic 5-fluoro-
uracil (Asaria et al, 2001) (Asaria et al., 2001), minimizing the size of and trauma to 
the para-macular retinotomy, and ensuring good chorioretinal adhesion around the 
retinotomy with minimal sub-retinal fluid post graft insertion. PVR is also minimized 
by as complete a removal of released RPE cells as possible and an extensive a 
vitrectomy as possible. The size and position of the donor site may also affect PVR 
rates as a posterior site may cause PVR traction on the retinotomy. Alternatively, an 
anterior location may result in PVR related anterior base contraction with traction on 
the donor site. Hence the mid peripheral site preferred utilized the investigations to 
date. 
 
 
Other late complications reported include serous macular detachment and macular 
oedema in the absence of a neovascular membrane (van Meurs and Van Den 
Biesen, 2003; Joussen et al., 2006). Finally, CNV recurrence is a major drawback to 
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the success of transplantation resulting in graft failure from secondary macular 
oedema, sub-retinal haemorrhage and fibrosis. CNV recurrence has been reported in 
9 of 58 patients (15.5%) (van Meurs et al, 2006), in 5 of 25 patients (20%) (Fawzy et 
al, 2006), and in the one patient with atrophic AMD  (10%) (Treumer et al, 2006). In 
all these studies the advent of anti-VEGF agents has provided a means of treating 
this complication without further surgical intervention, however the long-term impact 
of inhibiting neovascularisation of graft vascularity is not known.
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5 Effectiveness 
 
 
 
The effectiveness of RPE transplantation is ultimately gauged by the ability to restore 
stable central vision. The surgery aims to achieve this by reestablishing the defect 
created in the sub-foveal anatomy following CNV excision. The anatomical outcome 
can be monitored in a straightforward manner by the use of OCT (MacLaren et al 
2005,) to examine the photoreceptor-RPE-choroid axis, and angiography to examine 
the vascular supply. In terms of anatomical outcome, the studies described in the 
previous sections demonstrate that of the transplantation strategies, only patch 
grafting successfully provides a continuous monolayer of RPE cells, that are correctly 
orientated to interact with the photoreceptor layer above, and if resting on their 
natural substrate, namely Bruch’s membrane-choriocapilliaris, are able to reestablish 
an adequate blood supply. In terms of functional outcome, a number of parameters 
have been used to ascertain the success of transplantation. These include, visual 
outcomes (distance and near), autofluorescence, microperimetry, and 
electrodiagnositics.  
 
 
Visual Outcomes 
 
The visual outcomes for the autologous transplantation studies are outlined in Tables 
22-24.  These are considered below over homologous studies because, as 
previously mentioned, the outcomes with homologous transplantation are 
confounded by a number of additional variables including, the rejection response, the 
difficulties of RPE cell harvesting and preservation, RPE cell loss during transfer, and 
the absence of an adequate physiological substrate or replacement for Bruch’s 
membrane or the choriocapilliaris. In terms of visual outcomes, autologous 
transplantation studies have demonstrated only modest gains of vision with relatively 
high complication rates significantly influencing the outcomes (Tables 22-24). 
Furthermore, quality of life measures have failed to correlate with visual improvement 
following autologous peripheral full thickness RPE transplantation. 
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Distance Acuity 
 
The distance acuity outcomes for have been detailed in previous sections.  
Examining outcomes by series and method of transplantation, rather than individual 
case reports, reveals that for macular patch grafts the studies by Stanga et al (2001, 
2002) (n=9) recorded at a mean follow up of 19.7 months, an improvement in 
distance acuity in 11.1%, with 11% improving 2-lines or more, and vision stabilized in 
66.7%. The PVR rate in this series was 11.1%. The long-term follow up (McLaren et 
al, 2005) however revealed that despite transplantation, photoreceptor loss 
continued in the face of some graft survival, a finding that cast doubt on the ability of 
diseased macular RPE to maintain or recover lost function.  
 
For transplantation utilising RPE suspensions, Binder et al (2002, 2004) in their pilot 
study (n=14) and subsequent series (n=39) at 12 months recorded distance visual 
and 2-line improvements both of 57.1%, with vision being stabilized in 35.7% and 
30.8% respectively. The PVR rates in these series were 0% and 10% respectively, 
with intraocular haemorrhage occurring in 41% in the second study. A subsequent 
series by van Meurs, (2004) (n=8) was unable to repeat these results. In this study at 
a mean follow up of 11 months, vision improved in 12.5% with no patients improving 
2-lines or more, and vision being stabilized in 62.5%. The PVR in the study was 38%. 
The rates of visual stabilization appeared impressive however closer inspection 
revealed the pre-operative acuity was poor and the visual gains modest relative to 
the severe complications encountered. The technique was subsequently abandoned 
in favour of full thickness patch grafts harvested from the mid periphery. 
 
Since the original study by van Meurs and Biesen (2003), a number of investigators 
have reported on this technique.  Examining these series reveals the reported 
improvement in vision has ranged from 11.1% - 83 %, with a 2-line gain reported in 
the range 9 – 50%, and stabilization of vision in 11 – 50%. For this technique the 
PVR rate has ranged from 0 – 39% with sub-retinal haemorrhage reported intra-
operatively in 22% (Joussen et al, 2006) and post-operatively in 24% (Fawzy et al, 
2006) and 40% (Joussen et al, 2006). Furthermore CNV recurrence has been 
documented in 16% (van Meurs et al, 2006) and 20% (Fawzy et al, 2006). As with 
macular translocation surgery the outcomes are limited by the timing and incidence 
of complications. This can be influenced by a number of factors including the surgical 
learning curve and the continued refinement of the technique. 
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Near Acuity 
 
Very few transplantation studies have investigated the recovery of near function and 
reading (Table 23). Using Jaeger charts, Binder et al (2002) reported 21.4% (Jaeger 
Types 5 - 11) pre-operative reading ability. Post-operatively this increased to 85.7% 
however the range of Jaeger Types was much broader (Jaeger Types 1 – 16), 
although 7 patients (50%) achieved acuity in the range Jaeger Types 1 – 10. The 
subsequent study by this group failed to repeat this with only 10% achieving acuity in 
the range Jaeger Types 1 – 10. 
 
In contrast, Joussen et al (2006) used the Radner reading chart and reported a 
decrease in reading ability from 31%  (logRad 0.5 – 1.4) pre-operatively to 7% 
(logRad 0.4 – 1.4) post-operatively, however this was closely correlated to the 
occurrence of complications. 
 
 
Functional and Anatomical Outcomes 
 
Several studies have investigated graft vascularisation (angiography), retinal 
sensitivity (10-2 microperimetry; SLO fundus perimeter), fixation analysis (target of 
OCT, cross-pattern fixation target and single-point flashing light, SLO fundus 
perimetry, and Nidek Micro Perimetry 1), and autofluorescence patterns (SLO 
autofluorescence) over areas of RPE transplantation. It would be expected that good 
anatomical restoration would correlate strongly with functional recovery. Considering 
the larger series, fixation over the graft was reported in the range 21.4 – 77.8%, graft 
autofluorescence in the range 66.7 – 100%, and graft vascularisation in the range 
50.0 – 95.2 % (Table 23).  
 
 
Graft vascularisation suggests successful integration and autofluorescence and 
retinal sensitivity over a graft suggest a viable RPE bed supporting the overlying 
neurosensory retina. Examining the data no obvious pattern is apparent between 
these parameters however this may be due to the heterogeneity of the studies, 
including methods of measurements, duration of symptoms, presenting pathology, 
and follow up. It is important to note that these parameters may not always be 
associated. MacLaren et al (2005) demonstrated the loss of autofluorescence in the 
presence of vascularisation in their long term follow up, suggesting late RPE 
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/photoreceptor failure. Also autofluorescence may still be detected in the absence of 
vascularisation, in failing RPE cells, in the early stages of graft failure (Treumer et al, 
2006). Nevertheless, these studies have provided strong evidence associating 
anatomical with functional restoration, as well as an insight into the mechanisms of 
early and late graft failure. 
 
 
Analysing the results of fixation and retinal sensitivity, the 77.8% fixation documented 
in the series by Stanga et al (2002), was completely lost in the long-term follow up 
cohort (McLaren et al, 2005) despite a vascularised graft suggesting, as mentioned 
above, RPE/photoreceptor failure. Joussen et al (2006) reported fixation over the 
graft in 47.5% and showed that eyes with stable pre-operative fixation were more 
likely to maintain fixation post-operatively. A weak correlation between visual acuity, 
fixation locus, and stability was demonstrated. This study also showed that retinal 
sensitivity was present over grafted areas and absent over fibrosis, haemorrhage, 
atrophy, and non-autofluorescence.  Kirchhof et al (2006) reported fixation over the 
graft in 77.8% of patient in their series and also demonstrated that 6 patients with 
unstable pre-operative fixation had recovered fixation pre-operatively. Finally, 
Treumer et al (2006) demonstrated the absence of fixation at 3 months post-
operatively was associated with a lack of fixation at 12 months follow up. 
 
 
Graft revascularization and integration, has been extensively studied with 
angiography for full thickness grafts, high-speed indocyanine green angiography has 
demonstrated choroidal and choriocapillary perfusion. Joussen et al (2006) and 
Truemer et al (2206) reported early graft perfusion from 1 to 16 weeks after surgery. 
Fawzy et al (2006) and Joussen et al (2006) both reported that once early graft 
vascularisation was established, it persisted for virtually all patients throughout the 
follow up period in each study. Comparing the three series treating geographic 
atrophy  (Joussen et al, 2006; Kirchhof et al, 2006, Treumer et al, 2006) all reported 
similar revascularization rates between exudative and non-exudative disease. In 
terms of the mechanism of revascularization, Joussen et al (2006) also reported 
perfusion from the underlying choroid and their serial angiography suggested the 
initial vascular contact underwent later remodeling. 
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The studies to date suggest that RPE transplantation is a technically feasible 
procedure that is capable of restoring the choriocapilliaris-Bruch’s-RPE-
photoreceptor axis and providing support to the neurosensory retina. As with 360-
degree macular translocation, the current technique of autologous transplantation of 
mid peripheral RPE makes it an ideal donor as the tissue is not affected by macular 
disease, has intact Bruch’s and choriocapilliaris beneath it, and avoids the problems 
of rejection. The surgical technique has evolved from the first report however despite 
a number of advances, the recovery of function in neovascular AMD remains 
inconsistent and limited by a high rate of sight threatening complications. 
Nevertheless, the procedure, which is technically more straightforward than full 
translocation, offers a reconstructive treatment when neovascular disease leads to 
significant anatomical disruption not amenable to current treatments. Furthermore, 
full thickness autologous RPE transplantation may also provide a potential treatment 
for non-exudative disease, other macular disorders associated with RPE dysfunction, 
and a potential vehicle for sub-retinal delivery of therapeutic agents. This thesis will 
consider the surgical aspects of this treatment, the pre-operative factors influencing 
the outcomes, and the anatomical and functional outcomes in the context of 
neovascular AMD, as well as its potential for treatment beyond AMD.  
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II General Methods and Materials 
 
 
 
I Ethical Declaration  
 
All studies fulfilled the regulation requirements of the Moorfields Eye Hospital and 
Whittington Hospital’s Ethics and Research Governance Committees. These 
committees regulate research according to the United Kingdom Department of 
Health Research Governance protocols and the recommendations of the 1998 UK 
Data Protection Act. All research presented conformed to the tenets of the updated 
2000 Declaration of Helsinki. 
 
 
 
II Ophthalmic Assessment 
 
All patients underwent a complete ophthalmic assessment at day 1 pre-operatively 
and at the end of the specified trial period. The assessment consisted of: best 
corrected visual acuity (BCVA), near visual acuity assessment and reading speed, 
contrast sensitivity, slit lamp bi-microscopy, Goldman applanation tonometry, 
ophthalmoscopy, slit lamp assessment of foveal fixation, colour fundus photography, 
scanning laser ophthalmoscope autofluorescence, indocyanine green and 
fluorescein angiography and OCT. All clinical assessments were performed by 
ophthalmologists and imaging performed by trained technicians. 
 
 
1 Visual Acuity (Appendix 1) 
 
The best-corrected visual acuity was measured using a back-illuminated Lighthouse 
visual acuity chart at 6 metres (m) and recorded as a logarithm of minimal angle of 
resolution (logMAR) score. 
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2 Near Visual Acuity Assessment (Appendix 1) 
 
The Minnesota Low-vision Reading (MN-READ™) Acuity Charts were used at a 
viewing distance of 25cm in daytime northern hemisphere lighting conditions to 
measure: reading acuity (smallest print that can be read without significant errors), 
critical print size (smallest print that can be read with maximum speed) and maximum 
reading speed (reading speed when not limited by print size). Reading acuity and 
critical print size were recorded as a logMAR scores and reading speed as words per 
minute.   
 
 
3 Contrast Sensitivity (Appendix 1) 
 
Contrast sensitivity was measured using the Pelli-Robson contrast sensitivity chart at 
1m in daytime northern hemisphere lighting conditions. The chart consists of triplet 
opto types 20/60 in size, whose size remains constant throughout but whose contrast 
decreases both down and across the chart. Pelli-Robson scores reflect the logarithm 
of the contrast sensitivity of each triplet group.   
 
 
4 Colour Fundus Photography and Angiography 
 
All colour fundus photographic and angiographic images were taken and processed with a 
Topcon retinal camera (Topcon TRC-50IX™, Topcon Medical Systems, Inc, Paramus, NJ, 
USA 
 
 
5 Optical Coherence Tomography (OCT) 
 
An OCT3 scan of the posterior pole was performed on all patients (STRATUSOCT™ 
version 4.1low coherence interferometer, Carl Zeiss Meditec, Inc., Dublin, CA, USA). 
A single fast macular scan was performed passing through the fovea 
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6 Scanning Laser Ophthalmoscope (SLO) Autofluorescence 
 
An autoflourescence scan of the posterior pole was performed on all patients with the 
Heidelberg confocal scanning laser ophthalmoscope (Heidelberg Retina Angiograph 
2 (HRA2)™, Dossenheim, Germany). To amplify the autofluorescence signal, a 
series of at least 10 digital images were captured and aligned in the fluorescein 
angiograph mode (FA mode). The final scan represented the composite of the 
individual acquisitions after detection and correction of eye movements by using 
image analysis software. 
 
 
 
7 Slit-Lamp Assessment of Fixation (Appendix 3) 
 
A simple three step slit lamp based system was used to assess the quality of foveal 
fixation. Firstly an 8 x 2 millimetres (mm) slit was projected onto the posterior pole 
and patients were asked to fix on each corner of the slit with the slit first projected 
vertically and then horizontally. Secondly the slit size was reduced to 2 x 2 mm and 
the patient assessed to see if they could maintain foveal fixation for 2-5 seconds. 
Finally the same slit size was presented at three differing extra-foveal locations and 
the patient was assessed to see if they could re-fixate with the fovea with a single 
saccade. Fixation was classified as good – central, good – eccentric, poor – with 
macular fixation, no central fixation (Table 25). 
 
 
 
8 Post-operative Follow Up 
 
In addition to pre-operative and final ophthalmic assessments all patients were 
reviewed at day 1, day 7 and at 4 weeks following each procedure. Each visit 
consisted of: BCVA, near visual acuity, slit lamp bi-microscopy, Goldman applanation 
tonometry, ophthalmoscopy and slit lamp assessment of foveal fixation. 
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Table 25 Slit Lamp Assessment of the Quality of Fixation 
 
 
 
Fixation 
 
 
Slit Lamp Evaluation 
 
Good: 
Central 
 
 
8 x 2 mm Slit – Projects to Each Corner of Slit 
2 x 2 mm Slit – Maintains Foveal Fixation for 2 – 5 s 
2 x 2 mm Slit – Able to Re-fixate with Fovea with Single Saccade 
 
 
Good: 
Eccentric 
 
 
As Above but Using Extrafoveal Fixation Site 
 
Poor: 
Macular 
 
 
Inconsistent Fixation but Using Macula to Fixate 
 
No 
Central Fixation 
 
 
No Macular Fixation 
 
150
 
 
II Nidek MP-1 Microperimetry and Fixation Analysis (Appendix 2) 
 
 
Selected patients also underwent additional assessment of retinal sensitivity and 
fixation pattern using a Nidek MP1 microperimeter (Nidek Co.,Ltd., Tokyo, Japan), a 
full description of which is given in previous literature (Varano and Scassa, 1998) and 
Appendix 2.  Briefly each patient was presented with the minimum fixation target size 
that could be perceived. Microperimetry was performed using a Goldmann V stimulus 
and a 4-2 threshold algorithm. The supplied Nidek MP1 software was used to 
generate an interpolated map of retinal sensitivity projected onto a colored fundal 
photograph. Prior to each assessment, patients also underwent an objective fixation 
analysis with the Nidek MP-1 Micro Perimeter. Using a 1º single white cross target of 
intensity 200 cd/m2 patients were asked to fixate the target for 30 seconds. 
Identification of a retinal landmark enabled the fixation analysis to be superimposed 
onto a retinal image. 
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III Macular Translocation: Surgical and Visual Outcomes 
 
 
 
Introduction 
 
 
 
Macular translocation continues to be the only treatment for severe cases of wet age 
related macular degeneration (AMD) where there is significant mechanical disruption 
of the retinal architecture (large sub foveal haemorrhages and retinal pigment 
epithelial tears – involving ‘scrolling’ of the epithelium). Major changes in the 
treatment possibilities for exudative AMD have occurred with advances in anti-
vascular endothelial growth factor (VEGF) agents. Decisions to treat in AMD have 
historically been dominated by the characteristics of the sub-foveal neovascular 
membrane (CNV). This is an appropriate concept as laser photocoagulation (Group, 
1991a, Group, 1991b, Group, 1994) and photodynamic therapy (PDT) (Group, 1999, 
Group, 2001a, Group, 2001b) are directed at modifying the CNV. This is not as 
relevant to the current generation of anti-VEGF agents that are far less characteristic 
dependent (Michels et al., 2005, Gragoudas et al., 2004, Rosenfeld et al., 2005, 
Spaide et al., 2006) and is an inappropriate concept when considering macular 
translocation as the retina is physically separated from the underlying pathology. In 
this situation the health of the retina and that of the choroid-RPE at the new foveal 
location determine the outcome. We propose that outcome is defined by retinal 
neurosensory function at the time of surgery and the type of CNV is irrelevant to 
outcome in macular translocation.  
 
 
The conceptual requirements of macular translocation (MT360)(Machemer R, 1993a, 
Machemer R, 1993b) are to relocate the fovea while it has good restorable function, 
before irreversible retinal atrophy/damage has occurred and to re-establish normal 
sub-foveal anatomy. Despite good results reported by several workers (Eckardt C, 
1999, Toth and Freedman, 2001, Lai JC, 2002, Eckardt C, 2002, Mruthyunjaya et al., 
2004), the technique has failed to live up to initial expectations with a high degree of 
variability in visual outcomes. Although the technical aspects of surgery have been 
addressed, investigations into translocation surgery, to date, have concentrated on 
the characteristics of the CNV and visual acuity to define inclusion and outcome. We 
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present a novel algorithm that is based on: 1 a simple slit-lamp test of foveal fixation 
that allows good fixation to be determined, and 2. the duration of time between acute 
visual loss and presentation/surgery. 
 
 
Previously it has been shown that for MT360 good outcomes depend on good 
fixation (Fujikado et al., 2001, Oyagi et al., 2004). Fujikado et al (Fujikado et al., 
2001) demonstrated reading ability and stability of fixation as positive predictors of 
visual recovery and pre-operative foveal function respectively. Similarly Oyagi et al 
(Oyagi et al., 2004) also demonstrated with SLO microperimetry that pre-operative 
foveal sensitivity and fixation stability were significantly correlated with good post-
operative visual outcomes. 
 
 
MT360 is a therapy that attempts to rescue foveal photoreceptors and a window of 
opportunity for treatment exists that corresponds to the period of viability of 
neurosensory cells and it follows that early intervention should result in better 
outcomes. As visual acuity is a functional test of the neurosensory cells, good pre-
operative acuity will likely reflect good retinal function. However, poor visual acuity is 
not an accurate indicator of poor outcome. Instead determination of residual foveal 
function is the prime requirement for a rescue procedure. Our algorithm suggests the 
two strongest indicators of foveal function are pre-operative foveal fixation 
characteristics and time to presentation/surgery.  
 
 
This study firstly attempts to validate our slit-lamp foveal fixation task against fixation 
analysis as assessed by Nidek MP-1 microperimetry. Secondly the study proceeds to 
examine the outcomes of the case selection algorithm for MT360 by presenting the 
results of the first 27 consecutive cases of sub-foveal CNV treated with MT360 
selected by these entry criteria. No cases were excluded so the outcomes include 
the learning curve for the surgery. 
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Methods 
 
 
 
Slit Lamp Assessment of Fixation 
 
A simple five step slit lamp based system was used to assess the quality of foveal 
fixation as described in the General Methods. 
 
 
Validation of Slit Lamp Assessment of Foveal Fixation 
 
To validate the slit lamp assessment of foveal fixation, a cohort of patients with 
macular disease including patients referred for consideration for MT360 were 
assessed by two separate investigators and the fixation of both eyes classified as per 
the slit lamp assessment described above. These patients subsequently underwent 
objective fixation analysis with the Nidek MP-1 Micro Perimeter (Nidek Co.,Ltd., 
Tokyo, Japan)  as described in the General Methods and Appendix 2. When fixation 
analysis was not possible with a 1 degree cross the analysis was performed with a 3 
degrees cross. For comparison age matched patients with no macular disease also 
underwent two investigator slit lamp and microperimetry assessment of fixation. 
 
 
Patients 
 
A prospective series of 27 consecutive patients (17 female, 10 male) with a mean 
age of 76 (57 – 95) years and CNV secondary to AMD underwent MT360 with 
silicone oil tamponade and subsequent counter-rotation surgery at Moorfields Eye 
Hospital, London between May 2003 and May 2006 (Table 26). The study was 
conducted with full ethical approval as outlined in the General Methods. 
 
 
Case Selection Algorithm: Inclusion and Exclusion Criterion 
 
Patient selection was undertaken using an algorithm based primarily on the potential 
pre-operative viability of foveal photoreceptors and secondarily on the health of the 
retinal pigment epithelium-choroidal axis of the new foveal location. These 
parameters were assessed by direct and indirect methods (Table 27). 
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The patients were invited to take part in the macular translocation study with 
informed consent if they met all the following criteria: 
 
 
Inclusion Criteria 
• Good foveal fixation 
• Short duration from loss of reading ability 
• Healthy RPE-Choroidal axis at new foveal location  
• Sub-foveal choroidal neovascular membrane 
• AMD affecting the second eye where navigational vision remains present in the first eye 
• Potential for the fovea to adequately clear the edge of the sub-retinal pathology following 
45o rotation 
 
Exclusion Criteria 
• Unfit for general anaesthetic 
• Unwillingness to undertake follow-up 
• Other ophthalmic pathology precluding complex vitreoretinal surgery 
• Inability to give informed consent 
 
 
Pre and Post-operative Assessment 
 
All patients underwent a complete ophthalmic assessment at day 1 pre-operatively 
and at 12 months post-operatively. The assessment was performed as outlined in the 
General Methods.  
 
All patients were scheduled to return at 3, 6, 9 and 12 months following translocation surgery. 
In addition all patients were reviewed at day 1, day 7 and at 4 weeks following each 
procedure and assessed as outlined in the General Methods. Prior to and following counter-
rotation surgery all patients underwent a full orthoptic assessment.  
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Surgical Technique 
 
All surgeries were performed under general anaesthesia by a single surgeon: MT360 
(LDC); Removal of silicone oil (LDC); Counter-rotation surgery (JL/JA). The 
technique used for MT360 has been previously described by Eckardt and Eckardt 
1999 (Eckardt C, 1999), and Toth and Freedman 2001 (Toth and Freedman, 2001). 
During the procedure the primary CNV was managed by removal using Eckardt 
forceps, and the feeding choroidal vessel coagulated with endolaser. Counter-
rotation of the translocated eye was performed as described previously (Toth and 
Freedman, 2001). 
 
 
Statistical Methods 
 
The primary efficacy outcome was the change in: distance visual acuity (logMAR), 
reading acuity (logMAR), critical print size (logMAR), reading speed (words per 
minute), and contrast sensitivity. 
 
The data was described by means, standard deviations and frequencies, as well as 
corresponding 95% confidence intervals (CI). Detailed comparisons were performed 
with Wilcoxon-Signed non-parametric analysis using SPSS statistical software 
(SPSS Inc, Illinois, USA). Effects were assessed as significant if the P value of the 
corresponding test fell below P 0.05. 
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Table 26 Patient Demographics, Duration of Symptoms, and Pre-operative 
Status of the CNV 
 
 
Sex No. 
Mean Age 
/ Years 
Pathology 
 
Mean Duration 
of Visual Loss 
/ Weeks 
 
 
Female 
 
17 
 
75 
(57 – 95) 
 
 
Occult 12 
SRH  5 
 
8 
(03 – 12) 
 
Male 
 
10 
 
78 
(61 – 88) 
 
Occult 6 
SRH     4 
9 
(04 – 32) 
 
SRH  Sub Retinal Haemorrhage 
Occult  Occult Choroidal Neovascular membrane 
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Table 27 Algorithm for Patient Selection for Macular Translocation Surgery 
 
 
Foveal Photoreceptor Viability 
 
Adequacy of RPE – Choroidal Interface 
at the Recipient Foveal Site 
 
• Symptom duration (loss of reading 
ability) of less than 3 months   
 
• History of rapid onset of visual loss at 
presentation 
  
• Good foveal fixation as determined by 
the slit lamp fixation task 
 
• Indocyanine green and fluorescein 
angiography 
 
• Scanning laser ophthalmoscopy 
autofluorescence 
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Results 
 
 
 
Validation of Slit-Lamp Analysis of Fixation 
 
To validate the slit-lamp based analysis of fixation; two investigators on the slit- lamp 
and also with the Nidek MP-1 fixation analysis programme classified the fixation of a 
cohort of patients with macular disease and age-matched normals. There was 100% 
concordance between the two investigators for slit-lamp classification of fixation. 15 
eyes of age-matched patients with no macular disease and a mean logMAR acuity of 
0.11 (0.00 – 0.18) were all classified as having foveal fixation with the slit-lamp 
assessment. For this group Nidek MP-1 fixation analysis resulted in 99.8 % (99 – 
100) and 100% of test time that fixation remained within 2 and 4 degrees of the 
fixation target respectively (Figure1).  
 
 
Of 30 eyes of patients with macular disease (2 patients Geographic atrophy; 1 
patient inherited macular dystrophy; 27 patients AMD) 15 were classified as having 
unstable fixation and 15 as having no–fixation by slit lamp assessment. Eyes 
classified as having unstable fixation had a mean acuity of logMAR 1.01 (0.48 – 
1.62) and Nidek MP-1 analysis resulted in 51% (19 -79) and 79.5% (51 – 99) of 
fixation time within 2 and 4 degrees of the target respectively (Figure1). Eyes 
classified as no–fixation had a mean acuity of logMAR 1.56 (1.00 – 1.80) and Nidek 
MP-1 analysis resulted in 13.5% (06 -25) and 39.9% (14 – 58) of fixation time within 
2 and 4 degrees of the target respectively. The difference in logMAR acuities and 
fixation points within 2 and 4 degrees, between age matched normal eyes and those 
eyes classified with either unstable or no–fixation were highly significant (P<0.001), 
as were the differences in these parameters between eyes with unstable and no–
fixation (P<0.001). The results are summarised in Table 28. 
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Figure 1 Slit-Lamp Assessment and Nidek MP-1 Assessment of Foveal 
Fixation 
 
Foveal Fixation 
 
Unstable Fixation 
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Visual Outcomes 
 
 
Distance Acuity 
 
The ETDRS distance acuity improved from a mean pre-operative logMAR acuity of 
0.88 (0.18 – 2.10) to 0.68 (0.12 – 1.80) (P<0.03) post-operatively at an average 
follow up of 12.2 months (04 – 36). 66% of patients achieved a distance acuity of ≤ 
logMAR 0.8 (20/100), 22% distance acuity of ≤ logMAR 0.3 (20/40) and 33% gained 
3 lines of visual acuity. 
 
 
Reading Acuity 
 
During the same follow up period the mean MN Read™ reading acuity improved 
from logMAR 1.23 (0.60 – 2.00) to 0.91 (0.22 – 2.00) (P<0.01). 44% of patients 
achieved a reading acuity of ≥ logMAR 0.7(N10), 15% achieved near acuity of ≥ 
logMAR 0.4 (N5) and 44% gained 3 lines of reading acuity. Furthermore there was a 
significant improvement in reading speeds from a mean pre-operative speed of 89 (0 
– 176) wpm to a mean post-operative speed of 182 wpm (0 – 231) (P<0.03) and an 
improvement in the critical print size from a pre-operative mean of logMAR 1.26 (0.8 
– 2.0) to a post-operative mean of logMAR 0.96 (0.3 – 2.0) (P<0.001). Finally the 
Pelli-Robson contrast sensitivity also improved from a mean pre-operative logMAR of 
0.51 (0 – 1.20) to a mean post-operative logMAR of 0.92 (0 – 1.8) (P<0.01). The 
visual outcomes are summarised in Figure2. 
 
 
Pre-operative Acuity and Post Surgical Visual Outcomes 
 
29.6% (8/27) of patients had a pre-operative ETDRS acuity of ≥ logMAR 1.0 and this 
group demonstrated a mean improvement in distance acuity of logMAR 0.52 (0 – 
1.68).  74.1 % (20/27) of patients had a pre-operative MNRead™ reading acuity of ≥ 
logMAR 1.0 and this group demonstrated a mean improvement in reading acuity of 
logMAR 0.31 (-0.96 – 1.36). Finally of the 22% (6/27) of patients who achieved a 
distance acuity of ≤ logMAR 0.3, the mean pre-operative distance acuity was 0.74 
(0.18 – 1.8) (Table 29). 
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Time to Surgery 
 
The mean time between onset of presenting visual decline and surgery was 8.4 (03 – 
32) weeks. The relationship between the time to surgery and the change in logMAR 
acuity is illustrated in Figure 3. 
 
 
Surgical Outcomes 
 
Surgical complication rates are summarised in Table 30. 
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Figure 2 Pre- and Post-operative Distance and Reading Acuities 
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29 Pre-operative Acuity and Visual ≤ logMAR 0.3 
 
 
 
 
Patient 
No. 
 
3 8 9 10 21 23 
 
Preop 
Distance 
Acuity 
 
0.44 0.6 1.8 0.8 0.6 0.18 
 
Postop 
Distance 
Acuity 
 
0.1 0.3 0.12 0.2 0.18 0.3 
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Figure 3 Time to Surgery and Visual Outcome 
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Table 30 Surgical Complications 
 
 
 
Complication 
 
% 
 
Proliferative Vitreoretinopathy 
 
7 
 
Retinal Detachment 
 
7 
Macular Oedema 
 
7 
 
CNV Recurrence 
 
11 
 
Angle Closure Glaucoma 
 
4 
 
ERM with Pucker 
 
4 
 
 
ERM – Epiretinal Membrane 
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Discussion 
 
 
 
The concepts underlying translocation surgery for the treatment of neovascular AMD 
are significantly different to alternate treatments directed at suppression of the 
choroidal new vessels. Laser photocoagulation, PDT and to a lesser extent anti-
VEGF have focused on vessel characteristics while in translocation it is felt they are 
much less significant.  Translocation does not modify the disease process but is a 
rescue procedure for foveal photoreceptors. As such outcome depends on macular 
and foveal function.  Given this it is proposed that the case selection needs to be 
made in a completely different way, as outlined by this algorithm.  
 
 
This study has proposed a clinical case selection algorithm designed to identify 
patients who will maximally benefit from MT360. The algorithm consists of two 
components – a simple slit-lamp based clinical assessment of foveal function and an 
estimate of the duration of acute visual loss with a time cut-off for inclusion. The slit 
lamp beam provides a supra - maximal stimulus that allows the fovea to be 
stimulated even when sub-retinal blood, fluid and the CNV are reducing 
photoreceptor function.  With this supra-maximal stimulus the health of the fovea can 
be tested using the accuracy and persistence of fixation – a very powerful indicator of 
retinal function.  The simple tasks are easily carried out by the patient and give a 
quick and very clear indication of the level of foveal function, which appears to be a 
predictor of outcome. 
 
 
Estimating the duration of visual loss is based on the extrapolation that with no 
intervention in a case of neovascular AMD the vision becomes irreversibly damaged. 
Early in the disease process the retina is affected functionally and reversibly but with 
time the damage becomes permanent and irreversible (Green and Enger, 1993, 
Curcio et al., 1996). As such a critical window of opportunity exists to: 1. Salvage 
function from the existing photoreceptor pool before fibrovascular proliferation 
causes marked ‘irreversible’ photoreceptor loss 2. Treat any visual loss that may be 
due to secondary and potentially ‘reversible’ factors such as sub-foveal fluid and 
haemorrhage and 3. Mechanically restore normal anatomy. Consequently any 
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attempt to recover vision is more likely to succeed if early rather than late rescue is 
performed. 
 
 
This case selection algorithm proposes a simple slit-lamp based assessment of 
fixation using a supra-threshold slit lamp target to assess retinal function. To validate 
this method of fixation analysis a comparison was made against an objective method 
to determine foveal fixation – the Nidek MP-1 microperimeter. Two investigators, 
using the slit-lamp protocol, graded foveal fixation in a cohort of patients with macular 
disease and in a group of age matched normals.  There was 100% concordance 
between the two investigators and between slit-lamp and Nidek MP-1 microperimetry 
classification of fixation (Figure 1; Table 28). Each of the three groups, as classified 
with the slit-lamp, were also significantly different from each other for ETDRS acuity 
and for the duration of time that fixation was maintained within 2- and 4-degrees of 
the central target on microperimetry analysis. The results demonstrate that fixation 
can be assessed by a slit-lamp based method that has the advantages of being both 
easy to administer and accurate.  
 
 
The results of the first 27 consecutive patients treated with MT360, including the 
surgical learning curve, as selected by the algorithm illustrate a marked restoration of 
distance and reading vision. At an average follow up of 12.2 months there was a 
significant improvement in the mean distance acuity, improving from logMAR 0.88 to 
0.68 (P<0.03). 66% of patients achieved distance acuity of ≤ logMAR 0.8 (20/100), 
22% distance acuity of ≤ logMAR 0.3 (20/40) and 33% gained 3 lines of visual acuity. 
 
 
During the same follow up period a significant improvement in all the parameters of 
near function was observed. The mean reading acuity significantly improved from 
logMAR 1.23 to 0.91 (P<0.01). 44% of patients achieved a reading acuity of ≤ 
logMAR 0.7(N10) and 15% achieved reading acuity of ≤ logMAR 0.4 (N5). In addition 
there was a significant improvement in the mean reading speed from 89 to 182 wpm 
(P<0.03), the critical print size which improved from logMAR 1.26 to 0.96 (P<0.001) 
and the contrast sensitivity which improved from logMAR 0.51 to 0.92 (P<0.01). 
Reading is defined as fluent at > 80 words per minute (Whittaker and Lovie-Kitchin, 
1993, Crossland et al., 2005b) and 74.1% achieved this following MT360. 
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These results compare favourably with previous investigations into MT360 (Eckardt 
C, 1999, Seaber JH, 1997, Toth et al., 2004, Abdel-Meguid et al., 2003, Pertile and 
Claes, 2002), particularly the study by Pertile and Claes (Pertile and Claes, 2002) 
who performed MT360 on 50 patients with neovascular CNV. In this particular study 
68% of patients recovered reading vision with 58% and 18% achieving ≥ 20/100 and 
≥ 20/40 distance acuity respectively. When considering case selection we feel the 
crucial determinants with regards to outcome in the study by Pertile and Claes, as 
with the present study, were a short duration of symptoms – all patients had suffered 
a recent drop in vision and demonstrated good residual foveal function – most 
patients were able to read newspaper print until 3 months before the procedure. 
 
 
Subgroup analysis of patients with the best visual outcomes (post-operative distance 
or reading acuity of ≤ logMAR 0.3) (Patients 3, 8, 9, 10, 21, 23) revealed a mean 
duration of visual loss of 7.5 weeks (06 – 12). This compares with a mean duration of 
visual loss of 8.4 (03 – 32) weeks for the entire study group. Of further note is the 
finding that for this subgroup the pre-operative data suggests that while good pre-
operative vision (Patient 3, 23) will likely result in a good post-operative outcome, it is 
healthy pre-operative neurosensory retina that is required for MT360 to be able to 
rescue function and not necessarily good pre-operative vision, as evidenced by 
Patients 8, 9, 10 and 21 (Table 29).  
 
 
Subgroup analysis of patients with the worst pre-operative acuities (patients with a 
pre-operative distance or reading acuity of ≥ logMAR 1.0) revealed a mean 
improvement in distance and reading acuity of logMAR 0.52 (0 – 1.68) and 0.31 (-
0.96 – 1.36) respectively. This compares with distance and reading improvements in 
the entire study group of logMAR 0.20 (- 0.52 – 1.68) and 0.31 (-0.96 – 1.36). These 
subgroup analyses further support the premise of the case selection algorithm that 
those patients with a short duration of acute visual loss and displaying good foveal 
fixation, irrespective of pre-operative acuity, should have the best chance of visual 
recovery following MT360. 
 
 
An obvious weakness of this study is that surgery was not performed on those 
patients with poor visual acuity and poor fixation to objectively assess the predictive 
power of our algorithm. Furthermore it can be argued that duration of visual loss 
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could be used without assessing fixation behaviour as intuitively the two parameters 
are related. However simply using duration of visual loss to predict outcomes would 
not identify which patients were still within the critical window of opportunity to 
recover residual photoreceptor function. Although it is estimated this period is in the 
region of 12 weeks, the exact duration will depend on the number of remaining viable 
photoreceptors at onset of visual loss and the severity and course of the disease 
process. It is expected that patients with a slow insidious disease course will have a 
smaller window of recovery following acute loss of reading vision compared to 
patients with a short overall disease onset. As such fixation behaviour becomes an 
important determinant of the critical period of photoreceptor viability. When used 
together with time since acute visual loss, it is felt that both parameters become a 
powerful method of assessing suitability for MT360 and good outcomes. Finally, to 
strengthen this algorithm further and indicate the contribution of the fixation task vs. 
duration of visual loss, ideally an examination of cases where there is a marked 
discordance between fixation behaviour and duration of visual loss is required. 
However, as would be expected by the natural history of the disease, no cases of 
good fixation and a markedly extended period of visual loss were encountered, and 
neither were there any cases of poor fixation and immediate presentation. 
 
 
The study has demonstrated a simple case selection algorithm that assesses the 
residual foveal function and suggests good visual outcomes. The algorithm is based 
on the duration between acute visual loss and surgery and foveal fixation as 
demonstrated by a simple slit-lamp fixation task. Thus patients with a short duration 
of visual loss and demonstrating good foveal fixation have a good potential for visual 
recovery in uncomplicated MT360. Furthermore our algorithm suggests good visual 
outcomes independently of pre-operative visual acuity and CNV characteristics. 
There was no restriction on the entrance visual acuity – the traditional method of 
predicting good visual outcome – as the algorithm is aimed at selecting patients even 
in cases of poor vision at presentation. This was demonstrated by the pre-operative 
visual acuity of our first 27 cases that averaged logMAR 1.22 (0.42 – 2.10). This is in 
contrast to previous studies where case selection has relied on either the pre-
operative visual acuity and/or characteristics of the CNV, with variable outcomes. 
The algorithm suggests the two strongest indicators of foveal function are pre-
operative foveal fixation characteristics and time to presentation/surgery. The 
algorithm is simple in its application and does not require any additional 
investigations. 
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IV Macular Translocation: Quality of Rescue 
 
 
 
Introduction 
 
 
 
Difficulty in reading is the commonest disability reported secondary to central visual 
loss from macular disease. The ability to read is a highly valued task and its loss is 
linked to considerable psychological and social distress, and a marked reduction in 
quality of life (McClure et al., 2000, Elliott et al., 1997, Hazel et al., 2000, Legge et 
al., 1985, Legge et al., 1992, Regillo et al., 2008, Rubin et al., 1994). 
 
 
Exudative age related macular degeneration (wet AMD) is a common, rapid cause of 
central vision loss. Recent advances in anti-VEGF treatments have offered the 
possibility of reversal of vision loss.  In severe lesions, notably where there is 
significant disruption of the retinal anatomy (e.g.: large sub-retinal haemorrhage or 
retinal pigment epithelial tear), treatments options are limited to either surgical 
methods designed to restore normal anatomy (macular translocation or retinal 
pigment epithelial transplantation) or visual rehabilitation. In terms of visual recovery, 
a primary goal of such treatments is the restoration of reading. 
 
 
Conventional rehabilitation with low visual aids tries to restore reading by use of 
magnification. Despite magnification, reading speeds are often limited to < 50 words 
per minute, well below the level required for fluent reading (> 80 words per minute 
(Whittaker and Lovie-Kitchin, 1993, Crossland et al., 2005b)). Macular translocation 
surgery (MT360) has been used to restore reading vision in severe wet AMD. MT360 
attempts to rescue foveal photoreceptors before irreversible retinal atrophy/damage 
has occurred, re-establish normal sub-foveal anatomy, and provide stable improved 
central vision.  
 
 
Good visual outcomes have been reported when MT360 is performed during the 
window of opportunity for treatment that corresponds to the period of viability of 
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neurosensory cells (Eckardt C, 2002, Eckardt C, 1999, Lai JC, 2002, Pertile and 
Claes, 2002, Mruthyunjaya et al., 2004). In the majority of studies outcome measures 
have concentrated on distance acuity rather than near visual function or reading 
speed. Of note Eckardt (1999) (Eckardt C, 1999) and Lai et al (2002) (Lai JC, 2002) 
reported improvements in near acuity following translocation; Fujikado et al (2002) 
(Fujikado et al., 2002a) specifically examined reading ability following MT360 and 
reported an improvement in critical print size determined using a Japanese 1version 
of the Minnesota Acuity Chart (MN Read™ – J Chart); and Toth et al (2004) (Toth et 
al., 2004) investigated various parameters of near visual function after translocation 
and reported significant improvements in near acuity, contrast sensitivity and reading 
speed.  
 
 
This study aims to demonstrate the optimal potential of MT360 in the restoration of 
normal visual function. An infrared eyetracker and microperimetry are used to 
examine reading behaviour (reading speeds and saccadic activity), foveal fixation 
characteristics (preferred retinal loci and stability of fixation), and retinal sensitivity (to 
establish the threshold visual function) at the new macular location in order to 
describe the quality and extent of this recovery. These examinations are performed 
in the best outcome cases from a consecutive series of 23 patients with sub-foveal 
choroidal neovascular membrane (CNV) treated with MT360. MT360 is an invasive 
and involved procedure (new foveal location, extraocular muscle surgery, residual 
torsion) and documenting the potential for restoration of close to normal function is 
valuable. 
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Methods 
 
 
 
Patients 
 
Six patients (3 female, 3 male) with a mean age of 69 (61 – 74) were recruited from 
the prospective series of 27 consecutive patients detailed in Chapter III. The six 
recruited to the study represented the best outcomes from the translocation surgical 
series (Table 31). The study was conducted with full ethical approval as outlined in 
the General Methods. 
 
 
Inclusion Criterion 
 
The six patients were invited to take part in the trial with informed consent if they met 
all the following criteria: 
 
• A post-operative reading acuity of logMAR 0.70 or better when tested with the 
Minnesota Reading Acuity Chart (MN Read™) (Precision Vision, La Salle, IL, 
USA) to able to perform the reading and fixation tasks outlined below. 
 
• No symptoms of diplopia or tilit 
 
 
Infrared Eyetracker Assessment of Reading and Fixation 
 
Eye Movement Recording 
Eye movements were measured using the SMI Eyelink Gazetracker (SensoMotoric 
Instruments, Teltow, Germany) running EyeLink Software v2.04 (Appendix 4). The 
EyeLink gazetraker is a headband-mounted apparatus on which are mounted two 
adjustable infrared cameras that record eye position using the ‘bright pupil’ 
technique. A third camera on the headband tracks head motion by monitoring 
infrared emitters positioned at the corners a high resolution display monitor (21” 
Trinton GDM-F500R, Sony Corporation, Tokyo, Japan) with a resolution of 800x600 
pixels and a refresh frequency of 85Hz. The luminance of the white background of 
the screen was 125cd/m2. Patients were seated 50cm from the monitor and wore 
suitable refractive correction for the screen distance. With this arrangement 
174
 
 
compensation for head motion was made so that a real position of gaze could be 
calculated.  Eye position was measured at a temporal resolution of 250Hz with the 
manufacturers reporting a gaze position accuracy of <0.5º. 
 
 
Before each assessment, eyetracker calibration, validation, and drift correction were 
performed using the algorithms provided for this purpose.  Only trials where 
calibration was categorized as good by the Eyelink software were included. 
Saccades were defined as being eye velocity movements with velocity >30ºs-1 or 
acceleration >8000ºs-2 and described in terms of their number, average latency, 
average velocity, and direction (horizontal/vertical/forward/regressive). 
 
 
Reading Assessment 
A full description of the eyetracker assessment of reading is given in previous 
literature (Crossland et al., 2004a, Crossland and Rubin, 2006). 
 
 
Assessment of Horizontal and Vertical Saccades 
A full description of the eyetracker assessment of horizontal and vertical saccades is 
given in previous literature (Crossland et al., 2004a, Crossland and Rubin, 2006).  
 
 
Assessment of Preferred Retinal Locus/Loci (PRL) and Fixation Stability  
A full description of the eyetracker assessment of fixation stability is given in previous 
literature (Crossland et al., 2004a, Crossland and Rubin, 2006, Crossland and Rubin, 
2002, Crossland et al., 2004b). 
 
The data collected was used to describe fixation by calculating a bivariate contour 
ellipse as described in previous literature (Crossland et al., 2004a, Crossland et al., 
2005a, Crossland and Rubin, 2006, Crossland and Rubin, 2002, Crossland et al., 
2004b). A bivariate contour ellipse describes the locus of fixation in normal 
observers. The area of this ellipse – bivariate contour ellipse area (BCEA) – indicates 
fixation stability. The BCEA of normal individuals is approximately 80-1200minarc2 
(Crossland and Rubin, 2002) and with macular disease they range from near normal 
to over 13 000 minarc2 (Rohrschneider et al., 1995). The use of a non-parametric 
modeling technique (the kernel density estimator) was used to assess if individual 
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BCEAs provided a better fit to the data than a global BCEA. This analysis was used 
to determine the number of PRL 
 
 
Eyetracker Control / Comparative Data Groups 
Data collected from eyetracker assessment following MT360 was compared with 
similar data collected from normal controls (Normal), patients with dry age related 
macular degeneration (Dry AMD) and patients with wet AMD (Wet AMD). Each group 
contained ten age-matched patients who underwent the aforementioned eyetracker 
assessment of reading and fixation (Table 32). 
 
 
Microperimetry Assessment of Retinal Sensitivity and Fixation 
 
All patients also underwent of post-operative assessment of retinal sensitivity and 
fixation pattern using the Nidek MP-1 Micro Perimeter (Nidek Co.,Ltd., Tokyo, Japan) 
as described in the General Methods and Appendix 2. 
 
 
Statistical Methods 
 
Descriptive statistics (n, median, range, minimum, maximum, interquartile range) 
were obtained for each data set (MT360 cohort and the control/comparative groups). 
The data sets were examined for statistical differences in ETDRS acuity, MN Read™ 
Reading Acuity, MN Read™ Critical Print Size, MN Read™ Critical Print Reading 
Speed, Pelli-Robson Contrast Sensitivity, eyetracker reading speed, horizontal and 
vertical saccades and saccadic speed and latency, global fixation, and number of 
preferred retinal loci. Statistical analysis was performed using the Mann-Whitney test 
on SPSS statistical software (SPSS Inc, Illinois, USA). All outcome measures quoted 
below represent median values unless otherwise stated. 
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Table 32 Control / Comparative Group Demographic 
 
 
 
Group 
 
N Mean Age / Years Diagnosis 
Normal 10 
 
71.0 
(62 – 79) 
 
    No Pathology 
Dry AMD 10 
 
76.2 
(62 – 84) 
 
Geographic Atrophy 9 
Macular Drusen  1 
Wet AMD 10 
 
79.2 
(74 – 85) 
 
CNV   7 
PED   3 
MT360 06 
 
68.7 
(61 – 74) 
 
CNV   6 
 
CNV  Choroidal Neovascular Membrane 
PED  Pigment Epithelial Detachment 
178
 
 
Results 
 
 
 
Surgical Series 
 
The surgical series of 27 patients (17 female, 10 male; aged 57 – 95 years) with sub-
foveal CNV treated with MT360 illustrated a restoration of distance and reading 
acuity (Figure 2). 
 
 
Eyetracker MT360 Cohort 
 
The six best outcomes (3 female, 3 male; aged 61 – 74) form the aforementioned 
series were recruited to investigate reading behaviour post MT360 (Table 31). At 14 
(5 – 29) months follow up this cohort (MT360 cohort) improved their distance acuity 
from logMAR 0.70 (0.44 – 1.80) to 0.25 (0.10 – 0.65) (P>0.05) and the reading speed 
increased from 106 (52 – 150) to 158 (55 – 231) wpm (P>0.05). In contrast, there 
was a significant improvement in the reading acuity, logMAR 1.02 (0.60 – 1.43) to 
0.52 (0.22 – 0.66) (P<0.01), critical print size, logMAR 1.10 (1.10 – 1.20) to 0.80 
(0.50 – 1.10) (P<0.05), and contrast sensitivity, logMAR 0.75 (0 – 1.05) to 1.43 (1.20 
– 1.65) (P<0.02) (Table 33). 
 
The relationship between distance and reading acuity, pre- and post-MT360, is 
summarised in Figures 4 and 5. Pre-operative distance acuity was well correlated 
with pre-operative reading acuity (r = + 0.71), however no such correlation was found 
between pre-operative distance acuity and the pre-operative critical print size (r = - 
0.04) (Figure 4). Following surgery both the reading acuity and critical print size 
significantly improved and both parameters were well correlated with the post-
operative distance acuity (Figure 5). 
 
 
Comparison of Visual Function:  MT360 vs. Normal vs. AMD 
 
Distance Acuity, Reading Function, Contrast Sensitivity 
Outcome measures (distance and reading acuity, critical print size, reading speed, 
contrast sensitivity) for the post MT360 cohort and the comparative groups are 
summarised in Table 34. For each measure the recovery following MT360 was 
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greater than both of the untreated AMD groups and less than the age matched 
normal group (Figures 6,7 and 8). The improvement for the MT360 cohort over the 
AMD groups reached significance (P<0.05) for all parameters except critical print 
size and contrast sensitivity. The results for the MT360 cohort were also significantly 
different (P<0.05) to age matched normal subjects except for reading speed (Figure 
8). 
 
 
Eyetracker Assessment of Reading Function 
 
Horizontal Saccade Task 
Assessment of horizontal saccades demonstrated that the MT360 cohort performed 
a greater number of saccades than the comparative groups, a result that reached 
significance (P<0.05) for all but the wet AMD group. The saccades were of longer 
latency (P>0.05) and of reduced velocity (P<0.05) (Table 35) (Figures 9,10 and 11). 
 
 
Reading Task 
Saccadic assessment when reading revealed the MT360 cohort displayed a greater 
number of forward saccades than the age matched normal group (P<0.05) but less 
than the dry (P>0.05) and wet (P<0.05) AMD groups. There was no significant 
difference between the groups for the number of regressive saccades performed 
(Table 35). 
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Table 33 Outcome Measures MT360 Cohort: Pre-operative vs. Post-operative 
 
 
 
Variable 
 
Pre-operative Post-operative 
 
ETDRS Distance Acuity 
/ logMAR 
 
0.70 
(0.44 – 1.80) 
0.25 
(0.10 – 0.60) 
P = 0.09 
 
MN Read™ Reading Acuity  
/ logMAR  
 
1.02 
(0.60 – 1.43) 
0.52 
(0.22 – 0.66) 
P = 0.01 
 
MN Read™ Reading Speed  
/ words per minute 
 
106 
(52 – 150) 
158 
(55 – 231) 
P = 0.14 
 
MN Read™ Critical Print Size  
/ logMAR 
 
1.10 
(1.10 – 1.20) 
0.80 
(0.50 – 1.10) 
P = 0.05 
 
Pelli-Robson Contrast Sensitivity 
/ logMAR 
 
0.75 
(0.00 – 1.05) 
1.43 
(1.20 – 1.65) 
P = 0.02 
 
Values Represent Median (Range) and Significance Levels 
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Figure 4 Relationship Between Pre MT360 Distance Acuity + Reading 
Function 
 
 
 
 
 
 
 
r  Coefficient of Correlation 
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Figure 5 Relationship Between PostMT360 Distance Acuity + Reading 
Function 
 
 
 
 
 
 
 
r – Coefficient of Correlation 
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Table 34 Outcome Measures: MT360 vs. Comparative Groups 
 
 
 
 
Outcome 
 
 
MT360 Normal Dry AMD Wet AMD 
 
ETDRS Acuity 
/ logMAR 
 
 
0.25 
(0.10 – 0.60) 
 
0.02 
(- 0.14 – 0.14) 
P = 0.004 
0.57 
(0.44 – 1.10) 
P = 0.038 
0.67 
(0.38 – 1.18) 
P = 0.013 
 
MN Read™ Reading 
Acuity  
 
/ logMAR 
 
0.52 
(0.22 –0.66) 
0.10 
(- 0.11 – 0.29) 
P = 0.002  
0.64 
(0.52 – 1.15) 
P = 0.038 
0.72 
(0.54 – 1.27) 
P = 0.009 
 
MN Read™ 
Reading Speed  
/ words per minute 
 
158 
(55 – 231) 
151 
(116 – 194) 
P = 0.587 
94 
(44 – 173) 
P = 0.030 
51 
(28-99) 
P = 0.003 
 
MN Read™ 
Critical Print Size  
/ logMAR 
 
0.80 
(0.50 – 1.10) 
0.25 
(0.10 – 0.40) 
P = 0.001 
0.95 
(0.70 – 1.30) 
P = 0.324 
1.00 
(0.80 – 1.30) 
P = 0.101 
 
Pelli-Robson 
Contrast Sensitivity 
/ logMAR  
 
1.43 
(1.20 – 1.65) 
1.65 
(1.50 – 1.70) 
P = 0.042 
1.38 
(0.70 – 1.70) 
P = 0.702 
1.38 
(0.90 – 1.65) 
P = 0.585 
 
Values Represent Median (Range) and Significance Levels 
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Figure 6 Distance Acuity: MT360 vs. Comparative Groups 
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Figure 7 Reading Acuity: MT360 vs. Comparative Groups 
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Figure 8 Reading Speed: MT360 vs. Comparative Groups 
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Table 35 Horizontal Saccade and Reading Task: MT360 vs. Comparative 
Groups 
 
 
 
 
Horizontal Saccades 
 
 
MT360 Normal Dry AMD Wet AMD 
Number of Saccades 
 
2.44 
(2.15 – 5.56) 
 
2.00 
(1.25 – 1.45) 
P = 0.009 
1.84 
(1.40 – 2.80) 
P = 0.008 
2.35 
(1.30 – 3.89) 
P = 0.385 
Latency / ms  
 
269 
(200 – 291) 
 
225 
(156 – 542) 
P = 0.170 
238 
(159 – 304) 
P = 0.071  
209 
(172 – 331) 
P = 0.083 
Velocity / ms-1 
 
364 
(306 – 427) 
 
479 
(207 –1904) 
P = 0.050 
459 
(366 – 655) 
P = 0.013 
470 
(225 – 631) 
P = 0.023 
Forward Saccades 
 
13.5 
(10.1 – 25.1) 
 
8.7 
(7.1 – 10.4) 
P = 0.002 
17.3 
(10.0 – 30.5) 
P = 0.447 
29.1 
(17.0 – 50.2) 
P = 0.002 
Regressive Saccades 
 
29.4 
(20.3 – 42.7) 
 
 
31.5 
(7.0 – 43.0) 
P = 1.000 
12.0 
(5.0 – 43.0) 
P = 0.127 
33.0 
(21.0 – 70.0) 
P = 0.514 
 
Values Represent Median (Range) and Significance Levels 
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Figure 9 Horizontal Saccades: MT360 vs. Comparative Groups 
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Figure 10 Horizontal Saccade Latency: MT360 vs. Comparative Groups 
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Figure 11 Horizontal Saccade Velocity: MT360 vs. Comparative Groups 
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Vertical Saccade Task 
Assessment of vertical saccades demonstrated the MT360 cohort performed more 
vertical saccades (P<0.05) of increased latency (P<0.05) with a reduced saccade 
velocity (P>0.05) when compared to age matched normal subjects. A similar pattern 
of results was demonstrated between the MT360 cohort and the AMD groups 
although this failed to reach significance (Table 36). 
 
 
Reading Speeds 
Assessment of reading speeds revealed the MT360 cohort outcomes approximated 
toward the normal group and were greater than the AMD groups. The improvement 
following MT360 was found to be significantly different from normal group and the 
wet AMD group (P<0.05) but not the dry AMD group (P>0.05) (Table 37). Reading 
speeds as calculated from MN Read™ Reading Acuity Charts revealed a similar 
pattern and are shown for comparison in Table 37. 
 
 
Eyetracker Assessment of Fixation 
Analysis of fixation revealed the fixation stability global BCEA values for the MT360 
cohort to be closer to the normal group than to the AMD groups. No significant 
difference (P>0.05) was found between the MT360 cohort and any comparative 
group. However analysis of global BCEA values revealed a single preferred retinal 
locus for the MT360 and normal age controls (P<0.05) with multiple loci for both AMD 
groups (P<0.05)  (Table 38) (Figure 12). 
 
 
Microperimetry Assessment of Retinal Sensitivity and Fixation 
 
Microperimetry assessment of macular sensitivity demonstrated that for three 
(Patient 1, 3 and 4) of the six patients in the MT360 cohort, surgery restored near 
normal levels of foveal and para-foveal retinal sensitivity (Figure 13). Only Patient 6 
demonstrated a significant residual absolute scotoma.  
 
Microperimeter fixation analysis demonstrated stable fixation for all patients in the 
surgical cohort. The median percentage of time that the target was placed within 2º 
and 4º of the fovea over the 30 seconds of the test period was 90% (72 – 100) and 
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96% (86 – 100) respectively (Table 39). Pre and post MT360 BCEA values from the 
MP-1 are also shown for comparison. 
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Table 36 Vertical Saccades: MT360 vs. Comparative Groups 
 
 
 
Vertical Saccades 
 
MT360 Normal Dry AMD Wet AMD 
Number of Saccades 2.32 (1.95 – 3.00) 
 
1.76 
(1.50 – 5.25) 
P = 0.044 
 
2.20 
(1.37 – 4.94) 
P = 0.129 
2.09 
(1.39 – 3.82) 
P = 0.551 
Latency / ms  249 (211 – 297) 
 
197 
(163 – 335) 
P = 0.039 
 
217 
(198 – 306) 
P = 0.448 
234 
(165 – 333) 
P = 0.129 
Velocity / ms-1 378 (289 – 459) 
 
446 
(224 – 647) 
P = 0.193 
 
404 
(216 – 499) 
P = 0.914 
378 
(201 – 644) 
P = 0.828 
 
Values Represent Median (Range) and Significance Levels 
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Table 37 Eyetracker Reading Speed: MT360 vs. Comparative Groups 
 
 
 
Sentences 
 
MT360 Normal Dry AMD Wet AMD 
 
Eyetracker Sentences 
Reading Speed 
 
101 
(57 – 104) 
139 
(107 – 183) 
P = 0.039 
79 
(41 – 108) 
P = 0.114 
39 
(24 – 59) 
P = 0.002 
 
MN Read™ 
Reading Speed 
 
158 
(55 – 231) 
151 
(116 – 194) 
P = 0.587 
94 
(44 – 173) 
P = 0.030 
51 
(28 – 99) 
P = 0.003 
 
Values Represent Median (Range) and Significance Levels 
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Table 38 Eyetracker Assessment of Fixation and Number of Preferred Retinal 
Loci 
 
 
 
Fixation Analysis 
 
MT360 Normal Dry AMD Wet AMD 
 
 
Global BCEA 
/ min arc2 
 
 
310 
(49 – 1890) 
116 
(50 – 3081) 
P = 0.515 
1426 
(175 – 13078) 
P = 0.065 
651 
(59 – 6465) 
P = 0.329 
 
 
Preferred Retinal Loci 
 
 
1.0 
(1.0 – 2.0) 
1.0 
(1.0) 
P = 0.197 
2.0 
(1.0 – 4.0) 
P = 0.006 
3.0 
(2.0 – 7.0) 
P = 0.001 
 
Values Represent Median (Range) and Significance Levels 
BCEA – Bivariate Contour Ellipse Area 
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Figure 12 Number of Preferred Retinal Loci: MT360 vs. Comparative Groups 
 
 
 
§ 
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Figure 13 Nidek MP – 1 Assessment of Retinal Sensitivity: MT360 Cohort 
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Macular Sensitivity Foveal Sensitivity 
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Figure 13.1 Nidek MP – 1 Assessment of Retinal Sensitivity: MT360 Cohort 
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Table 39 Nidek MP - 1 Assessment of Fixation 
 
 
 
 
Nidek MP-1 
Bivariate Contour 
Ellipse Area 
(min arc2) 
 
 
Patient 
 
 
Mean % 
Time 
Fixation 
within 2 ° of 
Target 
 
Mean % 
Time 
Fixation 
within 4 ° of 
Target 
 
 
Nidek MP-1 
Classification 
of Fixation 
 
PreOp 
 
PostOp 
 
 
1 
 
99 99 High Quality Stable 
 
 
2160 
 
 
360 
 
2 
 
77 95 High Quality Stable 
 
 
 612 
 
 
216 
 
3 
 
100 100 High Quality Stable 
 
 
720 
 
 
756 
 
4 
 
98 98 High Quality Stable 
 
 
1512 
 
 
1,656 
 
5 
 
95 97 High Quality Stable 
 
 
2988 
 
 
792 
 
6 
 
72 86 High Quality Stable 
 
 
12,780 
 
 
3096 
 
High Quality Fixation = Greater than 50% of the preferred fixation points located within a 2º 
   diameter circle centred on the fovea 
 
Stable Fixation  = Greater than 75% of fixation points located within a 2º diameter 
   circle centred on the gravitational centre of all fixation points. 
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Discussion 
 
 
 
MT360 differs from current treatments for severe AMD that aim to modify the disease 
process. Instead, translocation offers a unique rescue procedure for foveal 
photoreceptors in patients whose fellow eye has already lost central vision. Previous 
reports of translocation have reported this rescue in terms of acuity alone (Eckardt C, 
1999, Pertile and Claes, 2002, Aisenbrey et al., 2002b). More recently several 
authors have examined the impact of MT360 on near visual function and reading 
ability (Lai JC, 2002, Mruthyunjaya et al., 2004, Fujikado et al., 2002a, Toth et al., 
2004). While these studies provide good evidence for the recovery of foveal 
photoreceptor function by mid-peripheral retinal pigment epithelium (RPE), none 
have described the quality and extent of this recovery compared to normal visual 
function.  
 
 
MT360 is an involved procedure encompassing both retinal and strabismus surgery. 
By observing the best outcome cases of MT360 in our surgical series this study has 
attempted to gauge the optimal potential of this complex surgery in restoring normal 
function. The study has documented not only the well recognised components of 
near visual function (reading acuity, contrast sensitivity reading speeds, critical print 
size) but also aspects of reading behaviour (number, duration and velocity of 
saccades), fixation characteristics (preferred retinal loci and stability of fixation), and 
retinal sensitivity (size, location and density of any post-operative scotoma) and 
compared these parameters to both untreated disease and normal function.  
 
 
The results of the first 23 consecutive patients treated with MT360, including the 
surgical learning curve, illustrate a restoration of distance and reading acuity. Despite 
the overall distance acuity change failing to reach significance, the results compare 
favourably with previous investigations into MT360 (Eckardt C, 1999, Lai JC, 2002, 
Pertile and Claes, 2002, Mruthyunjaya et al., 2004, Fujikado et al., 2002a, Toth et al., 
2004). The best outcome cases were recruited for eyetracker analysis of reading 
behaviour and microperimetry. At 14 months follow up the measured parameters of 
visual function all improved in this cohort. MT360 produced a significant improvement 
in reading acuity (P<0.01), critical print size (P<0.05) and contrast sensitivity 
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(P<0.02), however improvements in distance acuity and reading speed did not reach 
significance. 
 
 
The latter results are likely a function of sample size however several studies of 
MT360 have reported a greater improvement in near over distance acuity (Eckardt C, 
1999, Lai JC, 2002, Mruthyunjaya et al., 2004, Fujikado et al., 2002a). Other than 
sample size, the discrepancy in near over distance vision is difficult to explain and 
may reflect the complex interplay of location, density and size of a residual scotoma 
on reading function. A possible explanation is that MT360 results in a reduction in the 
foveal scotomatous area without an improvement in the overall retinal sensitivity, 
thus resulting in a greater improvement in near function. Additionally, alterations in 
micro-saccadic behaviour following counter-rotation surgery (discussed below) may 
have more of a deleterious effect on distance acuity than near reading ability. 
 
 
The failure of reading speed (which is not limited by print size) to significantly 
improve reflects the fact that a reasonable speed may be attained pre-operatively (at 
a larger print size) and only marked improvements in this parameter will reach 
significance. In this respect, the critical print size (smallest print read with maximum 
speed), which significantly improved following MT360, better reflects improvements 
in reading ability.  
 
 
Pre-operatively distance acuity was well correlated (r = + 0.71) with reading acuity as 
expected, however there was no such correlation (r = - 0.04) with critical print size 
(Figure 4). Patients suffer a profound central scotoma in their previously better 
second eye and it is predominately the loss of reading ability and not distance acuity 
that commonly instigates presentation. The poor reading stems from the scotoma 
forcing eccentric viewing (Timberlake et al., 1986), an unstable locus for fixation 
(Crossland et al., 2004a, Crossland et al., 2005a, Bellmann et al., 2004a, Culham et 
al., 1993) and compromised eye movement control (White and Bedell, 1990, 
McMahon et al., 1991, Whittaker et al., 1991). In the long term patients may develop 
adaptive mechanisms to partially overcome these problems, however a requirement 
of successful MT360 is a short duration between acute visual loss and surgery 
(Uppal et al., 2007). Thus, pre-operatively, while patients may still resolve smaller 
print sizes, the critical print size remains relatively poor and independent of distance 
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and reading acuity. The results again demonstrate that both distance and reading 
acuity are inadequate measures of reading abilities. 
 
 
Post-operatively, distance acuity was well correlated with both the reading acuity (r = 
+ 0.79) and critical print size (r = + 0.91) (P<0.001) (Figure 5). Surgery dramatically 
reduced or reversed the absolute central scotoma, recovering levels of macular 
sensitivity approaching normal (Figure 13) with stable central fixation (Tables 31 and 
32; Figures. 12 and 13). MT360 closely approximates foveal anatomy to a normal 
physiological state and this is reflected in significant improvements in function 
(reading acuity, critical print size, contrast sensitivity) and hence reading ability. 
These results support the premise that restoration of the choriocapilliaris-Bruch’s-
RPE-photoreceptor axis rescues foveal function and this can be achieved with mid-
peripheral RPE substituting for diseased sub-foveal RPE.  
 
 
To gauge the extent of the recovery detailed above, outcome measures (distance 
acuity, reading acuity, reading speed, critical print size and contrast sensitivity), 
eyetracker assessment of reading behaviour, and microperimetry were examined, 
comparing, where possible, the MT360 cohort to age matched normal subjects and 
patients with untreated wet and dry AMD. The comparison revealed that the recovery 
following MT360 was greater than either of the untreated AMD groups and less than 
the age matched normal group (Table 27, Figures 6,7 and 8). The results are 
consistent with an improvement in the absolute central scotoma with restoration of 
the macular threshold function and resolution of the size and or density of the pre-
operative scotoma. As microperimetry was not available pre-operatively, changes in 
retinal threshold function cannot be quantified directly, although all patients in the 
surgical cohort presented with large sub-foveal haemorrhages and a recent loss of 
reading ability. Although microperimetry revealed that surgery re-approximates 
macular sensitivity towards normal levels, a relative scotoma persists (Figure 13). 
This is likely to account for reduced reading ability and partly reflect the failure of the 
improvement in contrast sensitivity and critical print size to reach significance 
(Silverstone et al., 2000).  This would also explain the failure of the surgical cohort to 
match outcomes compared to normal subjects except for reading speed. As 
discussed above, although critical print size better reflects reading ability, it is of 
interest to note that patients post translocation/counter-rotation were able to recover 
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sufficient function to achieve a normal level of maximum reading speed (Table 27, 
Figure 8) 
 
 
In addition to near normal levels of macular sensitivity, Patient 1, 3 and 4 also 
displayed the best three post-operative outcomes (Table 24). Of note Patient 1 had 
the best pre-operative vision while Patient 3 and 4 the worst. This suggests that while 
good pre-operative vision will result in good post-operative outcomes, the limiting 
factor for this rescue procedure is likely to be the number and quality of the 
photoreceptor pool prior to surgery and not necessarily acuity. It has previously been 
demonstrated that a significant photoreceptor loss occurs in patients with AMD 
beginning in the para-fovea (Curcio et al., 1996). Electrophysiological studies have 
also demonstrated that wider retinal and RPE areas are involved in AMD than are 
evident from fundoscopy (Luke et al., 2001).  Furthermore, ultra structural studies 
have found a partial loss of photoreceptor outer segments following translocation, 
thought to be torn away during separation of the retina from the RPE (Machemer R, 
1993a). Therefore, considering that surgical recovery is undertaken on the 
background of an ageing and diseased retina, and the physical processes involved in 
MT360 will result in a further loss of photoreceptors, recovery of truly normal function 
is less likely. 
 
 
Fixation analysis established that translocation produces a single stable central 
retinal locus – the new foveal location, whereas the AMD groups demonstrated 
multiple loci. The eyetracker demonstrated that BCEA values for the surgical cohort 
were far closer to age matched normal subjects than either AMD group (Table 31 
and Figure 12) and microperimetry similarly confirmed high quality, central fixation 
(Table 32 and Figure 13). 
 
 
Eyetracker assessment of saccadic behaviour revealed that translocation results in a 
greater number of horizontal saccades (P<0.05 - except wet AMD) of reduced 
velocity (P<0.05) and increased latency (P>0.05) as compared to the other groups 
(Figures 9,10 and 11). The MT360 also displayed a greater number of forward 
saccades than age matched normal subjects (P<0.05) but fewer than the dry AMD 
(P>0.05) and wet (P<0.05) groups with no difference in the number of regressive 
saccades between groups. Examination of vertical saccades, which are implicated in 
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finding a new line when reading, revealed a similar pattern (Table 29). In the 
presence of high quality stable fixation, these results reflect the direct effects of 
counter- rotation surgery upon gaze control during reading rather than deficits in 
macular function. Counter-rotation surgery (which involves transposition of 2 – 4 recti 
muscles) is necessary to correct post translocation torsion to less than 10º (when it is 
considered that symptoms of diplopia and tilt are negligible). Despite the suboptimal 
oculomotor dynamics highlighted above, the MT360 cohort of patients are able to 
adapt and achieve near normal reading ability. 
 
 
MT360 is a complex two-stage procedure after which patients have a reduced 
peripheral field (secondary to 360º retinectomy performed during retinal 
translocation) and a degree of residual torsion (secondary to counter-rotation 
surgery). This study has additionally demonstrated, with infrared eyetracking, that 
when performing reading tasks following surgery patients perform an increased 
number of saccades of slower velocity and greater latency. Eyetracking and 
microperimetry also confirm the restoration of a single stable foveal locus of fixation. 
Furthermore microperimetry reveals post-operative macular sensitivity approaches 
normal levels leaving a relative central scotoma.  
 
 
The purpose of this study was to gauge the optimal potential of MT360 in rescuing 
function and describing the quality and extent of the recovery. Despite the profound 
anatomical disruption that MT360 induces, the results indicate that retinal surgery 
approximates normal macular threshold levels, and the limitations placed on 
oculomotor control appear not to adversely affect reading ability. Although the 
findings are clearly limited by the small sample sizes involved, the present study 
nevertheless shows that MT360 can successfully rescue photoreceptors with a 
significant improvement over untreated disease for distance acuity, near acuity and 
reading speed. 
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V RPE Transplantation: Age Related Macular Degeneration 
 
 
 
Introduction 
 
 
 
AMD is characterized by the growth of choroidal new vessels (CNV) under the 
central macula, which may lead to acute visual loss by hemorrhage or serous 
detachments of the retinal pigment epithelium (RPE) and/or neurosensory retina. The 
acute visual loss associated with CNV is widely believed to be the result of initially 
sub-retinal pathology, which impairs function of the overlying neurosensory retina 
(Hageman et al., 2001, Ambati et al., 2003). Over time, the chronic impairment of the 
neurosensory retina most likely leads to irreversible photoreceptor apoptosis 
(Dunaief et al., 2002, Piccolino et al., 2005). The aim of AMD surgery is therefore to 
restore contact between the macula and healthy sub-retinal tissue (RPE and 
choroid), before significant photoreceptor loss occurs. The concept of reversing 
photoreceptor loss of function has already been shown with macular translocation. 
 
It has previously been shown and recently confirmed that removal of CNV alone 
does not lead to an improvement over nonintervention in the management of acute 
AMD (Thomas et al., 1994, Hawkins et al., 2004b). This most likely occurs because 
the sub-foveal RPE and choriocapilliaris are damaged as a result of CNV growth 
and/or its subsequent removal, and are therefore no longer able to support foveal 
function (Gass, 1994). This concept also led Machemer and Steinhorst (1993) 
(Machemer R, 1993b) to develop macular translocation surgery as a means of 
restoring foveal contact to healthy RPE, which has been further refined with more 
effective surgical techniques to reduce complications (Eckardt C, 1999, Mruthyunjaya 
et al., 2004). Visual improvement after macular translocation is strong proof of the 
principle that foveal dysfunction in AMD can be reversed, at least in the early stages, 
by re-apposition of the fovea to healthy RPE choroid of non-foveal origin. 
 
 
A subsequent study proposed by Stanga et al (2002) (Stanga et al., 2002) explored 
surgery to the choroid as an alternative to macular rotation. This has the added 
advantage of avoiding image cyclotorsion, which would otherwise cause torsional 
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diplopia in patients with good vision in the fellow eye. The surgery involved cutting a 
2- to 3-mm triangular wedge of sub-macular choroid with attached RPE and 
repositioning it under the fovea after CNV removal in 1 continuous procedure. The 
technique was not, however, successful in maintaining vision at the 5 year follow-up, 
possibly because the neuroretina was already irreversibly damaged, either before 
surgery or by the procedure itself (MacLaren et al., 2005). van Meurs and Van den 
Biesen (2003) (van Meurs and Van Den Biesen, 2003) proposed a similar approach, 
but one using full-thickness RPE choroid grafts harvested from the equatorial retina. 
Equatorial RPE is abundant, contributes little to functional vision, and is relatively 
unaffected by AMD. As such it is a good donor site for this technique. Significantly, 
they noted that these grafts could become reperfused when placed into the sub-
foveal space, a critical prerequisite for supporting retinal function. This had a further 
benefit in that grafts could be larger and harvested with considerably less sub-foveal 
instrument manipulation (van Meurs and Van Den Biesen, 2003). The improvement 
in vision noted in some patients provided strong evidence that foveal photoreceptors 
could be supported by RPE harvested from the equator, despite the reduced density 
and flatter morphology of the latter compared to RPE at the fovea (Gao and 
Hollyfield, 1992). 
 
 
This study describes a prospective interventional cohort study to assess the surgical, 
anatomic, and functional effectiveness of peripheral RPE choroid transplantation in patients 
with severe vision loss due to acute neovascular AMD. The study also sought to gain a better 
understanding of surgery to the choroid, as this is a relatively unexplored procedure in 
ophthalmology. 
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Methods 
 
 
 
Patients 
 
A prospective series of 12 consecutive patients (2 female, 10 male) with a mean age 
of 80 (73 – 91) years and CNV secondary to AMD underwent autologous RPE 
transplantation with silicone oil tamponade and removal of oil at Moorfields Eye 
Hospital, London  (Table 40). The study was conducted with full ethical approval as 
outlined in the General Methods. 
 
 
Inclusion Criterion and Exclusion Criterion 
 
Twelve patients were invited to take part in the trial with informed consent if they met 
all the following criteria: 
 
 
Inclusion Criteria 
 
• Acute sub-foveal neovascular AMD with or without sub-retinal hemorrhage. 
• Ineligibility for conventional treatments, such as photodynamic therapy, which 
was not available in the UK for occult lesions during the course of this study and 
is contraindicated in the presence of an RPE rip. The pre-operative CNV 
classification for each patient is detailed in Table 40. 
 
• Vision loss of at least 3 lines over 3 months before study entry. 
• Clinical signs of CNV progression, as evidenced by increased sub-retinal 
hemorrhage or fluid, associated with the decline in vision. 
 
• No more than 6 months delay between vision loss and surgery. 
 
Exclusion Criteria 
• Unfit for general anaesthetic 
• Unwillingness to undertake follow-up 
• Other ophthalmic pathology precluding complex vitreoretinal surgery 
• Inability to give informed consent 
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Pre and Post-operative Assessments 
 
Pre-operative examinations were performed as outlined in the General Methods. In addition 
patients underwent a subjective refraction with Early Treatment Diabetic Retinopathy Study 
visual acuity, and cataract grading using the Lens Opacities Classification System III (Tyrrell 
and Wolfe, 1993). All patients underwent pre-operative assessment at 6 weeks to check for 
CNV recurrence and graft revascularization and all tests were repeated at 6 months, which 
was the defined end point of the cohort study. Selected patients also underwent additional 
assessment of retinal sensitivity and fixation pattern after 6 months using a Nidek MP1 
microperimeter (Nidek Co.,Ltd., Tokyo, Japan) as described in the General Methods and 
Appendix 2  
 
 
Surgical Technique 
 
Surgery was performed by 2 surgeons (GWA, LDC) at the study centre and closely followed 
the technique described elsewhere by van Meurs and Van den Biesen.14 Briefly, this 
involved a pars plana vitrectomy followed by CNV excision through a superonasal (left eye) or 
superotemporal (right eye) macular retinotomy. Haemostasis of the CNV bed was achieved 
by elevating the infusion bottle, and any surplus blood was aspirated through the retinotomy. 
Diode laser was then applied in a 2- to 3-mm square to the superior equatorial retina, which 
was subsequently cut out as a full-thickness RPE choroid graft after peeling off the overlying 
neurosensory retina. The graft was gripped on the choroidal surface with a customized 
aspirating cannula (Figure 14) designed by van Meurs (DORC Surgical Instruments, 
Zuidland, The Netherlands), and then slid through the original retinotomy into the sub-foveal 
space. A 5-ml syringe attached to the end of the cannula was used to create a sufficiently 
strong vacuum aspiration force, and gentle reflux released the graft once in position. A 3- to 
4-mm diameter perfluorocarbon bubble was used to hold the graft during 2 to 4 further 
manipulations to ensure correct unfolding and a sub-foveal position. Retinopexy was not 
applied to the macular retinotomy and the eye was filled with silicone oil. Three months later, 
patients underwent phacoemulsification cataract surgery combined with silicone oil removal, 
followed by further procedures as required for any complications. 
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Electron Microscopy 
 
For field emission scanning electron microscopy, a full thickness slice of RPE choroid 
was fixed and stored in a mixture comprising 3% glutaraldehyde and 1% 
paraformaldehyde in 0.08 mol sodium cacodylate buffer pH 7.4 at 4° C. It was then 
rinsed in 0.1 ml cacodylate buffer pH 7.4, fixed with 1% osmium tetroxide for 2 hours, 
dehydrated with 100% ethanol, critical point dried in liquid carbon dioxide, mounted, 
and coated with gold-palladium using a K550 sputter coater (Emitech, Ashford, 
United Kingdom). Secondary electron images of coated specimens were recorded 
digitally using an S4800 field emission scanning electron microscope (Hitachi, 
Maidenhead, United Kingdom) operating at 15 kV, as previously described 
(Erlandsen et al., 2004). 
 
 
Gene Transfer 
 
For gene transfer, a construct incorporating a cytomegalovirus promoter driving an 
enhanced green fluorescent protein (eGFP) reporter gene was incorporated into a 
self-inactivating third- generation human immunodeficiency virus vector, produced by 
a triple plasmid transient transfection system and pseudotyped with the VSV-G 
glycoprotein envelope as previously described (Dull et al., 1998). The virus was p24 
titered using a Beckman Coulter (Fullerton, CA) kit following manufacturer 
instructions. For ex-vivo gene transfer studies, slices of rat RPE choroid were initially 
used to optimize culture conditions, virus concentrations, and exposure times. 
Surplus human RPE choroid tissue subsequently became available from 3 patients in 
the study group. The specimens were divided and co-cultured at 37° C in 5% CO2 
within a 20-µl viral suspension containing 1.5 x 109 transducing units per milliliter in 
Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco, Grand Island, NY) for 20 
minutes, 40 minutes, or overnight. After exposure to virus, specimens were washed 
three times in DMEM with Glutamax (L-analyl-L-glutamine, Gibco), 1:100 antibiotic-
antimycotic solution (Gibco) and 3% fetal calf serum. The same solution was used for 
subsequent tissue culture at 37° C, which was examined daily for fluorescence and 
changed every 48 hours. Control specimens that had not been immersed in virus 
were co-cultured in contact with transduced tissue. After 1 week in culture, 
specimens were fixed in 4% paraformaldehyde, freeze embedded, and cut at 12 µm 
on a cryostat (Leica, Wetzlar, Germany). Sections were washed, counterstained with 
Hoechst 33342, and mounted. 
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Figure 14 The spatula designed by van Meurs and used in this study for 
holding and inserting the retinal pigment epithelium choroid graft into the sub-
retinal space. The hole at the tip of the spatula is connected via the lumen to a 
fluid-filled syringe and tube fitted to the base connector. The graft is held in 
position by suction aspiration during surgery. Length, 60 mm. 
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Results 
 
 
 
Presenting Features and Surgical Outcome 
 
Patient demographics, duration of symptoms, and pre-operative status of the CNV 
and retina, and the pre-operative visual status are shown in Tables 40 and 41. 
Patient 2 had a wholly classic CNV, but it had become too large for photodynamic 
therapy after 2 previous unsuccessful treatments. All other patients had a serous or 
hemorrhagic pigment epithelial detachment or RPE rip. Three patients had pre-
operative cystoid macular edema, which had re- solved at the final follow-up OCT 
scan. Retinal angiomatous proliferation was also present in 3 cases and, in 1 case 
(Patient 2), created an additional retinal break at the time of CNV excision. All 
cataracts were graded as mild by the Lens Opacities Classification System III 
assessment.16 
 
 
The surgical procedure was technically successful in all 12 patients with regard to 
CNV excision and RPE grafting (Figure 15), taking 1 to 2 hours to perform. 
Dissection of the RPE choroid graft and mobilization on the spatula was relatively 
straightforward and was achieved without significant intra-operative hemorrhage. In 1 
patient, the RPE choroid graft required trimming and a relatively large strip was 
removed en bloc from the eye. Electron microscopy of this specimen showed loss of 
sheets of RPE cells from the graft in some areas (Figure 16A), but the exposed 
underlying Bruch’s membrane invariably remained intact (Figure 16B). The 
morphology of RPE cells was generally good, but occasional areas of single cell loss 
or loss of the RPE apex could be seen (Figure 16C). 
 
 
Complications 
 
Post-operative complications and visual outcomes are listed in Tables 42 and 43 and 
examples are shown in Figure 17. Patient 10 developed a large dome-shaped 
hemorrhage deep to the graft on the first post-operative day. This graft became 
surrounded by fibrous tissue and is the presumed appearance of complete graft 
failure (Figure 15E). Three other patients (6, 7, and 11) developed hemorrhages over 
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the graft within the first week of surgery. Graft-occluding hemorrhage occurring within 
the first week was described as a surgical complication because it would most likely 
be related to the procedure and might impede graft revascularization. A late 
hemorrhage would more likely be related to CNV recurrence as part of the ongoing 
AMD disease process. Patient 8 developed a hemorrhage at 6 weeks that, although 
extensive, did not track under the graft (Figure 17D) and eventually cleared to yield a 
reasonable visual outcome. No CNV recurrence was detected angiographically in 
any of the grafted patients. Retinal detachment occurred in 5 patients after combined 
cataract surgery with removal of silicone oil at 3 months and in all cases was 
associated with proliferative vitreoretinopathy (PVR). In 4 cases, silicone oil was 
reinserted and remained in the eye at most recent follow-up. Presumed causative 
retinal breaks were found at the edge of the donor site in Patient 1, at the hole 
created by removal of a CNV–retinal anastomosis in Patient 2, and from the CNV 
retinotomy sites in Patients 9 and 12 (Figure 17A). 
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Table 41 Pre-operative Visual Status 
 
 
 
Best Corrected Vision 
 
 
Distance 
 
Near 
 
Pelli-Robson 
Contrast Sensitivity 
 Patient 
Operated 
Eye 
Fellow 
Eye 
Operated 
Eye 
Fellow 
Eye 
 
Operated 
Eye 
 
Fellow 
Eye 
 
1 1.20 0.20 1.20 0.30 0.60 1.50 
2 0.68 1.54 0.70 1.60 0.75 0.00 
3 0.40 0.80 0.70 1.00 1.05 1.20 
4 0.90 0.10 0.70 0.40 0.60 1.65 
5 0.40 0.38 1.40 0.90 1.35 0.15 
6 1.00 1.32 1.10 1.60 0.75 0.00 
7 0.90 0.76 0.70 1.35 0.90 0.75 
8 1.00 1.40 1.10 1.60 1.05 0.90 
9 0.62 1.12 0.70 1.35 0.15 0.15 
10 0.40 1.26 0.60 1.60 1.20 0.60 
11 1.10 0.14 1.40 0.40 0.60 1.20 
12 1.20 0.88 1.20 1.35 0.60 1.15 
 
Visual acuities and contrast sensitivity are calculated as outlined in Appendix 1. 
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Table 42 Surgical Complications 
 
 
Patient 
 
Complications PVR Number of Operations* 
 
1 
 
RD Yes 4+ 
 
2 
 
RD Yes 5+ 
 
3 
 
ITU No 2 
 
4 
 
None No 2 
 
5 
 
None No 2 
 
6 
 
Haem + RD Yes 2 
 
7 
 
Hem No 2 
 
8 
 
None No 2 
 
9 
 
RD Yes 3+ 
 
10 
 
Hem No 2 
 
11 
 
Hem Yes 2 
 
12 
 
RD Yes 3+ 
 
Haem  Hemorrhage Around Graft within First Week 
ITU  Admitted to Intensive Therapy with a Presumed Cardiac Event 
PVR  Proliferative Vitreoretinopathy 
RD  Retinal Detachment 
*  Silicone Oil to be Removed at a Later Date. 
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Table 43 Post-operative Visual Status 
 
 
 
Best Corrected Vision 
 
 
Distance 
 
Near 
 
Pelli-Robson 
Contrast Sensitivity 
 Patient 
Operated 
Eye Change 
Operated 
Eye Change 
 
Operated 
Eye 
 
Change 
 
1 1.30 -0.10 1.60 -0.40 0.00 -0.60 
2 1.60 -0.92 1.20 -0.50 0.60 -0.15 
3 1.60 -1.20 2.10 -1.40 0.00 -1.05 
4 0.30 +0.60 0.50 +0.20 0.60 0.00 
5 0.50 -0.10 1.30 +0.10 0.90 +0.45 
6 1.40 -0.40 2.50 -1.40 0.00 -0.75 
7 1.10 -0.20 1.30 -0.60 0.75 -0.15 
8 0.60 +0.40 0.70 +0.40 NA NA 
9 1.00 -0.38 1.20 -0.50 NA NA 
10 1.60 -1.20 1.60 -1.00 0.90 -0.30 
11 1.47 -0.37 1.40 0.00 NA NA 
12 1.47 -0.27 1.40 -0.20 NA NA 
 
Visual acuities and contrast sensitivity are calculated as outlined in Appendix 1. 
NA  Data Not Available 
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Figure 15 Fundal photographs and optical coherence tomography (OCT) 
images showing projection and sectional views of the retina, on the day 
before surgery (pre-op) and at 6 months (post-op), in 5 representative 
patients. Corresponding best-corrected visual acuities at subjective refraction 
are shown at the top right of each photograph, and OCT images represent 
vertical scans moving superiorly through the fovea, with the inferior retina 
represented to the left. A–C, Patients 4, 5, and 8 did well after autologous 
transplantation. D, Patient 7 had a successful graft with regard to 
revascularization but no gain in vision. E, Patient 10 had a primary failure of 
graft revascularization, presumed due to development of a large hemorrhage 
deep to the graft immediately post-operatively. 
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Figure 16 Field emission scanning electron microscope images showing a 
segment of a retinal pigment epithelium (RPE) choroid graft taken just after 
harvesting from the superior retina. Scale bars are shown beneath each 
image. A, Low-power view shows an area of denuded RPE (arrow) possibly 
caused by surgical trauma; boxed areas represent high-power views in B and 
C. B, Bruch’s membrane underlying regions devoid of RPE cells. Note that 
the integrity of this layer is maintained despite focal RPE cell loss. C, Flat 
hexagonal structure characteristic of RPE cells in the equatorial region. Note 
the varying morphology of cells in this area, which reveals a healthy RPE cell 
with microvilli (top left arrow), a completely avulsed RPE cell with exposed 
underlying Bruch’s membrane (middle arrow) and a partly de-roofed RPE cell 
exposing presumed phagocytosed outer segment discs (bottom right arrow) 
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Figure 17 Complications arising from surgery. A, Retinal detachment due to 
proliferative vitreoretinopathy (PVR) (patient 9). Note that the graft has 
remained attached to the posterior sclera but the retinotomy site is adjacent to 
a PVR membrane and has reopened (arrow). B, Proliferative vitreoretinopathy 
causing epiretinal membranes and contracture of the retina overlying the graft 
(patient 11). C, Mild hemorrhage from the graft donor site but a clear graft on 
the first post-operative day (patient 8). D, This same patient developed a late 
hemorrhage over the graft (arrow) 6 weeks after surgery. Despite this 
extensive hemorrhage, patient 8 eventually had an acceptable visual 
outcome. 
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Graft Revascularization 
 
ICG patterns of large choroidal vessels were examined 6 months after surgery to 
confirm the extent to which the free grafts could become revascularised by the 
residual sub-foveal choroid (Figure 18). In most cases, a new choroidal vascular 
architecture could clearly be identified as specific to the graft (Figure 18B, D). In 
contrast, the only presumed complete primary graft failure due to an immediate post-
operative hemorrhage (patient 10) had a well-circumscribed area of ICG hypo-
perfusion corresponding to the graft (Figure 18F). Choroidal filling of the grafts was 
also seen on FFA, but revascularization patterns were not obviously correlated to 
areas of graft autofluorescence (Figure 18). 
 
 
To examine the vascular properties of the grafts in more detail, high-speed 
angiography was performed in 4 patients, 3 of whom had a good visual outcome 
(Figure 19). In patient 4, single frame analysis from high-speed ICG sequence 
showed a short posterior ciliary artery (SPCA) originating from beneath the graft but 
filling only the choroidal segment distal to it. Thus sub-foveal choroidal perfusion 
initially bypassed the graft completely (Figure 19, SPCA1). The graft was 
subsequently perfused from its periphery by blood entering horizontally through a 
point of contact with the surrounding macular choroid (Figure 19, SPCA2). We also 
noted segmental areas of choroidal non-perfusion related to SPCAs that would 
ordinarily arise from beneath the graft,19 suggesting that these vessels may have 
been compromised (Figure 19, SPCA3–4). 
 
 
Visual Outcomes 
 
Changes in visual acuity and logMAR equivalents are documented in Table 43 The 
mean logMAR vision pre-operatively was 0.82 and fell to 1.16 at the final follow up 
refraction 6 months after surgery. The 3 patients with no complications (Patients 4, 5, 
and 8) showed a mean improvement in logMAR visual acuity from 0.88 to 0.79, 
which has been sustained.  Microperimetry was also performed in these patients to 
assess retinal function over and surrounding the grafts. Patient 8 had good sensitivity 
over the graft but relatively poor visual acuity at the time of examination (Figure 20A). 
Conversely, Patient 4 had excellent visual acuity but was unable to see stimuli 
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projected onto he superior half of the graft (Figure 20B), which corresponded to the 
non-perfused area seen on ICG (Figure 19C). 
 
The 3 patients who had good functional vision on the graft were also closely 
monitored beyond the formal 6-month study end point. The vision in patient 5 fell 
further in the year after surgery and an area of persistent sub-retinal fluid was seen 
over the graft inferiorly, with a small haemorrhage at the presumed fovea (Figure 
21A). No CNV could be identified on FFA, and microperimetry showed poor visual 
function at this time point (Figure 21B). Fortunately in this patient, the sub-retinal fluid 
and hemorrhage resolved spontaneously 3 months later, with corresponding 
improvements in both visual acuity and microperimetry. This was also associated 
with an improvement in fixation stability and restoration of presumed foveal fixation 
(Figure 21C, D). The visual acuity in patients 5 and 8 was also maintained or slightly 
improved beyond the 1-year follow up point. 
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Figure 18 Autofluorescence images (A, C, D) and corresponding indocyanine 
green (ICG) angiograms (B, D, E) taken in 3 patients at the 6-month follow-up. 
Patient 5 has good autofluorescence over the graft (A) and corresponding 
graft vascular architecture (B). Note that the ICG fills parallel vertical vessels 
(arrows), which are characteristic of equatorial choroid suggesting successful 
graft revascularization. Patient 8 has patchy autofluorescence (C), but a 
clearly graft-specific choroidal vascular pattern (D). Note again the linear 
arrangement of choroidal vessels within the graft (arrow), which is not 
normally seen in the fovea. In patient 10, there was autofluorescence from 
scar tissue surrounding the graft (E), but a corresponding perfusion defect on 
ICG (F). This patient had a large hemorrhage beneath the graft on the first 
day after surgery and revascularization is presumed to have failed. See also 
the corresponding color photographs in Figure 2E. 
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Figure 19 High-speed angiography with indocyanine green (ICG) was used to 
define the mechanism of graft revascularization in patient 4. A, Pre-operative 
(pre-op) ICG showing choroidal new vessels (CNV) at the fovea. B, C, Red-
free and 6-month post-operative (post-op) ICGs for comparison. Note that the 
superior half of the graft seems poorly perfused above the arrow in C. D–H, 
Serial high-speed ICG frames seem to show the graft being perfused 
horizontally from the residual choroid in contact with the graft inferiorly. The 
medial posterior ciliary artery (MPCA) fills first (D), followed by the short 
posterior ciliary arteries (SPCA) 1 and 2 (E). Note that SPCA1 originates from 
underneath the graft but does not perfuse it. F–H, The graft is perfused from 
its point of contact with the territory of SPCA2. I, The proposed mechanism of 
sequential revascularization through the SPCAs is shown diagrammatically. 
Note also that territories labeled for SPCA3 and SPCA4 fill very late and 
probably by anastomosis with adjoining territories. These arteries may have 
been avulsed together with the CNV at surgery or destroyed as part of the 
original neovascular disease process.  
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Figure 20 Static microperimetry interpolated maps displaying the range of 
retinal sensitivity to a Goldmann V stimulus using a Nidek MP1 
microperimeter in 3 patients 9 to 12 months after surgery. A, Patient 8 has 
good retinal function extending over almost all areas of the graft but only 
modest visual acuity. B, Patient 4 has retinal function limited to the inferior half 
of the graft but excellent visual acuity. Note the close correlation between 
retinal sensitivity and blood flow through the graft in this patient in Figure 6. C, 
A large absolute scotoma over a nonfunctional graft is shown as a negative 
control from patient 11. D, The relative attenuation range for this machine in 
decibels (dB) is shown against the false color scheme in the key. Green 
squares, normal retinal sensitivity through to bright red, which represents 
appreciation only of the brightest stimulus; dark red areas and hollow squares, 
absolute scotoma. 
 
 
 
 
226
 
 
Figure 21 Microperimetry showing progressive improvement in fixation 
pattern and retinal sensitivity in patient5 between13 and16 months after 
surgery. A, Presumed extra-foveal fixation due to a small hemorrhage (arrow) 
associated with sub-retinal fluid. Fixation was relatively unstable at this time 
(61% of points within 2 degrees of the baricenter of fixation). B, 
Corresponding interpolated map. C, By 16 months, the hemorrhage and sub-
retinal fluid had reabsorbed spontaneously and was associated with much 
improved fixation stability (98% of fixation points within 2 degrees) and 
presumed restoration of foveal fixation. This corresponded to improved retinal 
sensitivity over the graft and visual acuity (D). No choroidal new vessels were 
detected in this and 2 other grafts showing transient focal areas of leakage. 
See Figure 7 for key to color codes. 
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Ex Vivo Gene Transfer 
 
On of the study aims was to see if an RPE choroid graft could be genetically modified 
outside the eye during the transplantation procedure because this could provide 
adjunctive molecular therapies targeted to the sub-foveal RPE. This was achieved 
using a self-inactivating lentiviral vector expressing eGFP under control of a viral 
promoter (Figure 22), which is known to transduce the RPE highly efficiently. Using a 
logarithmic dilutional series, identified that 1.5x109 viral transducing units per milliliter 
in 20 µl of DMEM was the minimum concentration of virus that could transduce rat 
RPE after incubation at 37° C for 20 minutes. The same protocol was subsequently 
applied to small portions of human RPE removed from the eyes of 3 patients during 
RPE choroid grafting. This yielded successful transduction of approximately 10% of 
cells along the tissue surface, as evidenced by the appearance of GFP after 3 days 
in culture. Transduction of RPE was further confirmed histologically after 1 week in 
culture, which showed co-localization of lipofuscin granules in transduced cells 
(Figure  23). After 20 minutes of immersion in the vector suspension and washing 3 
times in culture medium, 3 RPE choroid specimens were co-cultured in contact with 
non-transduced tissue. In all cases, GFP expression was seen only in the specimens 
directly exposed to the virus, confirming that the washing procedure was sufficient to 
render the transduced tissue non-infective under these conditions. 
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Figure 22 Construct diagram of the reverse transcribed double-stranded DNA 
generated by the self-inactivating lentiviral vector used for ex vivo gene 
transfer in this study. 
 
 
 
 
 
CMV  Cytomegalovirus Promoter 
DLTR  Deleted Long Terminal Repeat 
eGFP  Enhanced Green Fluorescent Protein Reporter Gene 
PBS  Primary Binding Site 
PPS  Polypurine Tract; 
Ψ  Packaging Signal. 
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Figure 23 Ex vivo transduction of the retinal pigment epithelium as evidenced 
by green fluorescence co-localized in cells laden with red autofluorescent 
lipofuscin granules (arrows) after 1 week in culture. The nuclei of transduced 
cells are also identified (N). Scale bar, 25 µm. 
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Discussion 
 
 
 
At the time of writing, this study represents the largest published prospective case 
series assessing the role of autologous transplantation of the RPE in the 
management of AMD, and the second only after its original description by van Meurs 
(van Meurs and Van Den Biesen, 2003, van Meurs, 2005). Our angiographic 
observations provide evidence that a small patch of RPE choroid can become 
revascularised when transplanted as a free graft into the sub-retinal space after CNV 
excision. Furthermore, visual acuity was maintained or improved by grafting in 3 of 
12 patients (25%) and sustained for at least 1 year. Microperimetry confirmed retinal 
function over sections of the grafts in these patients, all of whom also commented 
that they had experienced a subjective improvement in their vision. 
 
 
Graft survival, assessed by bi-microscopy, autofluorescence, and OCT, was seen in 
11 of 12 patients. Electron microscopy of 1 specimen, however, suggested that the 
quality of RPE cells on the grafts might be variable, although Bruch’s membrane 
seemed consistently intact. It was not possible to determine whether this occurred 
during separation of the overlying neurosensory retina or during subsequent 
intraocular instrumentation, and this might require further investigation. 
 
 
One of the questions posed by the study was whether graft reperfusion occurred 
vertically, from the choroidal base of CNV excision, or horizontally, through 
peripheral contact with relatively healthy choroid. The macular choroid is perfused by 
about 6 to 8 SPCAs that radiate out from the posterior pole and normally fill just after 
the medial posterior ciliary artery (Hayreh, 1975). Although not conclusive in all 
patients, it did seem on one high-speed ICG that the graft was reperfused 
horizontally through contact with surrounding choroid. Graft reperfusion from the 
periphery may occur because AMD leads to a fibrotic avascular scar beneath the 
fovea, but the extra-foveal choroid remains highly vascular. Conversely, a recent 
preliminary study in pigs suggested that graft revascularization can occur from 
underlying healthy choroid (ARVO abstract 2005:4143). Confirming the horizontal 
mechanism of graft reperfusion is critical, because it would determine whether or not 
grafts should be placed in peripheral contact with residual choroid. Conversely, the 
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technique of laser ablation of the graft undersurface as proposed by Bindewald et al 
(2004) (Bindewald et al., 2004) would probably only facilitate reperfusion if it occurs 
from the base. 
 
 
The high rate of PVR compared with other vitreoretinal procedures may be due in 
part to the cutting and manipulation of the RPE choroid and consequent dispersal of 
RPE cells throughout the vitreal cavity. Bare choroid is also left exposed at the donor 
site, which may release further RPE cells during the post-operative period, 
particularly as the large defect was sited adjacent to the vitreous base. Posterior 
PVR in this study was common, and this may further contribute to the high incidence 
of retinal detachment because the retinotomy site was not routinely lasered, in 
keeping with usual practice in sub-macular surgery (Hawkins et al., 2004b). In this 
case, however, the insertion of the graft would further widen the retinotomy and 
might physically elevate it from the underlying RPE in the initial post-operative 
stages, during which there would almost certainly be impaired RPE absorption of 
sub-retinal fluid. This would make the posterior pole highly susceptible to 
detachment, even without PVR traction. 
 
 
Early post-operative haemorrhage developed in 4 patients within the first week. This 
could be problematic if it spread between the graft and underlying macular choroid, 
because it might prevent revascularization and lead to avascular necrosis. Despite 
this, complete failure of graft revascularization occurred in only 1 patient. 
Nevertheless, the visual outcome was poor in all cases of early post-operative 
haemorrhage; one explanation for this might be that sub-retinal hemorrhage is 
particularly toxic to the neuroretina. This is partly supported by the results of the Sub-
macular Surgery Trials, which showed that hemorrhage associated with CNV was 
the only indication for which surgery was beneficial in preventing severe visual loss 
(Bressler et al., 2004). With regard to haemorrhage, the technique described in this 
study is disadvantageous compared to macular translocation surgery for 2 principal 
reasons. First, by working through a retinotomy, it was not possible to apply cautery 
directly to the vascular bed after CNV excision. Also, the presence of a free graft that 
subsequently became vascularised indicates that angiogenic mechanisms must be 
active in the sub-retinal space during the post-operative period. 
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As a vitreoretinal procedure, autologous transplantation of the RPE is unique in that 
retinal tissue is dissected free from surrounding ocular tissues and might therefore be 
temporarily removed from the eye during surgery. This provides a potential 
opportunity to modify the graft genetically within the time frame of the operation, 
which might be used, for instance, to express angiostatic genes specifically within the 
sub-foveal RPE (Balaggan et al., 2006). The ability subsequently to render the graft 
non-infective (by washing off vector suspension ex vivo) may also have advantages 
over direct sub-retinal administration because vector spread would be more 
controlled. Gene transfer to the graft might also be combined with gene replacement 
for inherited retinal diseases that cause macular RPE loss owing to deficiencies in 
RPE-specific enzymes (Thompson et al., 2005). We have shown that gene delivery 
to the RPE and transplantation might be combined in a single operative procedure. 
 
 
The results of this study show that the transplantation of a free graft of equatorial 
RPE choroid can improve vision in some cases of acute neovascular AMD. The 
grafts can revascularise and support stable fixation for up to 18 months when 
transplanted into the sub-retinal space. Further surgical refinements are needed to 
address the complications, and better pre-operative assessment might provide more 
information on the visual potential of the neurosensory retina before transplantation. 
Recent developments in molecular treatments directed against vascular endothelial 
growth factor may transform the clinical management of exudative AMD. Preliminary 
data, however, suggest that about 5% of patients lose ≥3 lines of vision after 
commencing anti-vascular endothelial growth factor treatment (ARVO abstract 
2006:2959). These patients and those with a mechanical disruption of the RPE, such 
as a rip, or geographic atrophy may still be suitable for autologous RPE choroid 
transplantation. 
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VI RPE Transplantation: Inherited Dystrophy 
 
 
 
Introduction 
 
 
 
The inherited macular dystrophies are a diverse group of disorders leading to 
bilateral symmetrical progressive macular degeneration and irreversible central 
vision loss (Michaelides et al., 2003). Many phenotypic variations have been 
described and in a growing number of cases the genetic basis has been identified 
(Michaelides et al., 2005). Despite great variation in these disorders, retinal pigment 
epithelium (RPE) degeneration is often seen accompanying the primary retinal 
changes. This RPE degeneration occurs despite many of the mutated genes 
associated with these dystrophies, such as peripherin/rds (Francis et al., 2005), 
having been identified as photoreceptor specific. In terms of loss of photoreceptor 
function it has not been clear whether the primary degeneration occurs in the 
neuroretina, with secondary RPE dysfunction or whether there is a photoreceptor 
related ‘poisoning’ of the RPE primarily with secondary photoreceptor dysfunction 
and degeneration. 
 
 
Currently these disorders are untreatable and many affected individuals, including 
children, sustain irreversible loss of central vision. Although with the advent of gene 
therapy there has been some indication that treatments maybe available for inherited 
conditions (Acland et al., 2001) these have not translated into ophthalmic clinical 
practice.  
 
 
Eckhardt et al described macular translocation, an indirect form of RPE-choroidal 
transplantation, in a case of vitelliform disease (Eckardt et al., 2004). They showed a 
small near vision improvement possibly limited due to the late stage of the disease 
and surgical complications in that case. RPE transplantation using a full thickness 
RPE-choroidal graft from a peripheral site in the same eye (van Meurs and Van Den 
Biesen, 2003) has recently been described. The surgical technique in this is similar 
to that described by van Meurs. This was a development of previous descriptions of 
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full thickness choroidal RPE grafts (Peyman et al., 1991, Stanga et al., 2001) and 
extra-macular free pigment epithelial transfer (Binder et al., 2002, Aisenbrey et al., 
2006). 
 
 
The current study was based on observation that in certain cases of macular 
dystrophy central vision remained good for several decades but then dropped 
suddenly over a period of months. It is possible this may indicate a moment where 
the retinal neurons were present but dysfunctional and the RPE had ceased to 
support the neuroretina. Thus, RPE transplantation at this point might lead to 
restoration of the retinal function that was present until very recently. 
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Methods 
 
 
 
Patient 
 
A 51-year-old white male presented with macular degeneration that had been slowly 
progressive over many years. Visual acuity was 20/30 bilaterally at presentation but 
had declined to 20/120 over the year preceding surgery. Vision declined in the left 
eye 6 months prior to decline in the right eye. Functionally the patient described 
alternating between central and eccentric fixation depending on the task. He became 
unable to read or to play golf, his major pass-times. The study was conducted with 
full ethical approval as outlined in the General Methods. 
 
 
Inclusion Criterion and Exclusion Criterion 
 
The patient was invited to take part in the study with informed consent if all the 
following criteria were met: 
 
 
Inclusion Criteria 
 
 
• Vision loss of at least 3 lines over 6 months before study entry. 
• No more than 3 months delay between vision loss and surgery. 
 
Exclusion Criteria 
• Unfit for general anaesthetic 
• Unwillingness to undertake follow-up 
• Other ophthalmic pathology precluding complex vitreoretinal surgery 
• Inability to give informed consent 
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Pre and Post-operative Assessments 
 
Pre and post-operative examinations were performed as outlined in the General 
Methods. The patient also underwent assessment of retinal sensitivity and fixation 
pattern after 6 months using a Nidek MP1 microperimeter (Nidek Co.,Ltd., Tokyo, 
Japan) as described in the General Methods and Appendix 2 Microperimetry was 
repeated after dark adaptation of the patient (2 hours of complete light excluding 
patching) to assess the position and stability of fixation. Finally multifocal 
electroretinogram (ERG) were also recorded binocularly according to established 
techniques described in Bellman et al (Bellmann et al., 2004b).  
 
 
Surgical Technique 
 
The surgical technique used in this study was modified from that described earlier6 
for age related macular degeneration. Briefly, a 3-port pars plana vitrectomy was 
carried out with shaving of the vitreous base. The donor area in the superior retina 
was demarcated with intra-ocular diathermy.  The retina was peeled off this area and 
removed. A full thickness graft was harvested by cutting the RPE, Bruch’s membrane 
and Choroid to bare sclera. This was lifted on a specially prepared spatula (DORC) 
(Figure 14).  
 
 
The macula retina was detached via a single retinotomy temporal to the macula, to 
make space for the graft.  The graft was placed under the retina and was then 
flattened under heavy liquid.  The edge of he donor site was lasered and the heavy 
liquid was exchanged for silicone oil.  Two months later a lens extraction and silicone 
oil removal was performed. All surgeries were performed by a single surgeon (LDC). 
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Results 
 
 
 
Surgery 
 
Transplantation was performed without complication. 
 
 
Distance and Near Visual Acuity and reading 
 
Pre-operative distance vision was log MAR 0.8 with a + 0.2/-0.25 x 20 over refraction 
with a contact lens (-9.50/-0.50 x15) in situ. Post operatively with a spectacle 
correction of –1.00 sphere the logMAR vision was 1.1.  
 
Pre-operative reading speed was 0 words per minute using the standardised MN 
read test. Post-operatively the reading speed was 56.8 wpm at logMAR 0.6. Reading 
speed increased as the print size decreased. Higher reading speeds were achieved 
when the print size approximated and became smaller than the optimal functional 
area over the graft as shown by the microperimetry (Figure 25). 
 
 
Colour Fundus Photography and Angiography 
 
The fundus photograph reflects the bi-microscopic examination demonstrating a 
densely pigmented sub-macular graft in situ (Figure 24). Fluorescein angiography in 
the arterial phase demonstrates early and complete masking of the background 
choroidal fluorescence by the graft while the surrounding area of atrophic retina 
manifests a clear window defect. As the run continues there is greater fluorescence 
of the graft with equal intensity to the background fluorescence of perfused normal 
retina-choroid (Figure 24) 
 
The ICG post-operative pictures show a different choroidal vessel pattern within the 
area of the transplant. These vessels are perfused and fill early. Outside of the 
transplanted area the post-operative vessels pattern is the same as the pre-operative 
vessel pattern. 
238
 
 
Scanning Laser Ophthalmoscope (SLO) Autofluorescence 
 
Pre-operative SLO autofluorescence demonstrates loss of signal in the area of the 
macular dystrophy. Six months post operatively there is strong SLO autofluorescence 
from the graft. The fluorescence is of the same intensity, qualitatively, as the areas of 
normal RPE. 
 
 
Automated Microperimetry and Fixation Pattern Evaluation 
 
Automated fixation pattern assessment 6 months post-operatively demonstrated that 
100% of the fixation points were located at the fovea and within 2º of the gravitational 
centre of all points over the 30 second test period (Figure 25b). This indicates high 
quality, central fixation – defined as greater than 50% of the preferred fixation points 
located within a 2º-diameter circle centred on the fovea) and stable fixation - defined 
as greater than 75% of fixation points located within a 2º-diameter circle centred on 
the gravitational centre of all fixation points. 
 
Visual thresholds to a Goldmann V stimulus were within the normal range over some 
section of the graft temporally and in a small area centrally corresponding to fixation 
(Figure 25d, inset). However, stimuli were not perceived in large areas of retina over 
the graft. Visual sensitivities and the area of stimuli perception were greater following 
dark adaptation of the patient as described previously. 
 
 
Multifocal ERG 
 
Multifocal ERG was carried out pre- and 8 months post-operatively.  The post-
operative right eye recordings were significantly improved in the ring of traces from 
retina over the graft (group A, Figure 26). The average amplitudes of the traces are 
shown in Figure 26. There was no increase post-operatively in any ring outside of the 
graft or any ring in the left, un-operated eye. 
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Figure 24 24a. Pre-operative fundus colour photograph of the right eye 
showing the macular dystrophy and the area of RPE the unchanged in 
adjacent un-grafted areas. atrophy. 24b. Post operative picture showing the 
pigmented graft in situ. 24c. Scanning laser ophthalmoscope RPE 
autofluorescence of the graft showing qualitatively the same fluorescence as 
normal peripheral RPE and contrasted area of un-grafted RPE loss with no 
autofluorescence. 24d. Late stage fluorescein angiogram showing masking of 
background choroidal flush by the graft but an internal fluorescence 
suggestive of perfusion within the graft. Pre-operative e and post-operative f 
indocyanine green angiograms showing the new perfused vessel pattern in 
the graft (arrows). Note the choroidal vessel pattern is  
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Figure 25 Microperimetry combined with reading speed showing the 
increasing reading speed as the letter size reduces and approximates the 
functional area of the graph. a. The size of a 1.3 logMAR letter shows it falling 
on areas of non-functioning retina. b. The size of a 0.6 logMAR letter showing 
the peak reading speed at the point where the letter approximates the area of 
central function. c. The reading speed versus letter size.  The points illustrated 
in a and b are shown with a red arrow. d. A magnified image of the graft and 
microperimetry (following dark adaptation and using a Goldman V stimulus 
size and a 1 degree fixation cross) showing the thresholds, colour coded and 
numerically (the green areas and high numbers approximate normal visual 
sensitivities). The inset shows the thresholds for the central fixation area in 
greater detail. 
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Figure 26 Multifocal ERG analysis using summated responses from 
concentric rings of increasing eccentricity to represent different retinal areas. 
The para-central ring A, shown dark in the insert, corresponds with the area of 
transplant. The right hand columns contain the mean power values for each 
ring pre- and post-treatment in nV/deg2. The power of the responses from ring 
A from the right eye, indicated by the asterisk, more than doubles following 
treatment, but there is no significant change in the remaining rings, B-D. None 
of the left eye rings show significant change post-operatively. 
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Discussion 
 
 
 
This study demonstrates a successful transplantation of full thickness RPE/Bruch’s 
and choroid in a case of recent vision loss in the second eye of a patient with 
progressive inherited macular dystrophy. The results after surgery demonstrate a 
restoration of retinal function and partial restoration of reading. 
 
 
Viability of the graft was demonstrated by the presence of the pigmented cells and 
the autofluorescence 9 months after the graft was completed. The choroid was 
perfused as demonstrated by a choriocapilliaris flush in the fluorescein angiogram 
and the presence of a new and distinct pattern of choroidal vessels in the graft 
footprint on ICG angiography. Presence of a perfused choriocapilliaris is required for 
normal foveal function as this is its only blood supply. Full field ERG in this patient 
had suggested that the dystrophy was limited to affecting the central retina and that 
the peripheral RPE that was transplanted was functioning. 
 
 
The return of reading function was marked with no reading ability recorded pre-
operatively. The reading speed increased with decreasing letter size – a feature 
contrary to normal reading patterns but consistent with the size and location of the 
functioning areas of retina as shown by microperimetry (Figure 26.). As peak reading 
speed was consistent with the size of the functioning retina this is an independent 
support of the graft being the source of the improved reading vision. The patient also 
described that he was able to return to playing golf at his local golf club, as it only 
required a small field to see the ball and the red flag.  This is in keeping with the 
improved reading speed as being associated with effect of the graft on retinal 
function. 
 
 
The distance acuity decreased post operatively contrary to the other parameters 
showing improved function. This may be due to the test protocol commencing with 
large letters that are difficult to locate on the small area of central retina that had 
improved function. The test does not proceed to smaller letters if the larger ones are 
not completed. This will remain a problem for testing of distance acuity in cases 
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where the graft and rescued retinal functional area are small. The non – grafted 
areas of central retina would have continued to degenerate and may account for the 
decline between pre and post-operative distance acuity for essentially larger letters. 
The improvement in near vision with worsening of distance vision was also described 
following translocation (Eckardt et al., 2004). 
 
 
Multifocal ERG demonstrated that there was a significant improvement (more than 
doubling of the amplitude) in retinal function only in the area of retina over the graft.  
None of the other concentric rings showed an increase in the same or fellow eye.  
Once again this powerfully associates the improvement with the graft, as there is 
both an internal control of the same eye and the lack of change in the equivalent area 
in the fellow eye. 
 
 
This study describes the first successful RPE/choroidal graft in a case of inherited 
macular dystrophy associated with significant improvement of visual function and 
stabilization of retinal degeneration. It is possible that if the transplants are carried 
out earlier and the quality of the RPE is improved then this may provide a treatment 
for a currently untreatable group of blinding conditions. 
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VII Conclusions 
 
 
 
The end stage of a number of macular diseases is irreversible central visual loss, 
secondary to or associated with loss of support for the neurosensory retina. In the 
case of exudative AMD profound anatomical disruption of retinal architecture may 
also be observed.  Whilst the current generation of anti-VEGF medications are 
directed at treating the end stage of the vascular process, the CNV, they are 
ineffective when large sub-retinal haemorrhage, significant pigment epithelial 
detachments, and rips of the RPE complicate CNV. Furthermore, in non-exudative 
AMD currently no medical treatment is available to counter the loss of RPE support, 
particularly in geographic atrophy. Finally, a number of macular dystrophies are also 
characterized by loss of RPE support occurring with photoreceptor dysfunction. 
Under all these circumstances there is disruption of the choriocapilliaris-Bruch’s-
RPE-photoreceptor axis. This demands a physical restoration of retinal anatomy in 
order to attempt to recover function and alter the natural history of these disorders. In 
addition, this restoration needs to be undertaken relatively early in the disease 
process when photoreceptor loss is limited and visual loss may be secondary to 
reversible factors such as blood and fluid. This body of work has examined two 
surgical approaches designed to reconstruct sub-foveal anatomy, macular 
translocation and RPE transplantation, and gauged the feasibility of these 
techniques, and their potential in restoring lost function and providing stable long-
term vision. 
 
 
Macular translocation has provided the most compelling evidence for proof of 
principle that an extra-foveal RPE bed can support photoreceptors. The technique of 
full 360-degree translocation, as first described by Machemer and Steinhorst (1993), 
is in effect a functional RPE transplant. In terms of RPE transplantation, MT360 has 
the advantage that the foveal photoreceptors are placed at a relatively distant 
position from the original disease bed and onto RPE that is not affected by disease in 
the case of AMD, it is atraumatic with respect to the choriocapilliaris, Bruch’s 
membrane and the RPE, and there are no issues with regards to revascularization, 
the size of the RPE transplant, or reestablishing physiologically intact sub-retinal 
anatomy. MT360 thus represents the ideal full thickness RPE transplant and the 
outcomes from this surgical intervention represent a benchmark against which other 
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RPE transplantation techniques can be gauged. A wealth of studies, including the 
data presented by this thesis, have demonstrated anatomical restoration and 
recovery of function in AMD, and in CNV associated with myopic degeneration. 
Furthermore there is evidence that the recovery is maintained in the short (6 months) 
to medium term (3 years), although a long-term follow up, extending to at least 5 
years, will help determine the extent to which this is sustained. Long-term studies 
also offer an insight into the ability of peripheral RPE cells to continue to meet the 
metabolic demands placed upon them by foveal photoreceptors, and into the 
influence of the fovea on the disease process.  
 
 
In terms of outcomes, the translocation data was comparable with the best-published 
series and this was also reflected in the complication rates. Of particular note, the 
data confirmed the premise that one of the principal determinants of successful 
surgical intervention in macular disease is the number of viable photoreceptors 
present in the foveal pool at the time of presentation. Early in macular disease, 
particularly exudative AMD, visual loss may be secondary to factors such as sub-
retinal fluid, haemorrhage, exudation, and loss of retinal architecture. Under these 
circumstances photoreceptors are still viable despite a loss of support and so 
amenable to being salvaged. With time and disease progression the photoreceptors 
are irreversibly lost as is this critical window to intervene. The translocation series 
estimated this window to be approximately 12 weeks from acute loss of vision. This 
concept underpinned the proposed case selection algorithm, using fixation analysis 
and duration of symptoms to gauge residual foveal function and photoreceptor 
viability, as opposed to acuity measures, which can be compromised in the face of 
viable photoreceptors. This is particularly true of distance acuity, the default outcome 
measure, which is a poor predictor for outcome when the pre-treatment acuity is less 
than 20/100. 
 
The data in the thesis supported the case selection algorithm, as some of the best 
outcomes with translocation were observed in those with the poorest presenting 
acuity. The algorithm can be applied to any potential surgical or medical intervention 
for macular disease. In this regard the status of the photoreceptors, as the recipient, 
is as critical as the status of the RPE, as the donor. When studies of translocation or 
transplantation are examined closely (extended duration of symptoms with poor 
presenting acuities) a major factor in poor outcomes is that procedures were 
performed with a photoreceptor pool that was already at or beyond a critical tipping 
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point in relation to recovering function. Under these circumstances, any recovery is 
already compromised, and the surgical intervention itself is likely to additionally 
degrade the photoreceptor pool, and further limit outcomes. Therefore, to make a 
complete pre-operative assessment and predict outcomes for surgical intervention 
necessitates documenting not only distance and near acuities, reading speeds, 
contrast sensitivity, and an assessment of sub-macular and mid-peripheral RPE 
(autofluorescence), but also a measure of foveal function by documenting 
retinal/macular sensitivity (microperimetry/multifocal and full field ERG), symptom 
duration, and an analysis of foveal fixation, as these are powerful indicators of 
success. 
 
 
Additional pre-operative investigations that may assist in predicting outcomes include 
autofluorescence, angiography and optical coherence tomography. Autofluorescence 
of the periphery gives an indication of the viability of the donor RPE, and macular 
imaging provides valuable information regarding pre-existing photoreceptor numbers 
and the chronicity of visual loss. It has been well documented that in the presence of 
CNV, autofluorescence decreases with time, reflecting a loss of photoreceptors, 
RPE, and or disruption of the RPE-photoreceptor axis. Autofluorescence can 
therefore be a useful tool in helping to assess residual foveal function. Similarly, 
several investigators have examined outcomes and attempted to correlate these to 
angiographic subtypes of CNV.  In general, lesions that are larger in size, 
haemorrhagic or vascularised (PED and RAP), and predominantly occult have a 
worse prognosis. These classifications reflect disease with greater chronicity and 
extent and so suggest a depleted photoreceptor pool prior to treatment. Finally, 
recent advances in OCT, particularly spectral domain scanning offer the ability to 
image macular anatomy in greater detail to gauge the extent of sub-macular 
pathology, map the RPE pre-operatively, and identify co-pathology such as pre-
retinal membranes.  
 
 
The quality of the restoration achieved with successful translocation was examined 
with a detailed investigation of the best outcomes from this series. The study 
demonstrated that peripheral RPE was capable of supporting foveal photoreceptors 
to the extent of restoring normal retinal sensitivity with a single stable locus of 
fixation. Moreover the retinal function closely approximated or matched normal age-
matched subjects not only in acuity measures but also in measures of reading 
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performance. The latter was achieved despite translocation being shown to 
compromise saccadic behaviour when performing reading tasks. 
 
 
The studies of macular translocation and RPE transplantation conducted in this 
thesis confirmed the feasibility of these procedures to treat sub-macular disease and 
surgically reconstruct retinal architecture. While translocation was a far more 
involved, and longer procedure, the functional outcomes were more favourable than 
RPE transplantation. This result is a reflection of the complications associated with 
each procedure, particularly PVR detachments and early haemorrhage, and as 
mentioned earlier this result can be attributed to the fact that translocation is in fact a 
very atraumatic form of full thickness RPE transplantation. Despite translocation 
being a much more effective procedure, it is ultimately limited by its relative 
complexity, the surgical time required and the consequent impracticalities of meeting 
an ever increasing service demand, the need for cyclotorsion surgery, and the 
constraints of treating only second eyes due to the considerable problems of 
cyclotorsion if undertaken on a first eye. Furthermore, when compared to the modern 
era of medical therapies, translocation appears an even more cumbersome 
undertaking. Having said that it is a real and viable option when a salvage procedure 
is required in the face visual loss secondary to profound mechanical disruption of the 
retina in a second eye. 
 
 
In comparison, autologous full thickness RPE transplantation, while being a more 
straightforward, shorter, and more versatile procedure in terms of manipulation of the 
graft prior to placement and disease processes amenable to treatment, is susceptible 
to a high complication rate, particularly PVR. This technique of transplantation results 
in release of RPE cells into the vitreous cavity at a number of stages from harvesting 
the patch, to delivery into the sub-retinal location, to continued RPE release from the 
bare bed of the donor site. Furthermore, the high rate of posterior PVR documented 
in this study was felt to be due to the widening of the retinotomy required to deliver 
the graft, combined with the routine practice of not lasering the retinotomy site. All of 
the aforementioned factors combine to contribute to a high risk of PVR traction and 
detachment. In addition to PVR, other causes of graft failure include a paucity of RPE 
cells on the patch secondary to surgical trauma, pre-existing RPE dysfunction, or 
graft ischaemia. In comparison to translocation, considerable surgical trauma of the 
graft arises from the physical manipulation of the graft from harvesting to delivery, 
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and the technique still requires evolution and refinement to minimise disruption of the 
RPE layer.  In the transplantation series, electron microscopy provided evidence of 
this trauma by demonstrating areas of RPE loss overlying intact Bruch’s membrane 
and avulsion of the apical aspect of RPE cells. The study also showed strong 
adhesion between the retina and the underlying CNV, particularly with RAP lesions, 
further contributing to loss of photoreceptors and compromising the success of the 
graft. In terms of pre-existing disease, pre-operative work up with autofluorescence 
and full field ERG would ascertain if the peripheral RPE was suitable, especially 
when the procedure was performed on patients with retinal dystrophies. With regards 
to graft revascularisation, the transplantation series demonstrated revascularization 
in the majority of cases. Previous investigators have reported that revascularization 
occurs via direct contact with the choroid underlying the graft however high-speed 
ICG angiography conducted in one particular case in this series demonstrated that 
reperfusion occurs via connection between the edge of the patch and the choroidal 
bed as per a skin graft. This method of contact revascularization may well be the 
initial route of perfusion before subsequent underlying vascular remodeling occurs 
and further investigation is warranted. In terms of failure to vascularise, this is may be 
due to a failure to establish contact with the choroidal bed secondary to either a 
physical barrier, such as intervening haemorrhage, or an absence of choroidal 
vasculature secondary to pre-existing degenerative changes or vascular damage 
incurred at the time of surgery with CNV removal. As with translocation, long-term 
studies will help to determine the ability of peripheral patch grafts to maintain foveal 
function, the incidence of delayed patch ischaemia, the rate of continued RPE and 
photoreceptor loss over the patch, and the impact of disease recurrence and the 
effect of anti-VEGF agents on graft perfusion. 
 
 
For exudative AMD the surgical approaches outlined in this thesis, although capable 
of restoring the RPE, supporting photoreceptors, and reversing visual loss have 
shown limited and compromised restoration of overall visual function. This is 
particularly the case when compared to the current generation of anti-VEGF based 
therapies. In this regard these surgical approaches, especially RPE transplantation 
may be better deployed against other disease entities such as non-exudative AMD 
and macular dystrophies that are associated with the loss of the RPE and 
choriocapilliaris.  In this thesis we presented a case of autologous transplantation for 
a patient with a progressive inherited macular dystrophy. The surgery restored the 
RPE support to the photoreceptors with a partial recovery of reading ability and 
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stabilization of the retinal degeneration. There are a number of potential difficulties 
with this approach such as the timing of the intervention when the visual deterioration 
is gradual. Unlike exudative AMD there may be no acute visual loss and so there 
arises a difficult decision between intervening when vision may well be useful with 
sufficient photoreceptors to salvage, and when vision declines with too few 
photoreceptors. Another difficulty is that if RPE degeneration is secondary to primary 
photoreceptor dysfunction, then RPE transplantation is ineffective.  Furthermore, with 
a retinal dystrophy, all RPE cells may be affected and so autologous grafting will 
again be of little benefit. In this regard, the future of RPE transplantation may be a 
return to homologous techniques whereby RPE defects can be overcome by the use 
of an unlimited supply of artificial RPE lines, deliverable in a reproducible manner, on 
a stable platform, and without limitation on the size of the defect to be treated. This 
would also have the added advantage of reducing the surgical time and possibly the 
PVR rate if the graft does not need to be harvested. As such alternative RPE lines 
are an area of intense investigation with a number of candidate cell sources. These 
include immortalized RPE cell lines, retinal progenitor, embryonic stem cells, 
umbilical cord cells, and bone-marrow derived stem cells (Coffey et al., 2002, 
Klassen, 2006, Lund et al., 2006, Harris et al., 2006). 
 
 
Another advantage of homologous transplantation is the ability to modify the RPE 
either pharmacologically or genetically prior to delivery. The latter was successfully 
demonstrated in the transplantation series with ex-vivo modification of a graft through 
transduction of the RPE with a viral vector. This form of graft manipulation provides a 
method of gene replacement where the delivery is more directed, where the degree 
of vector spread is limited compared to the current method of sub-retinal injection of 
vectors, and where there is an opportunity for gene therapy to be combined with 
other modalities of retinal treatment. Potential directions for this type of therapy 
include delivering genes for specific inherited retinal diseases as well as treating 
acquired disorders with genes encoding neurotrophic and angiostatic factors. As 
previously discussed in this thesis, one of the major obstacles to homologous 
transplantation however is the rejection process, and overcoming this is a challenge 
for future research. 
 
 
The treatment of macular disease has rapidly progressed in recent years with 
surgical interventions providing a number of therapeutic modalities. Surgery has 
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advanced from the removal of subretinal pathology, to the reconstruction of anatomy 
, to being a delivery vehicle for novel adjuvant therapies. Animal and human studies 
of translocation and transplantation have demonstrated recovery of function in 
complex disorders such as AMD as well as retinal dystrophies. Both treatments 
represent RPE replacement, each with their own set of limitations. Of the two 
approaches RPE transplantation provides the most flexibility with homologous cell 
based methods in combination with pharamcological and genetic treatments offering 
the prospect of long-term stable central vision in a range of macular disorders. 
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Appendicies 
 
 
 
Appendix 1 _ Visual Acuity and Contrast Sensitivity 
 
 
 
I Retro-illuminated Lighthouse / ETDRS Chart at 4 metres 
(+ Distance Correction If Worn) 
 
At a visual acuity of 6/60 test the patient from 4 metres. If the visual acuity is worse than 6/60 
test the patient from 2 metres. 
 
Patient begins at top of the chart and reads down. 
 
If patient can read 3 letters or more from a line they can try the next line (use criterion free 
method). If patient fails to read all letters correctly on top line, then restart testing at half 
distance (minimum 1 metre). 
 
Calculate the total number of letters read correctly (if patient reads O instead of C or vice 
versa count as correct).  
 
 
 
II MN Read™ Charts at 25cm 
 (+ Near Correction If Worn) 
 
The patient reads sentences from the Minesota Low-vision Reading (MNREAD™) cards at a 
distance of 25cm in daytime northern hemisphere lighting conditions as quickly and 
accurately as possible.  A blank piece of card is used to cover the sentences below the one 
being read.  A note is made of words missed/read incorrectly and time taken to read each 
sentence. 
 
Reading Acuity 
The reading acuity is the smallest print size at which patient can read the entire sentence 
without making significant errors. 
 
After the patient has read as much of the chart as possible use following formula: 
  
Reading Acuity = 1.6 – (number sentences x 0.1) + (number of word errors x 0.01) 
 
e.g.             =   1.6 – (14 x 0.1) + (4 x 0.01) 
 
            =  0.24 logMAR.  
 
Reading Speed 
The reading speed is the time in seconds taken to read each sentence and recorded as 
words read per minute (wpm). The reading speed for each print size is calculated using the 
following formula: 
 
Reading Speed = 600 / time to read sentence (seconds) 
 
e.g.              = 600 / 5.0 
 
              = 120 wpm 
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Critical Print Size 
The critical print size is the print size at which patients can read with their maximum reading 
speed. The maximum reading is identified from a plot of reading speeds at each print size.  A 
patients reading speed should remain approximately constant; the print size at which the 
reading speed deteriorates is taken as the critical print size. 
 
 
 
III Pelli-Robson Contrast Sensitivity at 1 metre 
(+ Distance Correction If Worn) 
 
Contrast sensitivity is measured using the Pelli-Robson contrast sensitivity chart at 1m in 
daytime northern hemisphere lighting conditions. The chart consists of triplet opto types 20/60 
in size, whose size remains constant throughout but whose contrast decreases both down 
and across the chart. Pelli-Robson scores reflect the logarithm of the contrast sensitivity of 
each triplet group.   
 
The patient begins at top of the Pelli-Robson chart. 
 
Patients are asked to guess and to keep looking at letters as they sometimes start to appear.  
 
If a patient reads ‘O’ instead of ‘C’ or vice versa count as correct. 
 
If 2 letters of a triplet are read go to next triplet. 
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Appendix 2 _ Microperimetry 
 
 
 
Scanning Laser Ophthalmoscopy Microperimetry 
 
SLO: Heidelberg Retina Angiograph 2 [HRA2]™, Dossenheim, 
Germany  
 
Circular Grid:  4 x 4 - 24 Pixel Size 
 
Refraction:  Change to Distance Sphere 
 
 
 
Instructions 
 
The operator centres the optic nerve on screen and places a landmark over a recognisable 
area e.g. next to the optic nerve. 
 
The grid is placed over the macula to include the fixation area. 
 
The patient is asked to fixate on a stationary cross throughout the programme and will see 
flashes as the programme proceeds. The patient is reminded to continue to fixate on the 
cross and press a button each time they see a flash: 
 
‘When you see a flash I would like you to press this button - Remember all the time to fixate 
on the cross’ 
 
After the programme has run any scotoma detected are mapped out by placing extra targets 
around the area of reduced sensitivity to delineate the edge of the scotoma. 
 
 
 
SLO Microperimetry Measurements 
 
Fixation Stability 
 
Distance and Angle of Fixation from Fovea 
 
Presence and Area of Scotoma 
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Appendix 3 – Slit Lamp Assessment of Quality of Fixation 
 
 
 
Step 1 
 
A 0.2 millimetre slit lamp spot is projected onto the posterior pole of the patient and the 
patient asked to fix on the target. The response is positive if the patient fixes with the fovea 
and can maintain fixation for 1 – 3 seconds. 
 
 
 
Step 2 
 
The slit lamp stimulus is changed to a 2 mm square and the patient is asked to look at each 
corner of the square systematically. The response is positive if the patient fixes with a single 
saccade to each corner of the square and can maintain fixation at each position for 1 – 3 
seconds. 
 
 
 
Step 3 
 
The slit lamp beam is lengthened and narrowed to form a 4 mm X 1mm vertically orientated 
line. The patient is look asked to look at the top of the line and then the bottom of the line. The 
response is positive if the patient fixes to the top and bottom of the target with a single 
saccade and can maintain fixation at each point for 1 – 3 seconds. 
 
 
 
Step 4 
 
Step 3 is repeated with the line orientated horizontally. 
 
 
 
Step 5 
 
The final task is to place a 0.2 millimetre spot of light at an extrafoveal location and the patient 
is asked to re-fixate the target. The response is positive if the patient can re-fixate the target 
with a single saccade and can maintain fixation for 1 – 3 seconds. 
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Instructions to 
Patient 
 
 
Target 
 
Task 
 
Slit Lamp View 
 
Look at the spot of 
light 
 
0.2mm Spot 
 
Fixes with 
Fovea 
 
+ Maintains 
Fixation 1 – 3 s 
 
 
 
 
 
Look at the top right 
corner of the square 
 
Repeat instruction for: 
Bottom Right Corner 
Bottom Left Corner 
Top Left Corner 
 
2x2mm 
Square 
 
Projects to 
Each Corner of 
Square with a 
Single Saccade 
 
+ Maintains 
Fixation 1 – 3 s 
 
 
 
Look at the top of the 
bar 
 
Now look at the 
bottom of the bar 
 
Repeat once 
 
4x1mm 
Vertical Slit 
 
Fixes to Top 
and Bottom of 
Slit with a 
Single Saccade 
 
+ Maintains 
Fixation 1 – 3 s 
 
 
Look to the left side of 
the bar 
 
Now look at the right 
side of the bar 
 
Repeat once 
 
4x1mm 
Horizontal Slit 
 
Fixes to Left / 
Right of Slit 
with a 
Single Saccade 
 
+ Maintains 
Fixation 1 – 3 s 
 
 
 
Look at the spot of 
light 
 
0.2mm Spot 
Placed 
Outside 
Lesion 
 
Re-fixate to 
Fovea with a 
Single Saccade 
 
+ Maintains 
Fixation 1 – 3 s 
 
 
 
 
Failed Task: 
Defined as failure to follow instructions or maintain fixation for 1 – 3 s as outlined. 
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Appendix 4 _ EyeTraker™ 
 
 
 
Data from fixation stability and PRL is used to calibrate eye position for measurements with 
the EyeLink™ eye tracker (EyeLink™ Gaze Tracking, SMI SensoMotoric Instruments, Berlin, 
Germany). This system is used to record eye position and direction during reading while 
allowing binocular viewing and natural movements of the head.  Saccadic eye movements 
and fixation duration during reading will also be measured and quantified with the EyeLink™. 
 
 
 
EyeTracker™ (Fixation Stability / Fixation Accuracy Task) 
 
Habitual distance correction 
 
• Leave unaided unless refractive error > +/- 2.00DS or 0.75DC 
• If habitual correction is bifocal or varifocal then distance correction in trial frame 
 
BUT  
 
• Leave unaided unless refractive error > +/- 2.00DS or 0.75DC 
 
 
 
EyeTracker™ (Reading Task) 
 
+2.00DS addition over distance correction in trial frame ignoring small cyls (<0.75DS) 
 
 
Seat patient 50cm from EyeTracker™.  Set resolution to 800x600 pixels. 
 
Calibrate with 3 dots.  Validate (accept green or amber). 
• Fixation stability programme x 2 (A&D) 
 
Instructions: 
You will see a dot on the screen.  I want you to fixate this dot, that is, focus on the centre of 
the dot as best you can and follow it when it moves.   
• H Sacc (B) 
 
Again you will see a dot on the screen.  This time the dot will move on the screen from the 
centre to the left or right and then back again.  I want you to fixate the dot as closely as you 
can. 
• Vertical Sacc ( C) 
 
This time the dot will move from the centre and up or down and back again. 
• Sentences (E) – use critical acuity level from MN Read cards or ReadNavigator 
 
Read out loud as quickly and accurately as possibly, try not to correct yourself.  Make a note 
of the number of errors made. 
• EU texts (F) – use critical acuity level taken from MN Read cards or ReadNavigator 
 
Read out loud as quickly and accurately as you can, if you make an error try not to go back 
and correct yourself.  Make a note of the number of errors made. 
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EyeTracker™ Measurements 
 
Fixation Stability 
1. Number and sum of PRLs 
 
Eye Movement – Horizontal and vertical saccades 
1. Number of saccades taken to find target 
2. Latency up to first eye movement  
3. Peak velocity value of fastest saccade 
 
Sentences 
1. Number of forward saccades 
2. Percentage of total saccades which are regressive 
3. Average of number of saccades to find beginning of each line of 
Sentence 
4.  Number of words read per minute 
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Appendix 5_Macular Translocation: Pre-Operative Images 
 
 
 
Pre-Operative Data: Macular Translocation Patient_1 
 
 
 
Colours / Red Free 
 
OD  
 
OS 
 
 
 
 
FFA 
 
Red Free 
 
Early 
 
Mid 
 
Late 
 
 
ICG 
 
Early FFA 
 
Early 
 
Mid 
 
Late 
 
 
OCT 
 
OS 
 
OS 
 
286
 
 
Pre-Operative Data: Macular Translocation Patient_2 
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Pre-Operative Data: Macular Translocation Patient_3 
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Pre-Operative Data: Macular Translocation Patient_4 
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Pre-Operative Data: Macular Translocation Patient_5 
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Pre-Operative Data: Macular Translocation Patient_6 
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Pre-Operative Data: Macular Translocation Patient_7 
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Pre-Operative Data: Macular Translocation Patient_8 
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Pre-Operative Data: Macular Translocation Patient_9 
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Pre-Operative Data: Macular Translocation Patient_10 
 
 
 
Colours / Red Free 
 
OD  
 
OS 
 
 
 
FFA 
 
Red Free 
 
Early 
 
Mid 
 
Late 
 
 
ICG 
 
Early FFA 
 
Early 
 
Mid 
 
Late 
 
 
OCT 
 
OD 
 
 
 
SLO 
 
OD 
 
295
 
 
Appendix 6_Macular Translocation: Post-operative Images 
 
 
 
Post-operative Data: Macular Translocation Patient_1 
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Post-operative Data: Macular Translocation Patient_2 
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Post-operative Data: Macular Translocation Patient_3 
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Post-operative Data: Macular Translocation Patient_4 
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Post-operative Data: Macular Translocation Patient_5 
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Post-operative Data: Macular Translocation Patient_6 
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Post-operative Data: Macular Translocation Patient_7 
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Post-operative Data: Macular Translocation Patient_8 
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Appendix 7_RPE Transplantation: Pre-Operative Images 
 
Pre-Operative Data: RPE Translocation Patient_1 
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Pre-Operative Data: RPE Transplantation Patient_2 
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Pre-Operative Data: RPE Transplantation Patient_3 
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Pre-Operative Data: RPE Transplantation Patient_4 
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Pre-Operative Data: RPE Transplantation Patient_5 
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Pre-Operative Data: RPE Transplantation Patient_6 
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Pre-Operative Data: RPE Transplantation Patient_7 
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Pre-Operative Data: RPE Transplantation Patient_8 
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Pre-Operative Data: RPE Transplantation Patient_9 
 
 
Colours / Red Free 
 
OD 
  
OS 
 
 
 
FFA 
 
Red Free 
 
Early 
 
Mid 
 
Late 
 
 
ICG 
 
Early FFA 
 
Early 
 
Mid 
 
Late 
 
 
OCT 
 
OD 
 
OD 
 
 
SLO 
 
OD 
 
312
 
 
Pre-Operative Data: RPE Transplantation Patient_10 
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Pre-Operative Data: RPE Transplantation Patient_11 
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Pre-Operative Data: RPE Transplantation Patient_12 
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Appendix 8_RPE Transplantation: Post-operative Images 
 
Post-operative Data: RPE Transplantation Patient_1 
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Post-operative Data: RPE Transplantation Patient 2 
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Post-operative Data: RPE Transplantation Patient_3 
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Post-operative Data: RPE Transplantation Patient_4 
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Post-operative Data: RPE Transplantation Patient_5 
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Post-operative Data: RPE Transplantation Patient_6 
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Post-operative Data: RPE Transplantation Patient_7 
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Post-operative Data: RPE Transplantation Patient_8 
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Post-operative Data: RPE Transplantation Patient_9 
 
 
Colours / Red Free 
 
OD 
  
OS  
 
 
FFA 
 
Red Free 
 
Early 
 
Mid  Late 
 
 
ICG 
 
Early FFA 
 
Early  Mid 
 
Late 
 
 
OCT 
 
 
 
SLO 
 
OD 
 
 
 
OD 
 
324
 
 
 
 
